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ABSTRACT
Minimally and non-invasive glucose sensing techniques are instrumental in 
improving the quality o f life o f  diabetics, point-of-care testing, critical care monitoring, 
development o f new anti-diabetic drugs or therapeutic compounds, and the study o f basic 
physiology. The overall goal o f  this project was to build a fluorescent glucose sensor by 
incorporating relevant sensing chemistry within microcapsules. The specific aims for this 
research were to study various processes used for the fabrication o f micro-containers, the 
use o f these for encapsulation purposes, and the application o f the encapsulated system 
towards glucose sensing. The following is a brief description highlighting the key areas 
o f the research.
Different materials such as polystyrene sulfonate (PSS), polyallylamine 
hydrochloride (PAH), polydiallyldimethyl ammonium chloride (PDDA), chitosan (CHT), 
and polyvinyl sufate (PVS) were used to construct the capsule walls. Fluorescence 
recovery after photobleaching (FRAP) was used to study the effect of capsule wall 
architecture on the permeability o f  capsules to FITC labeled GOx (FITC-GOx). Long­
term stability and activity studies proved that (PVS/CHT}2 -{PSS/PAH } 2  capsules were 
the most stable and showed minimal leaching (79% of enzyme retained) and the activity 
o f the encapsulated enzyme did not change significantly over four weeks. Hence, they 
were selected for demonstration o f glucose sensing. Fluorescence sensors for glucose 
using pH-sensitive Pyrene 8 -hydroxy-1,4,6,-trisulfonylchloride (HPTS), which facilitates
iii
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ratiometric monitoring o f pH changes, was used to label GOx (HPTS-GOx), and 
encapsulated in these capsules. Changes in glucose concentration were monitored as a 
function o f  the pH changes during glucose consumption by GOx, and the sensors showed 
a linear response to sequential additions of glucose in the physiological region of interest 
(0mM-30mM).
In summary, the ideas, techniques and discussion o f the results presented in this 
dissertation are a significant contribution to the science of enzyme encapsulation. The 
preliminary data demonstrating glucose sensing using a labeled pH-sensitive dye is an 
important contribution to this application. Some o f the novel techniques presented here 
serve as a foundation for future application o f these to other areas. The experimental 
techniques and methods o f characterization described in this dissertation can serve as a 
comprehensive guide to researchers involved in similar study.
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CHAPTER 1
INTRODUCTION
Figure 1. Cover page: Fantastic Voyage, by Isaac Asimov
What was only a figment of the imagination of American author and biochemist 
Issac Asimov has become today’s quest for understanding our macroscale world with 
microscale innovations. Though living beings have yet not been shrunk and injected into 
the body as was envisaged by Asimov, there have been Promethean strides made in the 
field of micro- and nano-technology. Scientists and researchers are developing artificial 
cells that can replace damaged cells in the body, and miniaturized sensors have been 
injected into cells to monitor cellular events. Nanorobots—which were earlier dismissed
1
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2as mythical monsters are now being considered for diverse applications from 
mouthwashes to skin disease cures to medical nanodevices that can augment the human 
immune system and nibble away atherosclerotic plaques. The concept o f tattooing, 
viewed as a form o f body art, fashion, and rebellion is now also being used by researchers 
for embedding smart sensors for monitoring vital analytes in the body.
Dr. Gregory Fahy o f the American Red Cross aptly said in the paper 
“Nanotechnology in Medicine” presented at the U.S. Pharmacopeial Convention in fall 
1992. “Living organisms are naturally-existing, fabulously complex systems o f  molecular 
nanotechnology. ” With that in mind, it seems that the development o f  micro- and 
nanoscale sensors and actuators might prove to be instrumental in curing the human body 
o f its various ills. Among the various devices that are in great demand both in terms of 
improvement o f the quality of life o f patients, as well as in terms o f scientific challenge, 
is an ongoing quest for the “ideal” glucose sensor. Sensing glucose is imperative in a 
wide spectrum o f applications ranging from food industry to personal management o f 
diabetes. Many systems have been developed for ex vivo analysis o f glucose; however, 
there is still a need for development o f a reliable, implantable or minimally implantable 
glucose sensor for in vivo monitoring o f physiological levels o f glucose. Such a sensor 
needs to satisfy a number o f stringent criteria, such as selectivity, linear range, and 
response time, biocompatibility, storage and operational stability at body temperature, 
reversibility o f signal, and reproducibility o f sensor fabrication, which current endeavors 
have not been able to completely satisfy1.
Advances in the micro- and nano-fabrication industries together with rapid 
progress in the photonics industry have created a tremendous potential for development
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3of portable, minimally invasive sensors for monitoring a wide spectrum of micronutrients 
and analytes in the body2, especially the market driven demand in the glucose sensing 
industry for in vivo glucose monitoring o f diabetic patients. Self-monitoring o f blood 
glucose (SMBG) is the bedrock o f successful diabetes management. It has the potential to 
improve the quality o f life o f millions o f diabetics all over the world essentially by 
ameliorating the pain associated with the traditional finger prick method, and by 
developing a continuous and reliable in-vivo glucose monitoring system that would help 
the patient to optimize insulin therapy and metabolic control3. This method would also 
prevent the dangers associated with acute metabolic deterioration, such as hypo and 
hyperglycemia.
There have been several minimally invasive and non-invasive techniques 
developed for continuous monitoring o f blood glucose. Implantable subcutaneous glucose 
sensors and subcutaneous interstitial fluid sampling by microdialysis are examples o f 
techniques based on analysis o f  interstitial fluid. Electrodes developed for this purpose 
and which are inserted into the subcutaneous tissue cannot be used for long periods of 
time in humans due to fouling o f the electrode, which results in drift o f signal, and hence 
a loss o f glucose sensitivity. The microdialysis methods have a significant time lag 
associated with the process o f measurement, which can vary between 5 and 45 minutes4. 
Transdermal glucose monitoring systems and optical glucose sensors have also been 
developed. Most non-invasive approaches use optical techniques the basic principle 
being measurement o f the properties o f light reflected from the skin, either as a result of 
direct interaction with glucose using spectroscopic techniques, or due to indirect effects 
by changes in the physical properties o f  the skin (scattering). The non-invasive
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4techniques suffer from insufficient precision4. Implantable glucose sensors have the 
obvious major applications in diabetic self-monitoring, but other applications include 
critical care monitoring and the study o f basic physiology. As an example o f the latter, 
real-time monitoring o f neurochemical dynamics, including glucose and lactate, is 
important to understanding neural processing, cell biology, and drug activity. To date, 
some minimally invasive methods have been developed for sensing blood glucose 
concentrations, but all o f  the accurate devices on the market still require extraction o f 
blood samples. Fully-implanatable systems with wireless communication are an ideal 
solution; however, while many such devices are under development, the stability o f 
enzyme-electrochemical systems remains a difficult obstacle to overcome. Sensors based 
on optical measurements are an attractive alternative, as they may be analyzed 
spectroscopically.
Among the various non-invasive glucose biosensors reported in literature, several 
optical techniques have been cited, such as, near-infrared spectroscopy5, polarimetry6, 
Raman spectroscopy5, and fluorescence spectroscopy7. Optical sensors are generally 
advantageous in terms o f  minimal analyte consumption and can potentially be used to 
monitor real-time events. Fluorescence sensors provide a non-invasive method o f 
detection o f analytes, which is fast, reagentless, and versatile1. However, if  the 
fluorescent dyes are directly introduced into the body, their location cannot be controlled. 
Moreover, there can be problems o f cytotoxicity and compartmentalization o f the 
indicators in organelles. Hence, encapsulation o f the sensor chemistry is vital in order to 
overcome all these drawbacks. A number o f fiber-optic sensors for sensing various
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5analytes (oxygen8, carbon dioxide9, glucose10 and NADH11) have been developed; 
however, the measurement technique is invasive.
The study o f enzyme encapsulation has been o f significant interest both from the 
standpoint o f academic research as well as in several industrial applications12. The 
primary objective behind encapsulation o f enzymes is to use a semi-permeable support 
matrix to entrap the enzyme, prevent its leaching out o f the matrix, while allowing 
exchange o f analytes, products, and co-factors between the encapsulated enzyme and the 
surroundings13. Various methods o f encapsulation in micro and nanoparticles have been 
developed for applications in pharmaceutics, cosmetics, agriculture and biosensors, 
among others14,15,16, liposomes17, microspheres prepared by microemulsion 
techniques18’19, and silica matrices20 are among the various carrier systems used for 
various chemicals, drugs and biomacromolecules. Medical applications o f such micro- 
and nanocontainters include using them as protective shells for cell and tissue 
encapsulation or as carriers for drug-delivery. Some of these techniques suffer from the 
lack o f homogeneity o f particles, and lack o f repeatability in terms o f the quantity 
encapsulated within and between batches. In the field o f fluorescence biosensing, analyte 
specificity is achieved by co-encapsulation o f indicator and reference dyes and various 
receptor systems, such as synthetic receptors (i.e. boronic acid derivatives21’22’23), 
naturally occurring (i.e. enzyme glucose oxidase (GOx)24’25’26, lectin27’28’29 Concanavalin 
A, sugar binding proteins) and genetically engineered binding proteins30,31 (i.e. glucose 
binding protein, GBP).
Recently, encapsulating polymeric microcapsules with specialized multilayer 
compositions and controllable wall properties has been proposed32,33,34. Layer-by-Layer
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6(LbL) self assembly has proved to be a versatile method by which both planar thin film 
architectures and hollow core shells can be produced35,36,37. This method is advantageous 
due to the ease and repeatability o f the fabrication process, and because it does not 
require sophisticated and expensive equipment. Various templates have been used to 
fabricate microcapsules with different sizes and wall architectures. Among the various 
templates that have been used for fabrication o f microcontainers are silica, polymeric 
particles like polystyrene and melamine formaldehyde (MF)38,39,40, metal particles41, 
biological cells42,43, and inorganic crystals44. Using micro/nanocapsules made by LbL 
methods, several methods o f encapsulation have been developed. These methods include 
encapsulation o f both biomolecular and non-biomolecular materials.
To date, there have been no reports o f the use o f pH sensitive ratiometric dyes 
encapsulated using micro/nanoscale carriers, for the measurement o f glucose. Pyrene 8 - 
hydroxy-1,4,6-trisulfonylchloride (HPTS), is a pH indicator dye that has been used by 
several groups to demonstrate pH sensitivity in thin films45,46,47. It has numerous 
advantages such as large Stokes shifts, high quantum yield, high absorbance, excellent 
photostability, and lack o f  toxicity45.
The fundamental aim o f this dissertation was to develop a glucose sensor based 
on sensing pH changes associated with oxidation o f glucose by glucose oxidase to 
indicate changes in glucose concentration. With this goal aim in mind, two specific aims 
were identified. A im l, various enzyme encapsulation techniques were studied and 
compared with the purpose o f identifying the best method (percentage encapsulation 
efficiency, activity, and stability) for the encapsulation o f GOx. In the process o f 
developing methods o f encapsulation for GOx a novel method o f encapsulation o f HRP
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7was discovered. This method involved fabrication of a charged matrix o f acrylic acid 
inside the hollow capsule volume. The method is rather simple and can be extended to 
encapsulation o f macromolecules with slightly basic isoelectric points (pi). A short study 
o f the effect o f encapsulation parameters on the encapsulation efficiency and stability o f 
the encapsulated enzyme was performed48. Aim2, based on comparison of the relative 
merits o f the various methods o f encapsulation in specific aim 1 , a method was selected 
and used to encapsulate HPTS-GOx. The effect o f labeling on the pH sensitivity o f the 
dye was studied and compared with the response o f the free dye. The glucose sensitivity 
o f the dye was studied in solution and after encapsulation, both in DI water and in PBS 
buffer.
A novel method o f sensing glucose has been demonstrated. The marriage of 
fluorescence spectroscopy and nanotechnology has produced glucose sensors which can 
potentially be used to monitor glucose changes in the body as a function o f changes in 
pH. To date, there has been no reported research on glucose sensors based on translation 
of pH changes into changes in glucose concentration. Sensors were fabricated by 
encapsulating glucose oxidase (GOx), labeled with a pH sensitive fluorophore pyrene 8 - 
hydroxy-1,4,6-trisulfonylchloride (HPTS) in microcapsules. The microcapsules were 
fabricated using LbL assembly o f generic polyelectrolytes and chitosan on an MF 
template. The glucose sensitivity o f the encapsulated chemistry was demonstrated. The 
conceptual schema o f sensor fabrication and desired optical response is shown in Figure 
2. From the figure it can be seen that increasing glucose concentrations causes an 
increase in excitation ratio of HPTS, which is labeled to glucose oxidase. The principal 
advantage o f this method has been the simplicity o f  the encapsulation procedure, as well
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8as the lack o f a need for an additional reference indicator due to the inherent ratiometric 
nature o f  HPTS.
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Figure 2. Schema o f sensor fabrication and optical response
The following chapters o f this dissertation describe the background, experimental 
theory and methods, materials and techniques, results and conclusions o f the work done 
to fulfill the aforementioned specific aims. Chapter II is an overview of the literature and 
background pertaining to glucose regulation in the body, previous and current research in 
non-invasive and minimally Invasive, transdermai, fluorescence glucose sensing 
techniques; skin optics and the concept o f smart tattoos have also been reviewed. 
Chapter III gives details o f the chemical techniques (cross-linking, labeling reactions),
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9the optical imaging and spectroscopic techniques used for measurements and the surface 
characterization techniques used to achieve the aims o f the project. The materials and 
methods used to perform the experiments have been described in Chapter IV. Chapter V 
describes the experimental results with a detailed discussion o f the outcomes and the 
rationale behind them. Finally, the conclusions derived from the work have been 
described in Chapter VI.
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CHAPTER II
LITERATURE REVIEW
This chapter describes a wide range o f topics related to glucose regulation in the 
body, diabetes mellitus and its treatment options and the need for continuous glucose 
monitoring. Current research in implantable, non-invasive and minimally invasive, 
transdermal, fluorescence glucose sensing techniques, skin optics and the concept of 
smart tattoos have been reviewed. Further, it deals with layer-by-layer (LbL) assembly 
and various encapsulation techniques using this technique.
2.1 Physiology of Glucose Metabolism
2.1.1 Anatomy of the Pancreas
The pancreas (Figure 3), a large compound gland with an internal structure 
similar to that o f the salivary glands, lies parallel to and beneath the stomach. It is mainly 
composed of two main types o f  tissues: the acini, which secrete digestive juices into the 
duodenum; and the islets o f  Langerhans, which secrete insulin and glucagon directly into 
the blood. The human pancreas has one to two million islets o f Langerhans organized 
around small capillaries into which its cells secrete their hormones. The islets contain 
three major types o f cells: alpha cells, which secrete glucagons; the beta cells, which 
secrete insulin; and the gamma cells, which secrete somatostatin. The close interrelations
10
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among these cells types in the islets o f Langerhans allow direct control secretion o f some 
of the hormones by the other hormones; i.e., insulin inhibits glucagon secretion, and 
somatostatin inhibits the secretion o f both insulin and glucagon49.
Stomach
stom ach
Large Intestine pmSmall Intestine
duodenum
Capillaries
Figure 3. The pancreas— an important organ for insulin regulation o f the body. 
(Source: www.nlm.nih.gov/.../ ency/imagepages/8883.htm, www.nurseminerva.co.uk/ 
p ancreat.htm,cal.man.ac.uk/.../ 2000/mnby71c2/pancreas.htm)
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2.1.2 Effect of Various Enzymes on 
Glucose. Fat and Protein 
Metabolism
Though insulin secretion has been associated with energy abundance, i.e. with 
consumption o f foods rich in carbohydrates and proteins, it has also been found to affect 
fat and protein metabolism almost as much as carbohydrate metabolism. The secretion o f 
insulin in great quantities is especially true for excess carbohydrate consumption and is 
less for proteins and only slightly for fats.
Excess carbohydrates are stored as glycogen, mainly in the liver and muscles. Fat 
storage takes place in the adipose tissue; insulin causes all excess carbohydrates that 
cannot be stored as glycogen in the liver and muscles to be converted into fat. In the case 
o f proteins, insulin promotes amino acid uptake by cells and their conversion into protein. 
Insulin also inhibits the breakdown o f the proteins that are already in the cells.
Mainly, four hormones play an important role in switching between carbohydrate 
and lipid metabolism. The growth hormone from the anterior pituitary gland, cortisol 
from the adrenal cortex, epinephrine from the adrenal medulla, and glucagon from the 
alpha cells o f the islets o f Langerhans. Growth hormone and cortisol are secreted in 
response to hypoglycemia and inhibit cellular utilization o f glucose while promoting fat 
utilization. Epinephrine has both lipolytic effects increasing the fatty acids in the blood 
and glucogenolytic effects increasing glucose concentration o f blood, but mostly the 
former. The effect o f epinephrine is particularly important during periods o f stress, such 
as exercise, anxiety, and circulatory shock.
Glucagon encourages gluoneogenesis during periods o f  hypoglycemia by 
activating several enzymes that promote amino acid uptake by the liver and their
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
13
conversion into glucose. It also promotes glycogenolysis, which entails the breakdown of 
glycogen in the liver into glucose and its release as glucose into the blood.
2.2 Diabetes Mellitus 
Type I and Type II diabetes account for 99.9% o f all prevalence o f diabetes and 
affect about 135 million people worldwide. Type I diabetes results from a chronic 
autoimmune destruction o f the pancreatic /3-cells and usually starts from childhood or 
early adulthood (<35yrs). Type II diabetes results when organs become insensitive to the 
action o f insulin and/or the production o f insulin by the beta cells is insufficient 
(dysfunction o f /3 cells). Heredity plays a vital role in diabetes, both Type I and Type II49.
2.2.1 Pathophysiology of Diabetes Mellitus
Diabetes Mellitus is characterized by the following consequences o f lack of 
insulin: increase in blood glucose concentration up to 300-1200mg/dl (16mM-66mM) 
and increased fat immobilization from fat deposit areas, causing abnormal fat metabolism 
and deposition o f  cholesterol in arterial walls leading to atherosclerosis and protein 
depletion in the tissues o f the body49.
When blood glucose concentration rises above 180mg/ml (blood threshold), a 
significant portion o f this glucose entering the kidney tubules in the glomerular filtrate 
cannot be reabsorbed and hence spills into the urine. This leads to osmotic diuresis, or the 
increased loss o f  water in urine due to osmotic effect o f glucose decreasing tubular 
reabsorption o f fluid. It also leads dehydration o f cells. Extracellular and intracellular 
dehydration can lead to circulatory shock. Increased fat metabolism can also lead to 
acidosis and hence coma and eventually death. Polyuria (excessive elimination o f urine),
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polydipsia (excessive drinking o f water), polyphagia (lack o f energy), weight loss and 
asthenia (lack o f energy) are the earliest signs o f diabetes.
At elevated levels o f glucose (>5mM), glycosylation of proteins (hemoglobin, 
collagen etc.) takes place due to reaction o f glucose (without enzyme catalysis) with 
proteins. This can result in tissue damage and failure o f vital organs such as the kidneys, 
which is a long-term complication o f diabetes50.
2.2.2 Treatment of Diabetes Mellitus
For type II diabetes, a diet, oral hypoglycemic agents and/or the administration o f 
insulin is required and sufficient to regulate the blood glucose concentration. In addition 
to increasing glucose levels in the blood, there are also other concerns in type II diabetes. 
The emphasis in the treatment o f type II diabetes is on the reduction of chronic 
hyperglycemia and the long-term degenerative conditions that are associated with i t 49.
Type I diabetes is associated with absolute insulin deficiency. Hence, treatment 
specifically involves insulin injections in the subcutaneous tissues o f arms, legs or 
abdomen (IDDM). An intensive regimen o f short-acting insulin before meals, followed 
by an additional injection o f intermediate-acting insulin before bedtime are required to 
mimic the normal insulin profile in blood and assists in improvement o f the metabolic 
profile o f the patient. The patient needs to check his/her blood glucose regularly, 
currently by using a finger-prick method, and adjust the insulin dosage accordingly. 
Continuous monitoring can help achieve even better glucose regulation. Insulin delivery 
using implantable pumps to the peritoneal cavity can further improve metabolic control 
for type I patients who are difficult to regulate.
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A combination o f insulin injections and frequent self-monitoring of blood glucose 
(SMBG) have improved metabolic control in type I patients; normoglycemia is difficult 
to achieve because subcutaneous insulin injections cannot mimic non-diabetic insulin 
secretion patterns. For example, high concentrations o f peripheral insulin are needed to 
achieve sufficient insulin concentrations in the portal vein to slow down the production of 
glucose by the liver. Also, short-acting insulin is resorbed much more slowly than insulin 
secreted by the beta cells, and there is no feedback control for adjusting the insulin 
delivery rates according to the prevailing glucose level.
Yet another approach to improve metabolic control o f type I diabetic patients is 
transplantation of pancreas or isolated islets o f Langerhans51,52’53 The first transplantation 
o f pancreas was done in 1967. By the 1970s, due to significant improvement o f the 
surgical technique and better control o f  immunosuppression and infection post 
transplantation, the success rate o f transplantations greatly improved. Today, 
transplantations o f the pancreas are carried out in combination with kidney 
transplantation; this procedure has a success rate o f 75%. However, it still remains to be 
seen if  majority o f the type I diabetic patients will benefit from this procedure; patients 
have to be on immunosuppression for the rest o f their lives. There is also a paucity o f 
suitable donors. Hence, the American Diabetes Association (ADA) has proposed that 
transplantation o f pancreas be considered the appropriate therapy only for type I diabetic 
patients with end-stage renal disease who have to plan a kidney transplant or as an 
alternative therapy for patients who have a history o f frequent acute and severe metabolic 
complications.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
16
The success rate o f islet-transplantation is only 10% as opposed to 75% for the 
combined pancreas-kidney transplantation. This rate results from the rejection o f the 
transplanted islets due to the immuno response o f the acceptor site. Also, non-specific 
inflammatory responses occurring at the time o f implantation may alter islet function. 
The normal procedure for islet transplantation involves isolation o f islet tissue by 
collagenase digestion of the pancreatic donor tissue, then purification o f the tissue 
followed by injection o f a sufficient mass o f islet tissue into the hepatic parenchyma via 
injection through the portal vein. This procedure requires the use o f a large quantity o f 
immunosuppressant; an alternative is to use islets encapsulated in a porous material that 
is permeable for insulin and glucose but impermeable to leukocytes. Also, encapsulated 
animal islets can be considered as a solution to shortage o f donor islets from humans. 
However, though encapsulation makes the cells less vulnerable to immune response, it 
does alter the reaction dynamics o f the islets resulting in delayed insulin secretion. This 
alteration results from the elongation o f the diffusion pathway to the encapsulated cells 
since they are not directly provided by blood capillaries. A potential solution to this 
problem is the use o f a solid support for the encapsulated cells that can be placed in the 
peritoneal cavity. This placement will hasten the accommodation o f the implant with 
blood capillaries and thus reduce the diffusion pathway.
2.2.3 Need for Continuous Glucose-Monitoring 
Systems (Glucose Sensors) and Glucose 
Measurements in the Interstitial
Fluid (ISF)
The ultimate goal o f glucose regulation regimens should be preferably to achieve 
the same degree o f regulation o f blood glucose concentrations as non-diabetics. A new
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milestone in insulin therapy has been achieved by the development o f self-monitoring 
devices. A combination o f self-monitoring of glucose and an intensified insulin regimen 
has proved effective in managing the occurrence of hyperglycemic events. However, the 
same cannot be said about hypoglycemia. It has been found that the incidence o f 
occurrence o f hypoglycemia increases with tightly metabolic controlled patients. 
Hypoglycemic attacks are unpleasant and can lead to loss o f consciousness. Though 
hypoglycemia is not restricted to nocturnal attacks, they are especially dangerous because 
the patient is asleep and hence unaware o f the low blood glucose levels. A major focus 
o f  interest for diabetologists is the “hypoglycemia unawareness syndrome” which is 
characterized by the occurrence o f  sudden and unpredictable hypoglycemia without clear 
warning symptoms.
A major drawback o f self-monitoring is the simple fact that current methods are 
discontinuous. Most patients are deterred from making multiple measurements because o f 
the pain and boredom associated with the procedure and simple dislike because the 
patient is forced to confront the disease everytime he/she makes a measurement. Only 
highly motivated patients measure their blood glucose more than six times a day, and this 
is a miniscule fraction o f the total number o f diabetics. Hence, a continuous glucose 
monitoring system would prove to be a boon for diabetics in order to better control 
hypoglycemic events. A major factor in the regulation o f blood glucose is the delay time 
between the actual change in blood glucose concentration and the glucose measurement; 
this delay should be minimized. In a healthy person, a complex series o f events involving 
gut hormones and neural factors lead to anticipatory insulin secretion, prior to insulin 
secretion from a rising blood glucose level. Hence, a more realistic design for continuous
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monitoring would be a closed-loop glucose sensor for operation in the “non-meal” or 
basal periods, with additional insulin delivered at or just prior to the start o f a meal.
Though glucose monitoring had been confined mainly to measurement of blood 
glucose for historical reasons, there are obvious risks involved in inserting a glucose 
sensor in the intravasal compartment for prolonged time periods such as embolism, 
thrombosis, and septicemia. Hence, currently several methods involve placing the sensor 
in the extravascular spaces or the interstitial fluid (ISF). Minimally invasive sensors 
measure glucose levels in the ISF (Figure 4), and non-invasive ones measure a composite 
of glucose levels in the intracellular, interstitial, and intravascular compartments54.
arterial sensor
capillar
Fat/muscl 
ceii y
venous
Interstitial °
Figure 4. A glucose electrode inserted in the subcutaneous tissue to measure glucose 
in the interstitial fluid.34
Microcirculation, which is the body’s capillary system performs one o f the most 
important functions o f circulation—transport o f nutrients to the tissues and removal of 
cellular excreta. The diameters o f the arterioles are controlled by the local conditions in 
the tissues themselves. Capillaries are extremely thin structures with single layered walls 
o f highly permeable endothelial cells to permit free interchange o f nutrients and cellular 
excreta between the tissues and circulating blood49.
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About one sixth o f the body consists o f spaces between cells containing fluid 
called the interstitial fluid. It has solid structures composed of collagen fibers and 
proteoglycan filaments that give it its gel-like constitution. Figure 5(a) shows the 
lymphatic system, which represents an accessory route for fluid flow from the interstitial 
spaces into the blood, especially for large proteins and particulate matter from the tissue 
spaces that cannot be removed by absorption directly into the blood capillary. Though 
most o f the fluid filtering from the arterial capillaries flows among the cells and is finally 
reabsorbed back into the venous ends o f the blood capillaries, one tenth o f it enters the 
lymphatic capillaries instead and returns to the blood through the lymphatic system rather 
than the venous capillaries. Though this amount is a minute quantity, it is extremely 
important because this route is the only one allowing high molecular weight substances 
such as proteins to be reabsorbed into the blood. As shown in Figure 5(b), the walls of 
the lymphatic capillaries have a special structure. The endothelial cells are attached by 
anchoring filaments, and the edge o f one endothelial cell overlaps the edge of the 
adjacent cell in such a way that the overlapping end is free to flap inward, thus forming a 
valve. These valves can be pushed open by the interstitial fluid, and backflow is 
prevented because o f the closing of the valve.
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Figure 5. The interstitial fluid compartments o f the body, (a) lymphatic system (b) 
special structure o f the lymphatic system which allows for transport of large 
molecules
(Source: http://training.seer.cancer.gov/module_anatomy/unit8_2_lymph_compo.html 
and www.deeptissue.com/ leam/leam.html)
A prominent volume fraction o f the human skin is interstial fluid (45%), and 
blood vessels represent only 5%55. Hence, glucose changes in skin tissue for the most 
part represent changes in the extravascular spaces rather than blood glucose. However, in 
the adipose tissue, the proportion o f ISF is lower than in the skin and varies according to 
the size o f adipocytes. There is constant free and rapid exchange o f glucose molecules 
between blood plasma and interstitial fluid. Though there is much debate about the 
amenability o f measuring ISF glucose as a measure o f blood glucose, it has been reported 
that changes in blood glucose and interstitial glucose are strongly correlated55’50. 
However, there is a delay between changes in the ISF and the blood vessels, which can 
vary between few seconds to 15 minutes55,56. This delay reduces reliability o f ISF glucose 
measurements, and can lead to dangerous situations if  blood glucose levels decline to 
hypoglycemic values more rapidly than ISF. Also, diabetic patients have altered capillary 
walls due to glycosylation o f wall proteins by excess amounts o f glucose, which may
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increase the diffusion barrier and hence the time lag. It also remains to be established as 
to how much the intra- and inter-individual variability o f the delay between glucose 
changes in the intra- and extravasal compartments typically is. The agreement o f absolute 
glucose values between the two compartments is also debatable. It has been reported that 
there is 50-100% variation between glucose values in the two compartments55. Hence, 
even the percentage o f variation between glucose values in the ISF and blood shows a 
wide variability from one region of the body to another. This variability is mainly due to 
local factors determining ISF clearance in different body regions. Finally, the relationship 
between the two during non-steady-state conditions, i.e. exercise or postprandially, still 
need to be determined.
2.3 Smart Tattoos and the Use of Human Skin for 
Implantation of Minimally Invasive Sensors
2.3.1 The Human Skin
The human skin (Figure 6) is divided into two main regions: the epidermis, and 
the dermis (which is attached to the underlying hypodermis)57. The epidermis is the most 
superficial layer o f the skin, principally composed o f ceils called keratinocytes. It is 
composed o f five layers: the stratum comeum, the stratum lucidium (present in areas of 
very thick skin like the palms of the hands and the soles o f the feet), the stratum 
granulosum, the stratum spinosum, and the stratum germinatum. The epidermis is 
constantly regenerated. Newly formed cells from the stratum germinatum undergo a 
progressive maturing process called keratinization and migrate to the outer layer, the 
stratum comeum.
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The dermis is the innermost layer o f the skin. It supports the vascular network that 
supplies the avascular epidermis with nutrients. The dermis contains mostly fibroblasts 
which secrete collagen, elastin and ground substance that give the support and elasticity 
o f the skin. It is made out o f two layers: the outer papillary layer, which contains the 
vascular network, and the inner reticular layer, which houses hair follicles and glands 
among other things. The hypodermis is a subcutaneous layer o f connective tissue which 
connects the skin to deeper structures.
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Figure 6. Cross-section o f the skin.
(Source: http://www.agen.ufl.edu/~chyn/age2062/lect/lect_19/lect_19.htm)
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2.3.2 Optics of the Skin
The structure and chemical composition o f the skin is reflected by the optical 
properties o f the skin. As shown in Figure 7, when a beam of light reaches the skin 
surface, a part o f it is specularly reflected (4%) by the surface; the rest o f it will be 
reflected and transmitted into the skin (96%). The transmitted light will be scattered and 
absorbed by the skin tissue. After multiple scattering, some o f the transmitted light will 
re-emerge through the air-stratum interface into the air, which is called diffuse 
reflectance. This scattering contributes to a diffuse distribution o f light in the tissue that 
extends beyond the boundaries o f the collimated incident beam.
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Figure 7. Tissue Optics- What happens to light in the skin
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The amount o f diffuse reflection is determined by both scattering and absorption 
properties o f the skin. A back scattered photon from the diffuse part o f the light 
distribution that reaches the tissue-air boundary at an angle with the inward normal larger 
than the so called critical angle for total reflection, is reflected back into the tissue. A 
much smaller diffuse back-reflectance coefficient may be more appropriate for laser 
irradiated skin because light close to boundaries may not be perfectly diffuse but more 
forwardly directed. After a photon is absorbed by the skin, an electrically excited 
absorbing molecule may rapidly return to a more stable energy state by re-emission o f a 
photon with lower energy, i.e. fluorescence emission. Autofluorescence is caused by 
native fluorophores inside the skin.
2.3.2.1 Tissue Absorption and Scattering. An endogeneous or exogeneous 
fluorophore is required for interrogation o f tissue biochemistry and to obtain useful 
information from a reemitted optical signal. Endogeneous chromophores are oxy- and 
deoxyhemoglobin, melanin, myoglobin, and water. These chromophores are primarily 
responsible for absorption o f light in the wavelength region of 600-1000nm, or the 
“therapeutic window,” where tissue scattering predominates over absorption. Because o f 
the large absorbance o f hemoglobin and myoglobin at wavelengths <60Gnm and the 
predominant absorbance o f water in the IR range (>1000), optical characterization 
beyond a millimeter o f tissue is impractical when outside the therapeutic window o f 600- 
lOOOnm. Hence, back-scattering measurements at these wavelengths characterize surface 
and subsurface tissues. Typically, endogeneous tissue absorption coefficients range from 
0.1 to 10,000 cm '1 from NIR to UV range, and correspond to an optical penetration depth 
o f 10cm to 0.1mm before absorption. NIR light can propagate several centimeters, which
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enables one to extract information non-invasively and deeply. The elastic tissue scattering 
arises from the microscopic inhomogeneities o f refractive indices between extracellular,
c o
cellular, and subcellular components .
Water is the main tissue constituent o f the skin. Along with many other 
components o f the skin, it absorbs MIR radiation very effectively. Hence, in-vivo 
penetration o f MIR light is low. However, light in NIR and VIS regions penetrates deeper 
into the blood perfused skin layers allowing for glucose monitoring. If  tissue thickness is 
low, transmission spectra can be recorded, otherwise, only diffusely reflected light 
intensity can be used. For the most part, light scattering in tissue is caused by Mie 
scattering4. Mie scattering happens when the size o f the scattering particles and the 
wavelength o f the light are comparable or o f the same order o f magnitude. This idea has 
been illustrated in Figure 8. Mie scattering mainly happens due to the passage o f light 
through the boundary between media with different refractive indices. The scattering 
properties strongly depend on the ratio o f the refractive indices o f the scattering and the 
solute in a suspension. A decrease in the refractive indices o f the scattering particles 
causes a decrease in the scattering and vice versa. The scattering suspension becomes 
optically transparent when there is a perfect match o f both the refractive indices.
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Figure 8. Mie scattering- light scattering in turbid media.
2.3.3 Tattoos and Smart Tattoos
As discussed in the previous section, the skin is divided into three basic areas, 
epidermis, dermis, and the hypodermis. The epidermis constantly renews itself from the 
bottom up; new skin cells are created by stem cells at the bottom of the epidermis, 
pushing the older cells up towards the surface. The cells at the surface are the oldest, and 
they die and flake off. Hence, for a tattoo to be permanent, ink must be poked deeper into 
the skin, past the basement membrane and into the dermis. Ink molecules are too big and 
so unlike other foreign objects that are hauled away by leukocytes, the ink molecules can 
remain in the dermis for decades. The process has been illustrated in Figure 9. Tattoos 
are usually inserted in the skin’s dermal layer with needles.
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Figure 9. Process o f tattooing.
(Source: http://www.cockeyed.com/science/tattoo/tattoo.html)
The concept o f “smart tattoos” to monitor blood glucose was proposed as a 
minimally-invasive method for improved metabolic control in diabetics. Polyethylene 
glycol (PEG) beads coated with fluorescent molecules are injected beneath the surface of 
the skin, and the glucose in the ISF interacts with the fluorescent molecules o f the 
sensors. When the glucose concentration is low, the tattoo is highly fluorescent; when the 
concentration increases, the glucose binding causes displacement o f fluorescent 
molecules, and the overall fluorescence o f the tattoo decreases.
The excitation and detection system consists o f a fiber optic probe containing 
fibers for delivery o f excitation light and collection o f emission light or some other 
appropriate optical system that can be held to the skin at the implantation site.
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2.4 In-vivo Glucose Sensing: Totally Implanted, Minimally 
Invasive, Non-invasive Monitoring and 
Fluorescent Sensing Techniques
2.4.1 Totally Implanted Sensors
Needle-type sensors implanted transcutaneously for a short term have been found 
to be unstable because acute inflammation resulting in cellular accumulation, changing 
protein and fluid composition at the site o f implantation results in variable glucose and 
oxygen concentrations. Long term implantation, on the other hand, was found to be a 
more stable sensing environment after an encapsulating foreign body response. Glucose 
sensors implanted in the subcutaneous tissues o f dogs were inactive for the first few days, 
unstable for the next 7-14 days after which they became relatively stable for the next 
several weeks; the stability was insufficient for satisfactory clinical use59,60.
2.4.2 Minimally Invasive Techniques
2.4.2.1 Transdermal Methods. Transdermal methods are based on removal o f 
interstitial intradermal fluid (ISF) across the skin, thus avoiding penetration o f the 
skin61,54. Reverse iontophoresis is a popular method that is being used in a commercially 
available glucose sensor, GlucoWatch, (Cygnus, Redwood City, CA, USA). In this 
device, a low current is applied to the skin to drag ions through the skin, thereby 
extracting ISF across the skin. Small amounts o f glucose (1/1000 of blood levels) are also 
transferred with the fluid. Feasibility studies have shown that acceptable results for 
accuracy o f measured glucose levels can be obtained from 40 to 400 mg/dl. However, the 
glucose oxidase reaction used to measure glucose must be pushed to its limits for 
accurate measurements due to the small quantities o f  glucose available. Also, the system 
needs a three hour warm-up period and can provide up to three glucose readings per hour
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for 12 hour after a single-point calibration with a conventional self-blood glucose 
measurement54. The current applied to the skin can cause a mild to moderate skin 
irritation that clears within 3-27 days, and the reliability o f the device is questionable 
during sweating and varying degrees o f skin hydration.
Other methods involve using transdermal patches (TCPI, Fort Lauderdale, FL, USA) 
with permeation enhancers. The patch is placed on the skin for five minutes, after which 
time a meter is placed in the tabbed area o f the patch to take a spot glucose reading. Yet 
another method involves application o f ultrasound to increase skin permeability resulting 
in an increase in transdermal glucose flux60.
2.4.2.2 Electrochemical Methods and the Glucose Electrode. In the 1980s, 
biosensors were among the most promoted technologies both by researchers and industry, 
and were touted to have significant clinical applications62. Reagentless probes or 
“biosensors” for measuring glucose in vitro were first mentioned in the 1960s63, and it 
was in the early 1970s64 that glucose sensors were first tested in vivo in animals.
Figure 10 shows one o f the most studied type of glucose sensors called 
“amperometric enzyme electrodes”. Glucose oxidase is immobilized by chemical cross- 
linking at a charged electrode, and glucose changes are monitored by the change in 
current flow caused by the enzyme catalyzed production o f hydrogen peroxide65,66’67 or 
by the consumption o f oxygen68. The electrode itself is constructed of two different 
metals with an insulating material between them. A modified enzyme electrode is now 
being used in most commercial devices for self monitoring o f finger prick samples for 
blood glucose concentration (MediSense)69. Sensor configuration usually comprises a 
fine needle or flexible wire, the active sensing element being at the tip; it is implanted in
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the subcutaneous tissue. Such an implantation is regarded “minimally invasive,” and it 
avoids septicaemia, fouling and blood clot, and embolism associated with intravascular 
placement62.
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Figure 10. Typical construction o f an electrochemical/amperometric 
electrode62.
Although there have been encouraging test results with needle type sensors in 
animals and humans65,70 clinical development has been slow. The sensor output in vivo is 
suppressed by a variable amount compared with the in vitro signal at the same glucose 
concentration, requiring careful calibration procedures71. Also, there is an unpredictable
72drift in output over time . Since the exact cause o f these erratic responses is unclear, a 
rational modification o f the design has been precluded. Presently, evidence points 
towards a reversible coating o f the implanted sensor or a diffusion o f low molecular 
weight inhibitors into the sensor; the chemical nature of the interference is still unclear62.
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2.4.2.3 Microdialysis. Microdialysis has been the most popular among the tissue 
sampling methods, which has undergone considerable testing in humans60,73. It presents 
a possible alternative to the implantable and transcutaneous measurement methods, which 
have biocompatibility problems. Microdialysis imitates capillary function4. The 
procedure involves insertion o f a semi-permeable dialysis fiber into the subcutaneous 
tissue and perfusion o f the fiber with isotonic glucose-free fluid. Due the concentration 
gradient, glucose diffuses from the interstitial fluid through the dialysis membrane into 
the perfusate. By including a glucose sensing mechanism outside the body in the path of 
the perfusate, the glucose concentration can be measured continuously.
This method is advantageous in that a foreign body reaction is avoided and hence 
continuous monitoring without a pronounced signal drift is possible. A significant 
disadvantage, especially because applications such as continuously monitoring o f brain 
analytes mandates the use o f a method that can rapidly detect transient changes in 
concentrations, is that there is an inherent time lag o f 5-45 minutes associated with this 
technique74. This delay depends on the length, the inner diameter o f the tubing, and the 
perfusion flow rate selected (between 0.1 and lOpl/min). This method also requires re­
calibration at least once daily. Also, the procedure may buffer transient changes75, is 
imprecise because the dialysate concentration with respect to those in the body 
concentration never reaches 100% (the ratio depends on instmmental variables such as 
perfusion rate, surface area, and molecular weight cutoff o f the membrane, and 
physiological factors such as temperature, analyte species, anlayte metabolism etc.), also 
the sampling procedure may cause a depletion o f the analytes and hence is an 
underestimation o f the concentrations. Although incorporation o f capillary
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electrophoresis (CE) and laser-induced fluorescence (LIF) detection76, and
* 77microfabricated microdialysis have been suggested to improve temporal resolution, 
none are commercially available to date for in vivo applications.
2.4.2.4 Fiber and Submicron Fiber Probes. Fiber optic probes for glucose sensing 
based on both glucose oxidase and competitive binding assays have been developed by
no  O ')
various groups o f researchers ' . The sizes o f these fiber probes range from millimeter 
to submicron diameter. The sensing chemistry is immobilized at one end o f the fiber, and 
a light source and detector are connected to the opposite end. The larger probes suffered 
from disadvantages such as limited spatial resolution and sensing applications due to size. 
Also, the response time and sensitivity are reduced because methods o f immobilization o f 
sensing chemistry increase diffusion lengths. These problems were alleviated by the 
development o f submicron fiber-optic probes. However, these probes still had a limited 
lifetime (4-6 days) because o f the loss o f sensing chemistry from the immobilized 
polymer matrix.
2.4.3 Non-Invasive Sensing Techniques
The human skin allows penetration o f light up to some centimeters into the skin only 
in the near infrared region (NIR, 600-13QQnm)- the so called “optical window.” Above or 
below this optical window, light is absorbed by water, skin pigments, or blood within the 
outer layers o f the skin84; primarily, light in the NIR region can penetrate to the deeper 
blood-perfused skin layers, potentially allowing glucose monitoring.
Some o f the other technologies which are at the preclinical stage and have not yet 
been established as precise methods are polarimetry, far infrared radiation spectroscopy,
oe on
radio wave impedance, and pulsed photoacoustic spectroscopy ’ ’ .
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2.4.3.1 Spectroscopic Techniques. Glucose shows a characteristic absorption 
spectrum called “fingerprint” when a light beam is directed through a cuvette with a clear 
solution (otherwise, light scattering causes an additional attenuation o f light) of glucose 
in water. Spectrophotometry, which is a well established method for quantification o f 
solutes in liquids, is based on solute-specific absorption bands in the visible (VIS), near 
infrared (NIR) or mid infrared (MIR) spectral range. Using this method, solutes are 
quantified by determination o f light attenuation caused by absorption at a single 
wavelength (taking light path length into account). Hence, using high performance 
spectroscopic equipment in combination with sophisticated mathematical calibration 
procedures, ex vivo quantification o f glucose in complex matrices such as plasma, serum,
DO
or whole blood is possible using this approach . MIR radiation is particularly appropriate 
for this purpose because glucose exhibits specific absorption bands in this region. In vivo 
measurements in the skin, however, are difficult to make using MIR because of 
absorption by water. Hence, the in vivo penetration depth o f MIR light in the skin is 
low89. Light in the NIR and VIS regions penetrates into deeper blood perfused skin layers 
and provides an optical window for glucose monitoring. However, glucose does not 
exhibit specific absorption properties in this region.
Despite more than 25 years o f research, patents and publications, the major 
challenge with this approach has been to achieve sufficient precision within the clinically 
relevant blood glucose range over prolonged periods o f time90. The various problems 
associated with optical spectroscopy have been 1.) glucose has no specific absorption 
pattern in the near infrared region; 2.) low glucose concentration occurs in the tissue; 3.) 
scattering greatly reduces the absorption signal; 4.) high concentrations o f other light
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absorbers such as water interfering with the signal; 5.) light absorption depends on 
temperature; 6.) heterogeneous distribution o f glucose occurs in different tissue 
compartments, 7.) light absorbing structures are heterogeneously distributed in the skin. 
Due to these reasons very small and unspecific changes in the absorption spectra can be 
seen by changes in blood glucose.
2.4.3.2 Scattering. The major optical interaction mechanism in tissue is light 
scattering, caused by different structures in skin tissue such as cell membranes, cell 
organelles, collagen fibers. A photon in the NIR range is more likely to be scattered than 
absorbed in tissue because in this range, the wavelength o f light is comparable to the size 
o f the scattering structures. “Mie scattering” is the principal scattering mechanism that 
takes place in tissue when the size o f the scattering particles (cell membranes, collagen, 
organelles, etc.) is comparable with the wavelength o f light. The human skin comprises a 
turbid system, and the scattering o f light depends on the ratio o f the refractive indices o f 
the particles to the solution. Each change in the ratio o f the refractive indices o f the 
scattering particles and solute leads to a variation in the “transparency” o f the tissue54. 
When blood glucose increases, there is a subsequent rise in the refractive index o f blood 
and ISF (solution), whereas the refractive index o f scattering particles in the skin is not 
changed91,92. Thus, the ratio is reduced and so is scattering. Thus, since the proportion of 
light scattered in the skin is slightly lower, the intensity o f light reflected back into the 
skin is also lower.
The sensitivity o f  this method o f glucose monitoring (based on light scattering 
properties of the human skin) is small in absolute terms but was found to be much higher
A-2
than those due to glucose-specific light absorption in the NIR region . This method does
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not measure glucose concentration per se, but derives glucose concentration indirectly 
from glucose-induced changes in the refractive indices o f  components o f the human skin. 
Hence, other blood analytes and physiological factors, such as shifts in the water/plasma 
distribution between the intra- and exfravasal compartments, may influence the scattering 
coefficient. Due to a significant variability o f the baseline scattering coefficient, in vivo 
calibration o f the scattering signal with respect to the prevailing blood glucose is required 
at regular intervals.
2.4.3.3 Fluorescence Techniques. Numerous glucose-sensing mechanisms based 
on fluorescence spectroscopy have been proposed and are advantageous because o f their 
inherent characteristics o f specificity and sensitivity. Numerous fluorescence-based 
optical sensors have been developed94'96; most use GOx for oxidation o f glucose, and the 
fluorescence intensity is measured as a function o f dissolved oxygen concentration. For 
oxygen sensitive dyes that exhibit quenching o f fluorescence in the presence of oxygen, 
the relationship between the fluorescence intensity and oxygen concentration is given by 
the Stem-Volmer equation:
I / I c= 1+ K [02] (1)
where 70........fluorescence intensity o f the sensor in absence o f oxygen,
Ic fluorescence in a given dissolved oxygen concentration [O2],
K  .Stem-Volmer quenching constant.
Some o f the advantages o f optical sensing schemes over electrochemical schemes 
are absence o f electrical connection to the subject and potential for simultaneous multi­
analyte sensing using spectroscopy. The rapid development o f optical communication 
systems has produced cheap and reliable sources and detectors. Among the
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disadvantages are the limited penetration depth o f the optical signal due to scattering and 
absorption by the human skin tissue, and difficulty in calibrating changes in optical 
signals due to changes in analyte o f interest.
Fluorescence measurements are particularly useful for totally implanted sensors, 
particularly by using NIR dyes (dyes that are excited and emit in the NIR region). Light 
in the NIR region can penetrate through several centimeters o f  tissue and hence; NIR 
probes implanted in the subcutaneous tissue can be excited and interrogated from outside 
the body more efficiently, as they are less affected by interference from scattering or 
absorption by water or other components in the skin (collagen, organelles, membranes 
etc.). Also, lifetime measurements are advantageous over measurements o f fluorescent 
intensity because lifetime measurements are less affected by changing concentrations o f 
the fluorescent label, photobleaching or light scattering in the tissues.
The following is an overview o f the types o f fluorescent sensing mechanisms that 
can be used when a certain combination o f glucose receptor/enzyme and indicator can be 
co-immobilized. The items in the overview have been segregated on the basis o f 
receptor/enzyme type and further subdivided into various transduction mechanisms. 
Finally, there is a section on some o f the immobilized fluorescent sensing techniques 
currently being researched.
2.4.3.3.1 Fluorescence Resonance Energy Transfer (FRET) and Competitive 
Binding Sensors. Fluorescence resonance energy transfer (FRET) is based on the transfer
o f excitation energy from one fluorescent molecule (donor) to a nearby molecule
(acceptor) that has overlapping spectral properties. Changes in fluorescence intensity or
lifetime give an estimate o f the changing distance between the donor and acceptor.
Shultz97 demonstrated the basic principle o f this system as illustrated in Figure 11.
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Figure 11. Illustration o f a FRET-based competitive binding glucose sensor62
Concanavalin A (Con A) was used as a receptor for competing species o f FITC 
labeled dextran and glucose. TRITC-Con A binds with the FITC-dextran in the absence 
o f  glucose, excitation o f FITC results in TRIC emission due to FRET. With the increase 
in glucose concentration, FITC-dextran is displaced by glucose causing increased FITC 
emission. FRET systems for glucose sensing in vitro have also been developed using NIR 
fluorescent molecules coupled with Con A29.
Unlike the sensing scheme using glucose oxidase, there is no consumption of 
substrates or production o f  byproducts in the competitive-binding scheme. However, it is 
debatable whether the sensing scheme involving the Con A-dextran system is 
reversible98.
2.4.3.3.2 Boronic Acid Receptor Based Fluorescence Sensing. Synthetic boronic 
acid derivatives are able to complex glucose rapidly and reversibly by means o f covalent
* 99interactions . Synthetic receptor 1,2- anthrylbronic acid was used, with the boronic acid
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moiety being responsible for the binding o f glucose, and the anthracene moiety for the 
transduction o f the fluorescent signal. The major disadvantages o f this system are small 
analytical signal, poor selectivity in the order- D-fructose>D-allose>D-galactose>D- 
glucose, and the ability to work only in basic media (pKa o f 2-anthrylbronic acid =8.8).
The pka (4.8) o f the boronic acid receptor was improved by introducing a tertiary 
amine in the proximity o f the boronic acid moiety100. This improvement lead to the use of 
another phenomena, photoinduced electron transfer (PET) for transduction o f the 
fluorescent signal. The fluorescence signal is quenched by the nitrogen atom via PET in 
the absence o f glucose. Upon binding o f glucose, PET from the nitrogen to the 
fluorophore is suppressed, which “switches on” the fluorescence signal o f anthracene. 
The selectivity o f the synthetic receptors towards glucose was also improved by a 
designed alignment o f the two boronic acid moieties. The following selectivity was 
presented by this arrangement with the binding constants presented in paranthesis: D- 
glucose (3981 M_1)> D-allose (630 M ‘!)>  D-fructose (316 M_1)> D-galactose (158 M’1).
However, all these improvements do not really favor the use o f  this form o f the 
acid for physiological applications due to the limited solubility o f  the receptors. This 
situation, too, was improved upon by Norrild et al by developing the ionic receptor101. 
This modification however, reduced the sensitivity o f the system. Another aqueous 
soluble system was introduced by another group102 . It comprised o f two distinct parts, a 
pyranine playing the role o f the fluorescent transducer and a discrete diboronic acid 
receptor. A dual-fluorescence system was designed by Heagy et al which displayed two 
emission bands (430mn and 550nm) after excitation at 370nm103. It, however, had limited 
sensitivity at physiological glucose levels.
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Lifetime based sensing was introduced by Lackowicz’s group using phase- 
modulation methods. Upon interaction o f the boronic acid receptor with glucose, there is 
a shift toward low-modulation frequencies indicating longer mean lifetimes104. The same 
group is working on a glucose sensing contact lens for ex vivo glucose monitoring105. 
They designed boronic acid based receptor which was found to respond to physiological 
tear glucose within disposable contact lens. Even though it showed comparable 
selectivity for both glucose and fructose, the authors state that the interference for such an 
application was minimized due the fact that concentration o f fructose is tenfold lower 
than glucose.
2.4.3.3.3 Lectin-Based Fluorescence Sensing. Concanavalin A (Con A) is a plant 
sugar-binding protein which is mannose and glucose specific. It has been used in 
numerous fluorescence resonance energy transfer (FRET) glucose sensing 
mechanisms106. In this work, two sets o f dextran polymers, one labeled with rhodamine 
and the other with fluorescein, were used. In the absence o f glucose, a multivalent lectin 
interacted with the dextrans o f both types o f polymer beads bringing them close together. 
FRET occurs due to the close proximity o f the two fluorescent labels. These affinity 
sensors are based on fluorescene quenching o f the donor emission by FRET. When a high 
concentration o f glucose is added, the lectin binds to glucose instead and as a result the 
FRET decreases. Other work involves using TRITC-apo-GOx instead o f Con A with 
FITC-dextran107.
The attachment o f ruthenium to Con A to form a metal-ligand complex (RuCon 
A) permits the selective detection o f glucose. This method o f detection involves using a 
FRET based system with RuCon A as the donor and maltose-insulin-malachite green
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(MIMG) complex as the acceptor. The maltose offers the affinity o f an acceptor for 
ConA. The method utilizes the long lifetime of ruthenium, and changes in the decay time 
o f the complex due to the presence o f glucose can be measured . Frequency domain 
intensity decays showed a decrease in in the average lifetime o f the RuCon A emission, 
which was attributed to energy transfer. Steady-state fluorescence measured for 2juM 
RuCon A and 4 fxM MIMG demonstrated a consistent increase in the RuCon A emission 
signal as the glucose increased up to 150mM.
Another sensing mechanism used has addressed donor/acceptor distribution in 
FRET assays. The donor-acceptor distribution function was assumed to remain 
unchanged throughout a monitored FRET process (glucose sensing). Structural 
information can be obtained by measuring the fluorescent decay with nanosecond 
resolution, called distribution sensing. The donor/acceptor distribution changes were 
calculated at a single Forster radius for glucose concentrations ranging from 0-3 OmM .
2.4.3.3.4 Glucose Sensing Based on GBP (Glucose Binding Protein) Fluorescence 
Sensing. Proteins can be used as biorecognition elements because protein-based 
biomolecular recognition events are normally accompanied by conformational changes o f 
the protein due to binding with the ligand. Reporter groups can be introduced into the 
protein structure, which respond to ligand binding. Also, a pair o f fluorophores can be 
arranged on selected sites o f the protein to allow detection o f ligand binding by energy 
transfer.
GBP is a glucose/galactose binding protein that has binding affinity for glucose in 
the micromolar range. The protein has two conformations, an “open” conformation where 
the domains are far apart and a “closed” conformation where they come together. Thus,
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biosensing involves monitoring conformational changes that occur when proteins and 
ligands bind to each other. Incorporation of a fluorescent reporter near the ligand-binding 
site allowed sensing glucose due to conformational changes when the GBP binds glucose. 
The labeled GBP mutant was found to be stable at 37°C for over three months, and the 
secondary structure o f the protein is stable up to 64°C. Hence, this system was claimed to 
be as an ideal system for in vivo monitoring of glucose108’109.
2.4.3.3.5 Other Protein Based Fluorescence Sensing. Thermostable proteins that 
are isolated from bacteria are active at room temperature and do not lose activity at shelf 
temperature; e.g., BSGK is a thermostable glucokinase isolated by Lakowicz’s group and 
can be used to as a binding protein to develop a sensor for the substrate. This 
development is done in the absence o f ATP whereby it does not convert hexose to 
hexose-6 -phosphate (utilizing ATP).
Among the different sensing mechanisms that have been cited so far, FRET- 
based sensing mechanisms and those involving monitoring GBP conformational changes 
seem most promising. FRET-based sensing mechanisms do not require any referencing 
system for calibration, they have been shown to be linear in the physiological range with 
good response times, and analyte consumption can be avoided by using FAD deactivated 
enzymes. A variety o f donor-acceptor pairs with long Stokes shifts are available. By 
using NIR fluorophores, the sensor can be made amenable to skin tissue measurements.
GBP can be used by incorporating a wide variety o f  reporter groups at appropriate 
sites on the protein. Again, either intensity changes or FRET changes can be monitored 
with changes in conformation o f the protein as it binds the substrate. Genetic engineering 
o f GBP has made it possible to produce more robust forms o f the protein. Also, with
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genetically engineered GBPs, detecting perturbations in glucose homeostasis by 
monitoring glucose measurement in living cells with temporal and cellular resolution is 
possible. Mutants can be engineered with varying binding constants to sense different 
concentrations o f glucose at different locations in the body. For example, Formmer et 
al110 have developed GBP labeled with a FRET pair with a binding affinity o f 0.17uM for 
glucose to monitor cellular glucose. Yet another mutant has a glucose binding constant o f
0.59uM and can monitor physiological glucose (0.07-5mM)109.
2A 3.3.6 Enzyme Based- Glucose Oxidase, Hexo- and Glucokmases. 
Apoenzymes Fluorescence Sensing. Glucose oxidase (GOx) catalyzes the conversion of 
D-glucose and oxygen to D-glucono lactone and hydrogen peroxide. The detection o f 
oxygen consumption, hydrogen peroxide production, or local pH change has been widely 
used in the development o f GOx-based glucose sensors. GOx has been used in numerous 
biosensors due to its high selectivity over other sugars to glucose, ex vivo enhanced 
enzyme stability, and low cost.
This inner filter effect between FAD and GOx-FC (GOx is labeled with 
fluorescein) can be used as a transduction mechanism111. The molecular adsorption of 
FAD overlapped with the molecular adsorption o f GOx-FC (creating the inner filter 
effect) but not with that o f FADH2 . This inner filter effect is canceled in the presence o f 
glucose due to conversion of FAD to FADH2 , increasing the fluorescence o f GOx-FC. 
However, this method is found to be insufficient in terms o f sensing the physiological 
range o f glucose values.
Among the various transduction mechanisms o f glucose oxidase-based optical 
sensors, the sensing o f oxygen consumption by using an oxygen-sensitive dye, or use of
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pH sensitive polyacrylamide polymer gels which were fimctionalized with fluorescent
112dyes have been reported . Also a number o f  fiber-optic probes for pH sensing 
applications have been developed113,114. However, to date, there have been few reports of 
the use o f  pH sensitive ratiometric dyes for measurement o f glucose. Pyrene 8 -hydroxy- 
1,4,6-trisulfonylchloride (HPTS), is a pH indicator dye that has been used by several 
groups to demonstrate pH sensitivity in thin films46,47. It has numerous advantages such 
as large Stokes shifts, high quantum yield, high absorbance, excellent photostability and 
lack o f toxicity45.
Some o f the other pH sensitive dyes that have been used to demonstrate pH 
sensitivity in thin films are pyranine115, which is based on the analyte causing a 
wavelength shift in the excitation and emission spectrum; the amount o f analyte can thus 
be correlated with the ratio o f fluorescence intensities at the two wavelengths. Other pH 
sensitive probes include Benzo[c]xanthenes such as carboxy seminaphthorhodarfluors 
(SNARFs) and carboxy seminaphthofluoresceins (SNAFLs), which are long wavelength, 
dual emission dyes and can be excited in the green region116. All o f these have been used 
in fiber-optic configurations for pH sensing and not for glucose sensing. But with the 
incorporation o f GOx, they can potentially be used for glucose sensing. The main 
disadvantage in using pH sensing mechanism is that it is subject to interference from 
global pH changes and local pH changes due to factors other than the glucose-sensing 
reaction. In order to overcome this problem, in addition to sensing pH changes due to 
oxidation o f glucose, pH changes due to other reasons need to be monitored 
simultaneously. This can be achieved by using sensors incorporating pH-sensitive dyes 
with spectral properties different from those used in the glucose sensor without co-
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immobilizing GOx or other enzymes which catalyze the oxidation o f glucose; a 
combination o f these, together with the glucose sensors will help differentiate between 
pH changes due to glucose oxidation and otherwise.
To monitor oxygen consumption, an oxygen sensitive fluorophore (ruthenium 
(II),4,7-diphenyl-1, 10-phenanthroline)-dodecylsulfate- Ru(dpp) or Ru[dpp(S0 3 Na)2]3Cl2 
) has been used by some groups23,26. The basic principle is the monitoring o f quantity o f 
oxygen consumed by the enzymatic reaction. The excitation and emission wavelengths of 
the dye are 465 and 610nm, respectively. The drawback is that they should be 
accompanied by an oxygen sensor to compensate the partial oxygen pressure variations 
from sample to sample and during the continuous monitoring o f glucose.
In the case o f hydrogen peroxide based sensors, not much work has been reported 
in optical sensing of hydrogen peroxide produced during glucose consumption by GOx. 
Most references to H2O2 sensing have been with respect to amperometric sensors. Some 
work has been done regarding fiber-optic biosensors for H2Q2 and glucose117. Arnold et 
al have developed two different configurations. In the first biosensor used homovanillic 
acid as the substrate; the H2O2 diffused across a microporous PTFE (Teflon) membrane 
and entered an internal solution o f the substrate and horseradish peroxidase (HRP) and 
the fluorescence of a dimeric product formed was monitored as a function o f time118. The 
rate o f the fluorescence intensity was related to the H2O2 concentration in the sample. In 
the second configuration, the substrate was luminol and the HRP-catalyzed 
chemiluminescent reaction between hydrogen peroxide and luminol produced light, 
which was measured and related to the HPR concentration. The second configuration 
produced faster response times and lower limits o f detection. The resulting H2O2
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biosensor was used as an internal sensing element o f a glucose biosensor by 
immobilizing GOx on the outer surface o f  the gas-permeable membrane159.
Sukhorukov et al16 reported the use o f  an Amplex red reagent to visualize the 
localization of the active enzyme into microcapsules produced by LbL assembly o f 
biodegradable polyions, dextran sulfate, and protamine on MF cores, followed by 
dissolution o f the core. In the presence o f peroxidase (HRP), Amplex Red reacts with 
H2O2 in a 1:1 stoichiometry to produce red-fluorescent resorufin (ex 563nm and em 
587nm). Though this scheme was not used to sense glucose, it could be applied in the 
following way. By co-encapsulation o f GOx, HRP and Amplex Red, the changes in 
fluorescent emission o f the dye can be monitored with changes in glucose consumption 
by GOx resulting in production o f H2O2 .
Researchers from the University o f Illinois at Urbana-Champaign120 have created 
a near-infrared nanoscale glucose sensor by using carbon nanotubes as the fluorescent 
indicators. This sensor was fabricated by assembling a monolayer o f GOx on the surface 
o f nanotubes and then functionalizing the surface with ferricyanide (an ion sensitive to 
hydrogen peroxide). When glucose encounters GOx, hydrogen peroxide is produced, 
which reacts with ferricyanide to modulate the electronic structure and optical 
characteristics o f the nanotube and cause it to fluoresce in the NIR region, which is very 
advantageous for measurements from deeper tissues or blood. The more glucose that is 
present, the brighter it will fluoresce. However, carbon nanotubes have been proven to be 
toxic121.
Glucokinases in the liver and Hexokinases in most other cells are responsible for 
phosphorylation o f glucose by utilization o f ATP122. Hexokinases, unlike glucokinases,
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have a broad specificity and are sensitive to D-mannose, D-fructose, sorbitol, and D- 
glucosamine in addition to glucose ’ . Glucokinases, unlike hexokinases, are
insensitive to inhibition by glucose-6 -phosphate and can respond to changes in glucose 
concentration in the physiological range125. Hexokinases, on the other hand have a Km of
0.1mM and get 95% saturated at 5mM glucose; a further increase in glucose does not 
significantly affect glucose binding. Hence, hexokinase is ruled out as a possible glucose 
sensor. Only a few species, especially bacteria, are known to contain true glucokinases,
1.e., enzymes specific for glucose126. However, glucokinases with true glucose specificity 
are not easily available and are, therefore expensive.
An insignificant amount o f work has been done in the use o f hexokinases and
1 97 1 98 1 90glucokinases for glucose biosensing applications ’ ’ perhaps due to high cost and
lack of availability. However, if  recombinant forms o f these enzymes could be produced, 
it may aid in mass production and hence decrease in cost. One group has reported (though 
the work has not been published yet) the use o f a conformational change in heterokinase 
on glucose binding, and the optical monitoring (intrinsic fluorescence or FRET) o f this 
change, both in solution and after entrapment, in a sol-gel matrix. The intrinsic 
fluorescence has been attributed to tryptophan (ex 290nm, em 330-340nm); it decreased 
with increasing glucose concentration. Also, extrinsic covalent labeling o f  the enzyme 
with RBITC (donor) and Cy5.5 (acceptor) led to changes in FRET with changes in 
glucose concentration130.
D ’Auria et al presented an approach for reversible GOx fluorescent sensors by 
using apo-GOx (obtained by removal o f FAD, which still binds glucose with comparable 
affinity to that o f the holoenzyme, but does not consume glucose)24. Apo-GOx interacts
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non-covalently with the fluorophore ANS (8 -anilino-1 -napthalene sulfonic acid) with 
excitation wavelength at 325nm and emission at 480nm. The fluorescence intensity and 
mean lifetime o f ANS decrease with an increase in glucose concentration. These give 
reversible sensors; however, the dynamic range o f the sensors was not found to be 
satisfactory.
The same group demonstrated a similar mechanism with glucose dehydrogenase 
(GD)131. The main advantage o f the apoenzyme sensors is that there is no consumption 
o f the analyte and no formation o f byproducts such as gluconic acid and hydrogen 
peroxide, which may cause inflammatory responses in the body.
Hence, an ideal system for glucose sensing must not consume analytes, is non­
toxic, is unperturbed by changes in local oxygen or pH, and yet has the range and 
sensitivity to measure physiological glucose changes. If  glucokinases can be mass 
produced by DNA recombinant technology, which will also reduce the cost, then it may 
be ideal to label it with a FRET donor-acceptor pair o f NIR dyes (cy5 and cy5.5). In the 
absence of ATP, glucose is not consumed (phosphorylated), and there are no reaction 
products. Since the transduction mechanism has nothing to do with sensing changes in 
oxygen or pH, it is not prone to interference due to random changes in oxygen partial 
pressure or pH. It has also been reported that glucokinases can respond to changes in 
glucose in the physiological range.
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2.5 Immobilization Methods for Dyes and 
Enzymes Used in Optical Sensors
2.5.1 Fiber-Optic and Non-Fiber 
Optic Immobilization Methods
The early use o f fluorescent probes involved injection o f liquid fluorescent 
indicator dyes into the sample and analysis using a spectrometer or microscope. This 
procedure has numerous disadvantages including toxicity to the biological sample, 
compartmentalization o f the dye and leakage over time, and hence requires reintroduction 
o f the dye. For these reasons, sensor systems involving immobilization of the dye using 
microelectrodes and special sub-micron fiber optic probe tips have been
1 “XO 1 '3 1  1 'XAdeveloped ’ ’ . Encapsulation o f enzymes is primarily aimed at using a semi-
permeable support matrix to entrap the enzyme, prevent its leaching out o f  the matrix, 
while allowing exchange of analytes, products and co-factors between the encapsulated 
enzyme and the surroundings135.Liposomes136, microspheres prepared by microemulsion
|  •> '7  -i fv
techniques ’ , and silica matrices are among the various carrier systems used for 
various chemicals, drugs and biomacromolecules. Medical applications o f such micro- 
and nanocontainters include using them as protective shells for cell and tissue 
encapsulation or as carriers for drug-delivery.
Among the non-fiber optic micro and nanosensors are the probes encapsulated by 
biologically localized embedding (PEBBLEs), ranging in sizes from 20 nm to 200 nm in 
diameter that have been developed by the Kopelman group at the University o f Michigan. 
Microemulsion techniques were used to fabricate these probes, which consist o f a 
polymer matrix containing dyes and/or enzymes. The main advantages o f these sensors
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are protection o f the dye from the environment and vice versa, ability to immobilize 
multiple dyes for multianalyte monitoring and ratiometric monitoring, a good correlation 
between in vitro and in vivo calibrations, and a biocompatible surface provided by the 
polymer matrix. Though PEBBLEs have been used for intracellular monitoring (pH138, 
glucose138, sodium139, calcium142, zinc540, oxygen141, potassium142), they have a few 
significant disadvantages. There is no guarantee o f uniformity from sensor to sensor 
within the same batch and from batch to batch fabricated using the same process, due to 
the nature o f the emulsion process. Another problem is leaching o f the encapsulated 
chemistry over time143. Since, PEBBLEs are typically less than 200nm in diameter, they 
are useful for intracellular monitoring but unsuitable for use as “smart tattoos” because 
the size o f implants plays an important role in phagocytosis144. Implants or substances in 
particulate form are o f a size that can easily be phagocytosed by macrophages.
2.5.2 Laver-bv-Layer Assembly (L b L )
Electrostatic layer-by-layer self-assembly (LbL) has been employed for highly 
controlled assembly o f charged polyions (polymers), nanoparticles, proteins, dyes and 
other supramolecular species onto arbritrary sufaces of any shape and size. It is possible 
to design ultrathin ordered films in the range o f 5 to 1000 nm, with precision better than 
Inm, and a definite knowledge o f their molecular compositions. The method consists o f 
alternate depositon o f oppositely charged polyions after re-saturation o f the terminal 
charge after each layer is deposited. The forces governing spontaneous assembly of 
layers are primarily ionic and covalent in nature; however, they can also include 
hydrogen bonding, hydrophobic, and other types o f interactions. This idea also implies 
that there are no major restrictions on the choice o f  polyelectrolytes.
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There have been numerous reports demonstrating assembly of polyions and 
dyes145' 148, viruses and charged nanoparticles149’350, and organized protein multilayers on 
charged substrates. Proteins have been assembled by alternate electrostatic adsorption 
with positively charged polyions such as polyethyleneimine (PEI), poly 
(allylaminehydrochloride) (PAH), poly(dimethyldiallyl ammoniumchloride) (PDDA), 
and chitosan or with negatively charged PSS, DNA, and heparin. Proteins are maintained 
sufficiently charged under experimental conditions by setting the protein solution pH 
apart from the isoelectric point. There are numerous references to assembly o f water 
soluble proteins in alternation with oppositely charged polyions, including cytochrome c 
and P450, lysozyme, histone type YIII-S, myoglobin (Mb), pepsin, horseradish 
peroxidase (POD), hemoglobin, glucoamylase (GAM), concanavalin A (Con A), 
albumin, glucose oxidase (GOx), catalase, invertase, diaphorase, acteriorhodopsin, and 
immunoglobulin IgG151"154.
The pioneering work o f Her155 first demonstrated the principle of film formation 
by alternate adsorption o f charged colloids and proteins; a related method was later 
introduced for film assembly by alternate adsorption o f linear polycations and 
polyanions145"150. This method has been illustrated in Figure 12. Polyions are used at pHs 
that ensure a high degree o f ionization.
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Figure 12. Schema o f layer-by-layer film assembly on flat solid supports 
(Source: Dissertation, Mengyan Li. 2003)
A negatively charged solid planar substrate is immersed in a solution o f cationic 
polyelectrolyte, thus adsorbing a layer o f polycation. Since a relatively high 
concentration o f polyelectrolytes is used, a number o f ionic groups remain exposed, thus 
reversing the surface charge and preventing further polycation adsorption. The substrate 
is then rinsed and immersed in a solution o f anionic polyelectrolyte. The adsorption o f 
the anionic polyelectrolyte layer reverses the original surface charge.
Various templates have been used for the fabrication o f microcontainers such as 
polystyrene, melamine formaldehyde (MF) 156’157’158, metal particles159, inorganic 
crystals44and biological cells42,160. Figure 13 illustrates how the assembly o f polyions on
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flat supports can be extended to charged solid spherical supports (polystyrene, MF and 
silica particles 0.1-5jUm).
Mierotessplates
(Latex)
Pdyanioa Polycatoi Amomc enzymes
(PAAi (RET)
Figure 13. Schema of layer-by-layer film assembly on spherical solid supports 
(Source: Dissertation, Mengyan Li. 2003)
This method can be used to create hollow microcapsules by removal o f the solid 
template post polyion multilayer assembly for encapsulation o f dyes161’162, enzymes163
A'y
and other macromolecules , or the template can be retained for creation o f complex 
catalytic particles. The process involves addition of polyelectrolyte solution to a 
suspension of particles. After adsorption saturation is reached, the particles are separated 
from  the polyelectrolyte solution by centrifugation or filtration and then rinsed and 
exposed to the oppositely charged polyelectrolyte solution.
2.5.2.1 Encapsulation Techniques for Macro/Biomacromolecules. Over the last 
ten years, the use o f electrostatic layer-by-layer assembly to assemble particles and 
molecules in a highly controlled manner has advanced rapidly164’163,166. Multilayer 
coatings of thickness in the range o f  5 to lOOOnm, with precision better than Inm and a 
definite knowledge o f their molecular compositions, have been fabricated on both solid 
supports as well as charged micro- and nano-sized particles to produce hollow core
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shells. This method is also advantageous in that the fabrication process is easy and 
repeatable and does not require complicated and expensive equipment. Various templates 
have been used for the fabrication o f microcontainers such as polystyrene, melamine 
formaldehyde (MF) 16/’168’169, metal particles170, inorganic crystals44 and biological 
cells42,43. Also, several groups have demonstrated encapsulation o f biomolecular and non- 
biomolecular materials by different methods.
The following is an elaboration o f the use o f LbL in encapsulation of 
macromolecules. Although some o f these techniques have been used to encapsulate non- 
enzymatic macromolecules, the techniques have been described as potential methods for 
the purpose.
Encapsulation o f urease163 and FITC-dextran171 into prefabricated capsules by 
solvent and pH induced variations in arrangement o f polyelectrolytes in the capsule wall 
has been reported. The capsule architecture used was {PSS/PAH}4 and the MF template 
was used. It was shown that the capsule walls are in the open state at low pH (pH 3) and 
closed state at high pH (pH 10). Hence, the opening o f pores allows the FITC-dextran 
(MW 45000) to penetrate the capsule interior. The closing o f pores at pH 10 ensured that 
the capsules remained loaded with FITC-dextran. The open state for FITC-dextran was 
observed for pH values up to 6 . Most o f the capsules were closed from pH 8  and above. 
The capsules were initially exposed to a FITC-dextran solution at pH 3. Then the pH was 
shifted to 10, and the rest o f  FITC-dextran was removed from the bulk by centrifugation. 
Similar results were obtained for MW 2000000 FITC-dextran.
It was observed that the transition between the open and closed state o f  the 
polyelectrolyte multilayer capsules introduced by adding ethanol in aqueous solution is
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reversible165. The permeability o f capsules {PSS/PAH}4 (MF template) for high 
molecular weight compounds changes from closed to open by adding water and ethanol 
respectively to a capsule suspension. For encapsulation o f  urease, the enzyme was first 
exposed to polyion capsules in a water/ethanol mixture, then ethanol was removed after 
centrifugation, and the capsules were resuspended in water. At this point, their walls were 
closed and the urease was captured inside. This process has been illustrated in Figure 14. 
It has been speculated that there is a segregation o f the polyion network in water/ethanol 
media. This segregation leads to defects in the shell, and the pores might be open big 
enough to pass 5-nm diameter urease globules through the wall. Returning the capsules 
into pure water relaxes the polyion walls to a closed state again. The encapsulated urease 
was found to retain 13% o f its activity compared with the free enzyme.
In W ater, dosed Ethanol/W ater 1:1, open In W ater, Encapsulated
Figure 14. Illustration o f encapsulation o f materials by changing solvent161
The advantages o f the above methods include the ease with which enzymes and 
drugs can be encapsulated for sustained release and other drug-delivery applications after 
treatment with pH or salt treatment. Selective wall permeability allows for substrates and
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reaction products to diffuse rather easily through the walls while the encapsulated 
enzymes are kept in the capsules. The disadvantages o f the methods include the inherent 
reversibility o f the mechanism and dependence o f the processes on external environment. 
Hence, they are not suitable for all applications, especially in the case o f biosensors 
where an irreversible change in the physico-chemical properties o f the wall architecture is 
warranted in order for the encapsulated material to be retained.
Another method of encapsulation involves the use o f microcapsules as reaction 
cages for formation of a charged internal matrix by polymerization o f monomeric units 
by enzyme-catalyzed or free-radical reactions172 and the use o f the matrix to attract and 
encapsulate oppositely charged macromolecules. This technique is based on the principle 
that microcapsule walls are impermeable for polymers whereas monomers penetrate the 
wall easily. This procedure is called “ship in bottle” synthesis. Polymers and 
functionalized copolymers have been synthesized inside the capsules ({PSS/PAH}^ MF 
template) from water-soluble anionic, cationic, and neutral monomers. Polymerization 
was carried out at various sodium styrene sulfonate (SS) concentrations in the presence o f 
capsules for 4 h at 80°C under nitrogen atmosphere. 1% potassium peroxodisulfate was 
added as initiator. There was increased polymerization in the walls.
This approach was based on the selective permeability o f capsule walls for 
monomer molecules, while the biocatalyst and the polymeric chains formed in the 
capsule interior were trapped inside because o f their higher molecular weight. In another 
similar approach, horseradish peroxidase (HRP) was encapsulated into {PSS/PAH}4 
capsules (MF template) using pH driven pore regulation. Tyramine was used as a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
56
monomer173. It started fluorescing after polymerization upon addition o f hydrogen 
peroxide to the system to catalyze the reaction.
The advantages o f these techniques include use of these capsules In 
micromechanics by inducing a reversible swelling and collapse o f the capsules by 
application o f a high concentration o f polyelectrolytes in the bulk solution and the 
subsequent application o f a counter pressure. Due to synthesis o f polymers in and on the 
capsule walls, it can be strongly charged and hence used as an ion exchange membrane. 
Moreover, they can be used to attract and entrap enzymes and proteins.
The technique is limited by the availability o f suitable monomeric units which 
will form polymers that are oppositely charged to the enzyme o f interest. Moreover, the 
polymers should not hamper the conformation and hence the activity o f the encapsulated 
enzymes.
Dyes have been precipitated into hollow polyelectrolyte capsules in a controlled 
manner by changing the ionic or solvent composition174,175. Also, DNA has been 
precipitated on manganese carbonate templates after which polyelectrolytes were 
adsorbed to form a protective biocompatible shell, followed by dissolution o f the core 
material to entrap the enzyme in the hollow interior176 as shown in Figure 15.
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Figure 15. DNA encapsulation by precipitation on M11CO3 template 176
Capsules with architecture {PSS/PAH}4 were used to demonstrate the 
precipitation o f water soluble dyes, acid 6 -carboxyfluorescein (6 -CF), and base 6 G 
rhodamine (R-6 G). 6 -CF was precipitated from basic solution in the presence o f empty 
capsules by dropwise addition o f 10' M HC1 until supersaturation took place at pH 6. R- 
6 G was precipitated by increasing the value o f pH (2x10' M NaOH). Fast and random 
precipitation o f the dye occurs at pH 12. The cationic cyanine dye 1,1’- diethlcarbocanin 
(pseudoisocyanine, PIC) was precipitated by the addition o f 10’3 M solution of 
ammonium hexafluorophosphate to a solution o f PIC bromide (10'3M) and capsules. The 
crystals showed a narrow fluorescence band after aggregation.
Yet another method o f encapsulation involved formation of protein
I -nn 1 nq
(chymotrypsin) aggregates followed by LbL adsorption o f polyelectrolytes " . This
encapsulation was performed by salting out the proteins by mixing with appropriate 
volume of saturated solution o f NaCl (0.0IN  HC1 and NaCl 1:1 by volume) yielding
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particles between Q.ljxm to 0.4/rm in dimension. The advantages o f these methods 
include the fact that they are simple, and they obtain high encapsulation efficiency.
These methods, however, may cause denaturation o f enzyme and other 
biomolecules due to the use o f extreme pHs and solvents. Also, crystallization may lead 
to an unfavorable conformation o f the enzymes and hence render them inactive (though 
the protein crystals were found to retain 73% o f their activity as compared with free 
enzymes, which lost 56% of activity after six days. This result may not hold true for all 
proteins, enzymes and biomolecules).
Low molecular weight dyes have been encapsulated by first coating them as weak 
inner sacrificial layers capped by layers o f strong polyelectrolytes (the weak layers 
dissociate when the template is dissolved, whereupon they get encapsulated in the
1 RAcapsule interior) . Multilayer films composed o f Tb3+/polystyrene sulfonate (PSS) and 
4-pyrene sulfate/polyallylamine (PAH) were successfully assembled on polystyrene 
sulfonate (PS) and MF latex particles.
Dissolution o f the MF particles leads to formation o f hollow capsules with the 
release o f multivalent ions and the entrapment o f the inner polyelectrolyte layers, due to 
selective permeability o f the walls. The simplicity o f the method is its main advantage. If  
this method were used to encapsulate biomolecules, they would be subjected to very low 
pHs. Hence, they m aybe selectively appropriate for encapsulation o f biomolecules.
Some groups have reported the encapsulation o f macromolecules into capsules 
fabricated using MF template due to the formation o f a gel-like matrix comprising o f the 
inner polyelectrolyte layers and MF. A case in example is the loading o f horseradish 
peroxidase (HRP) into capsules “spontaneously” due to electrostatic attraction between
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the positively charged enzyme and the negatively charged complex of the innermost 
anionic layer, namely, poly (styrene sulfonate, sodium salt) (PSS) and MF oligomers 
formed during the dissolution o f the core181.
However, it has also been pointed out that this matrix formation does not occur in 
all cases, and that to a large extent it is dependant on the nature o f polyelectrolytes used
1 fi 1 S’?to coat the MF and in some cases the age o f the capsules . Hence, depending on the 
nature o f interaction between the template and the multilayers, microcapsules that are 
completely hollow or those with internal charged matrices are produced. Other examples 
include encapsulation o f a- chymotrypsin in capsules formed by assembling 8  bilayers of 
negatively charged alginate/protamine followed by formation o f an alginate matrix in the 
interior by dissolution o f the core . 183
The above method has high encapsulation efficiencies since the loading is 
spontaneous and driven by electrostatic attraction o f the dense charged inner matrix, 
rather than just by diffusion. A possible disadvantage is that there is some MF in the 
capsule interior and may be toxic. However, long-term studies have not been done with 
in-vitro experiments to prove it.
Diazoresin has been used in the past to demonstrate cross-linking with 
polyelectrolyes having sulfonate or carboxyl groups by photocrosslinking reaction as 
shown in Figure 16. Recently, hollow capsules were fabricated with 5jum manganese 
carbonate (MC) templates, by depositing {PSS/PAH} i+{PSS/PAH} 5 + (PSS/PAH) i and 
dissolving the core with 0.1M HC1. Loading o f RITC-GOx, RITC-HRP, and FITC 
dextran was demonstrated followed by irradiation with UV lamp for five minutes to 
crosslink the multilayer wall (refer Figure 17)184. This method is useful for biosensors,
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where a permanent alteration o f wall properties is desired for stable encapsulation o f the 
molecules. However, diazoresin is a known carcinogen.
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Figure 16. Crosslinking of diazoresin 184
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Figure 17. Fabrication, loading and crosslinking o f capsules with DAR in their walls. 184
Though alginate-based hydrogels have been used for encapsulation o f materials
before, the high porosity o f the matrix has made it difficult to retain macromolecules
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inside the alginate matrix, leading to leaching out o f the encapsulated material over time. 
However, recently, it has been shown that by coating alginate microspheres with different 
combinations o f polyelectrolyte bilayers, it is possible to reduce leaching and maintain 
activity o f  encapsulated glucose oxidase183. Alginate microspheres (<5f£) were fabricated 
using an emulsiflcation technique and were ionically crosslinked with calcium ions; 
glucose oxidase was encapsulated inside. It was found that with a single bilayer o f 
{PSS/PAH}, the total loss of enzyme was reduced to 20%. Alginate is biocompatible, 
and alginate microspheres have high encapsulation efficiency.
Almost all methods described above have certain advantages and disadvantages. 
The parameters on the basis of which they can be compared are the application/purpose, 
cost, repeatability, ease o f fabrication, mono/polydispersity, biocompatibility, stability 
and activity o f  the encapsulated enzyme, ease and feasibility o f commercialization, and 
effect o f the location o f entrapped enzyme on desired activity. Some o f  the methods 
involve use o f harsh conditions such as low or high pHs, high salt concentrations, and/or 
organic solvents when the biomolecule is present in the capsule, or encapsulation is 
carried out using harsh conditions. The capsules fabricated after coating the MF and 
removing the core are rinsed after acid treatment and hence are under milder conditions 
before encapsulation o f biomolecules. Some of these methods have higher encapsulation 
efficiency than others. However, this difference does not directly translate to higher 
activity o f the enzyme. A tight packing o f the enzyme can actually hamper enzyme 
activity due to diffusion constraints and the unfavorable conformations o f  enzymes. Also, 
a stable entrapment o f  enzymes in the walls may actually lead to higher activity due to 
easy availability o f  the enzyme to the substrate and assay chemistry. On the issue of
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biocompatibility, none o f these methods have been tested in-vivo to confirm 
biocompatibility or toxicity. The use o f  DAR in capsules for medical applications is 
questionable because of its known carcinogenicity. As far as cost is concerned, MF is 
expensive compared with the inorganic crystal templates. However, it does offer other 
advantages such as formation o f charged internal matrices when certain materials are 
coated on it, whereas with inorganic crystals, other techniques have to be used for the 
same purpose.
In summary, this chapter has described the pathophysiology o f  diabetes, which is 
not the only though the single most important reason for the development o f inexpensive 
and reliable minimally invasive glucose sensors. The exciting prospect o f using “smart 
tattoos” for glucose sensing has also been discussed. Various totally implanted, 
minimally invasive, non-invasive and fluorescent sensing techniques have also been 
elaborated. The need for reliable encapsulation techniques for immobilization o f the 
sensing dye and the enzyme required for sensor fabrication has been underlined; some 
methods for encapsulation have been discussed and application o f the versatile LbL self- 
assembly technique to encapsulation o f molecules has been elaborated. The next chapter 
describes the techniques used to characterize the fabrication of microcapsules and the 
encapsulation, activity and stability o f enzyme. Also discussed are the techniques for 
characterization and testing o f glucose sensors fabricated by encapsulation o f GOx 
labeled with a pH sensitive fluorophore HPTS.
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CHAPTER III
EXPERIMENTAL DESIGN AND THEORIES
The ultimate goals o f this project were to fabricate and test glucose sensors using 
GOx for glucose specificity, and to delineate a method to optically sense the reactants 
consumed or the products o f the reaction involving the enzymatic consumption of 
glucose. Another purpose o f this research was to demonstrate the use o f nanotechnology, 
particularly the versatile LbL technique to construct hollow microcapsules and use them 
as microcontainers for the encapsulation o f the sensing chemistry.
With the above aims in mind, numerous experiments were performed; capsules 
with different wall architectures were compared for loading, stability, and activity o f 
encapsulated GOx. The wall permeabilites o f capsules with these architectures were also 
compared using fluorescent recovery after photobleaching. In the course o f this study, it 
was discovered that the presence o f  a charged internal matrix in some capsules aided the 
attraction and encapsulation o f oppositely charged GOx. These matrices were produced 
during the capsule fabrication process (during LbL assembly o f  polyions) due to the 
interaction o f the polyions with the template material.
For capsules that did not have internal matrices, a novel method of polymerization 
o f internal matrices using free-radical polymerization o f acrylic acid monomers was
63
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found to be suitable for encapsulation o f HRP but not for GOx. Another method involved 
the use o f  amino acid arginine and its polymerization using a heterobifonctional cross­
linker EDC. Finally, HPTS (a pH sensitive excitation ratiometric dye) was used to label 
GOx, and the glucose sensitivity o f the system was studied both in solution and after 
encapsulation.
This chapter gives a detailed description o f chemical techniques and 
instrumentation used to perform the above experimental procedures. The first section 
describes the chemical cross-linking techniques used in the fabrication o f charged capsule 
internal matrices. The second section describes the optical techniques used for imaging 
the capsules and sensors, obtaining fluorescence spectra for glucose sensitivity tests, and 
for obtaining fluorescence recovery profiles for photobleaching studies used to compare 
permeabilities o f capsules with different wall architectures. The third section describes 
the various surface characterization techniques for studying surface topographies o f 
capsules, and the instrumentation and methodology for studying the coating of charged 
materials on surfaces (thin films and on particles). The last section is an account on the 
working o f enzymes, the pH sensitive dye HPTS used in the sensor and theory behind 
absorbance measurements used to assess efficiency o f encapsulation, stability, and 
activity of the encapsulated enzyme.
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3.1 Chemical Techniques for Fabrication 
of Internal Matrices of Capsules
3.1.1 Cross-linking Techniques
Cross-linking is the process o f using a covalent bond to chemically join two or 
more molecules; they contain reactive ends to specific functional groups (primary 
amines, sulfhydryls, etc.) on proteins and other molecules. Due to the availability o f 
reactive chemical groups in proteins and peptides, they can be easily conjugated and 
studied using cross-linking methods. Among the various applications o f cross-linking 
techniques are determination o f three-dimensional structures o f proteins; near-neighbor 
relationships; hapten-carrier protein conjugation; molecular associations in cell 
membranes; and preparation o f enzyme-antibody conjugates, immunotoxins, and other 
labeled protein reagents. Cross-linking techniques have also been used to modify nucleic 
acids, drugs, and solid surfaces.
By performing cross-linking studies before and after the interaction occurs, 
conformational changes o f  a protein with a particular reaction can be studied. Distances 
between molecules can be determined by comparing cross-linkers with different arm 
lengths. Information can be obtained about the exposure o f  specific protein domains and 
amino acids in the tertiary and quaternary structure and may be interpreted as 
conformational changes in proteins by examining which cross-linkers effectively 
conjugate to specific domains o f the proteins. Cross-linking techniques also made the 
study o f receptors easier. Isolation o f the receptor-ligand complex was possible by 
derivatizing a receptor with a cross-linker before and after contact with a ligand 186.
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3.1.2 Homo- and Heterobifunctional 
Cross-linkers
Homo- bifunctional cross-linkers have two identical reactive groups. They are 
used in one-step reactions to crosslink proteins, to each other, or to stabilize quaternary 
structures, in solution. This procedure is unsuitable when the goal is to cross-link two 
different proteins, as it often results in seif-conjugation, intramolecular cross-linking 
and/or polymerization. Such procedures can be performed effectively using hetero­
bifunctional cross-linkers, which have two different reactive groups that allow two-stage 
sequential conjugations. This method helps minimize undesirable polymerization or self­
conjugation. Hetero- bifunctional cross-linkers are especially useful when modification o f 
amines is problematic due to the locations o f these reactive groups at the active sites. In 
such cases, other moieties such as sulfhydryls, carboxyls, phenols and carbohydrates are 
more appropriate targets. For example, cross-linkers that are amine-reactive at one end 
and sulfhydryl-reactive at the other end are particularly useful in such cases.
In sequential reactions involving heterobifunctional reactions, the cross-linker is 
reacted with one protein using the most labile group o f the cross-linker first, followed by 
removal o f excess non-reacted cross-linker and addition o f  the modified first protein to a 
solution containing the second protein where reaction through the second reactive group 
o f the cross-linker occurs. The most widely-used heterobifunctional cross-linkers have an 
amine-reactive succinimidyl ester (NHS ester) at one end and a sulfhydryl- reactive group 
on the other end. The sulfhydryl-reactive groups are usually maleimides, pyridyl 
disulfides, and a-haloacetyls. Since NHS-ester stability is less in aqueous solution and is 
usually reacted first in sequential procedures. NHS-esters react with amines to form 
amide bonds. Carbodiimides are zero-length cross-linkers (EDC) and cause direct
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coupling between carboxylates (-COOH) and primary amines (-NH2) and have been used 
in peptide synthesis, hapten-carrier protein conjugation, subunit studies and protein- 
protein conjugation.
Some heterobifunctional reagents have one reactive group that is photoreactive 
instead o f  thermoreactive. These groups are useful in case o f protein-protein interaction 
studies where the availability o f thermoreactive target groups is a factor. This option 
allows for specific attachment o f the labile thermoreactive group first, followed by 
conjugation to any adjacent N-H or C-H sites, which may be initiated through the 
photoreactive group by UV light activation. The reactivity o f the photochemical reagent 
allows for formation of a conjugate that may not be possible with a group-specific 
reagent. Photoreactive cross-linkers have low efficiency; yields o f 10% are considered 
acceptable.
N-Hydroxysuccinimide-Esters (NHS-Esters) react with primary amines with 
relatively efficient coupling at physiological pH and yield stable products (a covalent 
amide bond is formed when the NHS-ester cross-linker reacts with a primary amine, 
releasing N-hydroxysuccinimide) as shown in Figure 18.
Carbodiimides couple carboxyls to primary amines or hydrazides resulting in the 
formation o f amide or hydrazone bonds (Figure 19). No spacer exists between the 
molecules being coupled. Both carboxyl as well as glutamic and aspartic acid residues 
can be targeted, and in the presence o f excess cross-linkers, polymerization occurs 
because all proteins contain carboxyls and amines. EDC reacts with carboxylic acid 
group and activates the carboxyl group to form an active O-acylisourea intermediate, 
allowing it to be covalently attached to the amino group in the reaction mixture. The O-
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acylisourea intermediate is unstable in aqueous solutions. This instability makes it 
ineffective in two-step conjugation procedures without increasing the stability of the 
intermediate using hydroxysuccinimide. Failure to react with an amine results in 
hydrolysis o f the intermediate and regeneration o f the carboxyls. The reaction is 
performed between pH 4-5, though the yield o f the reaction is similar between pH 4.5-
7.5.
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Figure 18. Reaction ofN H S cross-linker
(Source: www.piercenet.com/Proteomics/)
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Figure 19. Reaction o f EDC cross-linker 
(Source: www.piercenet.com/Proteomics/)
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3.1.3 Free Radical Polymerization
Free-radical initiators are chemical substances that, under certain conditions, 
initiate chemical reactions by producing free radicals. These free radicals are the starting 
point o f the free radical polymerization process which can be broken down into three 
main steps: Initiation, Propagation and Termination.
Prior to the aforementioned steps, the initiator is first decomposed into free 
radicals. This decomposition is followed by initiation, which involves reaction of the free 
radical with double-bonded monomers. This reaction leads to generation o f free radical 
monomeric units, which further propagate the reaction by attacking other double bonded 
monomers. The termination o f the reaction happens by a combination reaction (two free 
radicals react and combine to a single molecule) or a disproportionation reaction (transfer 
o f a proton from one monomer to another leads to formation o f a double bond in one). 
These steps have been illustrated in the following reactions:
Radical Generation R—R  --------► 2  R*
Initiator Radicals
Initiation R® + C=C --------► R— C--C®
M onomers
Propagation r _ c _ c * + C=C --------► R -C —C-C®
Term ination R— C-C® + ®C— C— C—R --------► R -C — C— C— C— C--R.
Polym er
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In summary, this section described the chemical cross-linking techniques (faomo- 
and heterobifunctional crosslinking agents and free-radical polymerization technique) 
used in the fabrication o f charged capsule internal matrices.
3.2 Optical Imaging Techniques
3.2.1 Fluorescence
The past 15 years have seen a sensational growth in the use of fluorescence 
techniques in biological sciences. What was confined to the fields of biochemistry and 
biophysics until a few years ago is now being extended to applications in environmental 
monitoring, clinical chemistry, flow cytometry, genetic analysis by fluorescence in situ 
hybridization (FISH), DNA sequencing, and the study of intracellular substances by 
fluorescence microscopy to name a few187. The high costs and handling difficulties 
associated with radioactive substances, combined with the sensitivity of fluorescence 
detection, have led to continuous development of medical tests based on fluorescence 
principles. Enzyme linked immunoassays (ELISA) and fluorescence polarization 
immunoassays are examples of this development.
Fluorescence is the result of a three-stage process that occurs in certain molecules 
(generally polyaromatic hydrocarbons or heterocycles) called fluorophores or fluorescent 
dyes188. Fluorescent probes are fluorophores designed to localize within a specific region of a 
biological specimen or to respond to a specific stimulus. The Jablonski diagram (Figure 20) 
demonstrates the process responsible for the fluorescence o f fluorescent probes and other 
fluorophores. It is a simple electronic-state diagram Illustrating the processes involved in 
the creation o f an excited electronic singlet state by optical absorption and subsequent 
emission of fluorescence For polyatomic molecules in solution, the discrete electronic
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transitions represented by So, Si, S2, etc., are replaced by rather broad energy spectra called 
the fluorescence excitation spectrum and fluorescence emission spectrum, respectively. The 
bandwidths of these spectra are parameters of particular importance for applications in which 
two or more different fluorophores are simultaneously detected.
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Figure 20. The Jablonski diagram
(Source:http://elcliem.kaist.ac.kx/vt/chem-ed/quantum/jablonsk.htm)
The entire fluorescence process is cyclical; the same fluorophore can be repeatedly 
excited and detected unless the fluorophore is irreversibly destroyed in the excited state (an 
important phenomenon known as photobleaching). The fact that a single fluorophore can 
generate many thousands of detectable photons is fundamental to the high sensitivity of 
fluorescence detection techniques. With few exceptions, the fluorescence excitation spectrum 
of a single fluorophore species in dilute solution is identical to its absorption spectrum. Under 
the same conditions, the fluorescence emission spectrum is independent of the excitation 
wavelength, due to the partial dissipation of excitation energy during the excited-state
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lifetime. The emission Intensity is proportional to the amplitude of the fluorescence 
excitation spectrum at the excitation wavelength as shown in Figure 21. Currently, 
fluorophores used as fluorescent probes offer ample permutations of wavelength range, 
Stokes shift, and spectral bandwidth to satisfy demands imposed by instrumentation, while 
allowing flexibility In the design of multicolor labeling experiments. The fluorescence output 
of a given dye depends on the efficiency with which it absorbs and emits photons and its 
ability to undergo repeated excitation/emission cycles.
lM tess i% r
100 1
Figure 21. Excitation and fluorescence emission spectra 
(Source:http://www.zeiss.com/C12567BE0045ACFl/allBySubject/A 
0ACC4A12EA4EF86C1256AEA0050794E)
Important parameters for quantification of absorption and emission efficiencies are 
the molar extinction coefficient (e) for absorption and the quantum yield (QY) for 
fluorescence, both of which are constants under specific environmental conditions. The value
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of e is specified at a single wavelength (usually the absorption maximum), whereas QY is a 
measure o f the efficiency of conversion from excitation to emission.
W ith the availability o f a wide spectrum of reagents, fluorophores, and 
derivatization methods for the development o f fluorophores with improved sensitivity,
* • 2*h p |selectivity and applications, the use o f dye indicators for ions (Na , K , Cl , Ca , Mg , 
Zn2+), pH etc. to study intracellular events and related extracellular dynamics has grown 
tremendously. However, there are limitations to the current technology, in that liquid- 
based indicators after introduction into cells leak over time, get compartmentalized within 
organelles, are toxic and cannot be used for long-term monitoring without being 
reintroduced. Hence, encapsulated-dye-based monitoring systems offer several 
advantages over liquid indicators and, for this reason, great potential. In combination 
with analyte specific receptors or enzymes, they can respond to specific reactions in the 
body.
3.2.2 Confocal Microscopy
New and improved synthetic fluorescent probes and genetically engineered 
fluorescent proteins, a wide spectrum o f laser light sources coupled to very accurate 
acousto-optic tunable filters, and more advanced software packages combined with high 
performance computers have led to one o f the most significant advances in optical 
microscopy, namely, the refinement o f laser scanning confocal microscopy (LSCM). 
Confocal microscopy has several advantages over conventional wide-field optical 
microscopy, namely, ability to control the depth o f field, ability to take serial optical 
sections from thick specimens, and reduction o f background information from planes 
away from the focal plane.
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The basic principle of the confocal approach involves the use o f  spatial filtering 
techniques to eliminate out-of-focus light or glare in thick specimens from planes other 
than the plane o f focus. The tremendous popularity o f confocal microscopy in recent 
years has been due to the ease with which high quality images can be obtained, and the 
growing number o f applications in cell biology for imaging both fixed and living cells 
and tissues.
Figure 22 shows a schematic o f the optical train in a typical confocal microscope, 
indicating all the vital optical components. Point A in the specimen is in the focal plane. 
The laser beams focus at the observation point; fluorescent light generated by the 
specimen (red line) enters the overhead detector.189
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Figure 22. Schematic o f a Confocal Microscope 
(Source:http ://www.nikon. co .jp/main/eng/ society/tec- 
rep/ confocal_02_e.htm)
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Light from the specimen’s surface and the underside (green and blue lines) also 
heads towards the detector. The Z axis indicates the depth o f the specimen, which is 
crucial mapping information. The image blurs if  light from anywhere other than the focal 
plane enters the detector. The pin-hole, which allows light only from the observation 
point (point A) to enter the detector, prevents such blurring.
3.2.2.1 Optical slicing o f 3-D specimens. As shown in Figure 23, numerous points 
along the Z axis o f the specimen can be imaged or examined in order, just as if  the 
specimen has been sliced into segments. This information can be fed into a computer, and 
3-D reconstruction software can be used to obtain a 3-D image o f the specimen by 
combining all the sections.
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Figure 23. Concept o f optical slicing o f specimen using confocal microscope 
(Source :http ://www.nikon.co .jp/main/eng/ society/tec- 
rep/confocal_02_e.htm)
The confocal system’s ability to discriminate between slices o f the specimen 
made it invaluable in imaging capsules and identifying the area o f  localization o f the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
76
enzyme. Imaging with a fluorescent microscope made it impossible to distinguish 
between entrapment o f the enzyme in the walls and encapsulation in the interior because 
o f the out-of-focus blur.
3.3 FRAP -  Application to Studying 
Capsule W all Permeabilities
3.3.1 FRAP History and Applications
Fluorescent recovery after photobleaching experiments were started over 30 years 
ago as a non-invasive technique to visualize the lateral diffusion and dynamics o f 
fluorescent proteins in living cells, especially over the last 10 years after non-invasive 
fluorescent tagging became popular using the green fluorescent protein (GFP) 190,191. This 
research facilitated the performance o f FRAP on living cells without disruption by 
microinjection. FRAP has been used extensively to study the lateral diffusion of 
membrane-associated proteins has been used to study protein localization, dynamics, and 
interactions with other components in living cells. Also, membrane continuity and 
mobility o f molecules within specific cell compartments has been visualized.
FRAP can also be used to study events during cell division and signaling as well 
as to measure protein interactions, conformational changes, and protein dynamics. FRAP 
has also been used to study diffusion o f macromolecules in cross-linked polymer 
solutions and gels192. An important example is the study o f effect o f enzyme treatment on 
diffusion of macromolecules in guar galactomannan and titanium guar hydrogels. These 
hydrogels are extensively used in petroleum, textile, and food industries because o f 
advantages such as, natural abundance, biodegradability, low cost, and unique ability to 
alter rheological properties.
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In most o f the studies involving the study o f lateral diffusion o f adsorbed proteins, 
data acquisition was performed by using a photomultiplier tube (PMT), which measures 
the total intensity in a single spot192. The diffusion coefficient was obtained by fitting the 
plot o f the total fluorescence intensity versus time after bleaching to a diffusion model. 
This method did not provide spatially resolved fluorescence intensities, and hence was an 
exchange o f  protein between the surface and the bulk. Thus, changes in total intensity 
contributed from factors other than lateral diffusion would also be attributed to lateral 
diffusion. Using a charge-coupled device (CCD) camera helps in direct visualization of 
the bleached and unbleached areas and the measurement o f intensity profiles showing 
surface mass transfer and fluorescence recovery. These intensity profiles can be 
normalized relative to those prior to bleaching. Hence, by changing the measurement 
method, the reliability o f can be improved and non-standard transport mechanisms can be 
detected by making use o f a more complete data set. However, the potential to obtain and 
analyze the intensity profiles within the microscope filed o f view has not been fully 
utilized to date. Another method of improving the reliability o f FRAP is by obtaining 
spatially resolved fluorescence data by scanning confocal fluorescence microscopy, by 
which the collected intensity can be limited to the focal plane. It thus enables the 
performance o f 2D diffusion measurements in bulk samples.
Yet another application that merits the use o f using CLSM is the study of 
diffusion of macromolecules through cartilage193. This study is important because the 
transport of solutes is critical to the normal function of articular cartilage and is affected 
by the local structure and composition o f the cartilage, which is dependent on depth from 
the tissue surface. Magnetic resonance imaging (MR!) and nuclear magnetic resonance
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
78
(NMR) have been used to track the movement o f  only very small molecules and ions. 
Tracking of radiolabled solutes and fluorescence desorption allow for tracking o f a 
variety o f  molecules. They measure spatially averaged diffusion coefficients over large 
volumes and for this reason are not reliable.
3.3.2 What is FRAP?
FRAP (also microphotolysis) is the process by which irreversible photobleaching 
o f fluorescent molecules (permanent destruction o f the fluorescence of molecules) is 
carried out in a small area o f the region o f interest by a high-powered focused laser beam. 
The geometry o f the bleached spot can be either a spot or parallel stripes (P, or pattern 
photobleaching) 194. Subsequent diffusion o f non-bleached fluorescent molecules from 
the surrounding area into the bleached area leads to fluorescence recovery in the 
previously photobleached area, which is recorded at low laser power, and the diffusion 
coefficient (D) o f the fluorescent molecules can be derived. The rate o f recovery o f the 
fluorescent signal is a measure o f the mobility o f  the species in the system. The amount 
o f recovery is a measure o f the fraction o f the species that is mobile in the observed 
region195. The lateral diffusion o f fluorescent molecules into the bleached spot can be 
modeled on the basis o f two assumptions: all fluorescence recovery is due to two- 
dimensional diffusion in an infinite plane, and that there is no diffusion in or out o f  the 
spot during bleaching194. Bleaching during measurements is assumed to be also ignored.
3.3.3 Principle of FRAP
Two parameters regarding mobility o f a fluorescent molecule in a defined 
compartment can be obtained from, namely, the mobile fraction o f fluorescent molecules
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and the rate o f mobility, which is related to the characteristic diffusion time rD, The 
mobile fraction can be determined by comparing the fluorescence in the bleached region 
after full recovery (F») with the fluorescence before bleaching (Fi) and just after 
bleaching {Fg), as shown in the typical fluorescence recovery curve in Figure 24.
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Figure 24. Fluorescence recovery after photobleaching (FRAP).
The mobile fraction is given by R defined by:
*  =  ( F . - F o > ' ( F , - F o >  ' (2)
The mobile fraction is affected by the interaction between fluorescent molecules 
with other molecules and by presence o f membrane barriers and microdomains in 
membranes, which are discontinuities that can prevent or temporarily restrict the free 
diffusion of membrane molecules. In the context o f study o f cellular proteins in living 
cells, when motion due to active transport or unidirectional flow can be ruled out, protein 
mobility is due to Brownian motion. The mobility is expressed in terms o f diffusion
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
80
coefficient, D, which is related to the characteristic diffusion time T&, which is given by
the two-dimensional diffusion equation described by Axelrod et al.
To = « V 4 D  (3)
2  * 4o) radius o f focused circular laser beam at the e' intensity
7  -correction factor for the amount o f bleaching
The equation holds good for unrestricted two-dimensional diffusion in a circular bleached 
area and assumes that there is no recovery from above and below the focal plane. The 
Stokes-Einstein formula describes unrestricted diffusion of a particle in a free-volume 
model:
D=kT/67n?Rh (4)
T----- absolute temperature
r]------viscosity o f solution
k------Boltzmann constant
Rh---- hydrodynamic radius
The diffusion coefficient D is determined mainly by Rh because the temperature 
and viscosity remain constant during bleaching. The diffusion coefficient is directly
1 /Tproportional to the inverse of the cube root o f the molecular mass (D~M‘ ), when the 
diffusing molecule is assumed to be a sphere with a volume proportional to its molecular 
mass.
New FRAP recovery equations for three-dimensional apertured scanning using a 
Gaussian approximation for the axial beam profile have been successfully developed and 
used to extract lateral diffusion coefficients from CLSM experimental data. Two­
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dimensional diffusion coefficients o f  fluorescent species can be successfully measured by 
FRAP using CLSM; a big advantage o f using this technique is that bleaching can be 
targeted at a well-defined volume element in bulk samples. Diffusion coefficients as high 
as 2x1 O'6 cm2/s can be measured. FRAP can be performed within a conventional 
microscope. A laser beam is focused into a specimen placed on a stage o f a light 
microscope. The fluorochrome is excited as well as bleached by the laser; an acousto- 
optic device switches between low laser intensity for measuring and high laser intensity 
for bleaching. A photomultiplier is used for measuring the intensity o f the fluorescent 
signal. This system suffers from the dearth o f good imaging and probing techniques for 
the bleach experiment; the laser beam cannot be positioned for exact local bleaching. On 
the other hand, using a CLSM, images can be obtained from a two-dimensional area 
located at a precise depth inside a specimen. The CLSM also has the advantage o f three- 
dimensional laser beam probing and three-dimensional imaging. Thus FRAP can be 
performed on well-defined volume elements in a sample.
Axelrod et al (1976) developed the FRAP theory, and this theory is valid for the 
idealized case o f pure two-dimensional diffusion monitored by a laser beam with a 
Gaussian intensity profile195. The normalized recovery is given by:
- k "
n=0 nl
1
l + *P + <— )]
T d
(5)
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k is the bleach constant given by
f = e ‘ w
F i
To is the 2-D characteristic diffusion time, which is related to the 2-D diffusion 
coefficient, D by
t  = F L  (7)
T d AD
half the width of the Gaussian profile o f the focused laser spot determined at e‘ 
times the height o f the profile. D(cm2/s) is defined by
D= kT/6x»jRh (8)
k->Bolzmann’s constant 
T-> temperature (K)
'y
ij-> viscosity (N.s/m ) o f the medium
Rh~> effective radius (m) o f the diffusing particles
The fluorescent recovery when an immobile fraction is present, e.g. due to irreversible 
adsorption, is given by
F ( t) = F ( i ) { i - m - f m  m
Where F(i) is the intensity o f  the bleach spot before bleaching, and R is the mobile 
fraction defined by equation x above.
By using FRAP and the inherent advantages o f a CLSM system, permeabilities o f 
various hollow capsule architectures to labeled GOx were compared. This comparison is 
essential for understanding how the composition o f the wall affects the loading o f 
enzyme and the leaching after loading.
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3.4 Suface Characterization Techniques
3,4.1 Atomic Force Microscopy (AFM)
There are about two dozen types of scanned proximity probe microscopes that work 
by measuring a local property (height, magnetism, optical absorption, etc) with a probe or 
“tip” placed close to the sample. The ability of these devices to image at atomic resolution 
together with the ability of most of these devices to image a wide variety o f samples under a 
wide variety of conditions has facilitated its usage in the study o f biological structures196. 
Typical applications include materials evaluation (surface roughness of silicon wafers, 
surface profiles, and magnetic field mapping of recording media or reading heads), failure 
analysis (defect analysis of compact disk stampers), and quality control (surface finish of 
substrates for thin film deposition)197. The AFM works by measuring attractive or repulsive 
forces between a tip and the sample. Unlike its predecessor the scanning tunneling 
microscope (STM), which maps the surface topography by measuring the tunnel current 
between an atomically sharp tip and a metallic sample, the AFM can be used to image 
insulated samples. Measurements can be taken over a small area because of the small probe- 
sample separation (on the order of the instrument’s resolution, which is typically of 
nanometer range198 and can even go as low as 10pm199). Image acquisition is done by a raster 
scanning the probe over the sample while measuring the local property in question.
The concept of the AFM and the optical lever is illustrated in Figure 25. In its 
repulsive "contact" mode, the instrument lightly touches a tip at the end o f a leaf spring or 
"cantilever" to the sample. A detection apparatus measures the vertical deflection of the 
cantilever as a raster-scan drags the tip over the sample; this scan indicates the local sample 
height. Hence, hard-sphere repulsion forces between the tip and sample are measured in the 
contact mode.
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Though in principle, AFM resembles the record player as well as the stylus 
profilometer, it incorporates a number of refinements that enable it to achieve atomic scale 
resolution. Also, because AFM is based on interaction between the tip and sample, as well as 
surface topography, local properties, such as stiffness and friction can be determined.
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Figure 25. Working o f the Atomic Force Microscope. Inset (Feedback control o f the 
AFM). (Source: http://www-ermm.cbcu.cam.ac.uk/00001587h.htm)
The high resolutions attainable using the AFM make it ideal for the study o f 
surface topography o f capsules. It was used to assess the change in surface structure and 
the overall structure o f capsules before and after loading, as well as to study the effect o f 
formation o f internal matrices inside a capsule on its overall structure. While
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transmission microscopy can give this information by indicating changes in optical 
properties (such as opaqueness o f capsule interior when it is not hollow), it cannot give 
fine details o f  the surface and the overall topographical (or physical) information.
3.4.2 Zeta-potential Analysis
A charged particle suspended in an electrolytic solution attracts ions of opposite 
charge to those at its surface, where they form the Stem layer (Figure 26). To maintain the 
electrical balance of the suspending fluid, ions of opposite charge are attracted to the Stem 
layer. The potential at the surface of that part of this diffuse double-layer of ions that can 
move with the particle when subjected to a voltage gradient is the zeta potential. This 
potential measured is very much dependent upon the ionic concentration, pH, viscosity, and 
dielectric constant of the solution being analyzed.
C a p illa ry  w aif 
\
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Figure 26. The electrical double layer— Stem layer 
(Source:http://www.desicca.de/index.html?/intemational/engl 
and/zeta-potential/hauptteil_zeta-potential.html)
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Thus, the zeta potential is based on the measurement o f migration rate o f 
dispersed particles under the influence o f an electric field.
v /E = pE (U)
v -  observed velocity
E=strength o f the applied electric field
Pe = electrophoretic mobility
The zeta potential can be calculated from mobility using the Henry equation:
H E  =  e * 4 * f { m ) l 6 7 n j  ( I2)
e - dielectric constant o f the medium 
h - viscosity o f the medium
f(k a) - correction factor which takes into account the thickness o f the 
double layer and particle diameter.
The unit k is a reciprocal length. 1/k is frequently described as the thickness o f the 
double layer. In practice an approximation can be made for f(k a), this is f(k a) = 1.0 for 
non-polar media,
f(k a)=1.5 for particle dispersions in polar media. This number is a good 
approximation for particles >100nm In aqueous solutions with an ionic strength >10‘3 M. 
This formula is known as the Smoluchowski approximation.
p i E  =  e * £ * l 4 jr r ]  ( I3)
The second limiting case f(k a)=1.0 applies for very small particles in media with 
a low permittivity. This equation is known as the Hiickel approximation.
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Charged particles in a liquid suspension can be made to move by applying an electric 
field to the liquid through two electrodes as shown in Figure 27. By alternating the charge 
between the electrodes, the particles move back and forth between the electrodes at a velocity 
relative to their surface charge and the electrode potential. This velocity can be determined 
by measuring the Doppler shift of laser light scattered off the moving particles.
Photomultiplier
Cover
Electrodes
Sample
Reflective
Coating
Reflective 
; Coating
Prisms
Figure 27. The sensing portion o f the zeta potential instrument 
(Source:http://www.rpi.edu/dept/chem-eng/Biotech-Environ/COAG/zeta.htm)
This instrument is particularly useful in determining the feasibility o f using 
charged polymers for coating charged templates and was used to confirm the assembly o f 
polyions on charged templates.
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3.5 Absorbance Measurements for Characterization 
of Efficiency., Stability, and Activity of 
Encapsulated Enzyme
3.5,1 Beer’s Law
The absorbance, A(>l), of a species at a particular wavelength of electromagnetic 
radiation, A, is proportional to the concentration, c, of the absorbing species and to the length 
of the path, L, of the electromagnetic radiation through the sample containing the absorbing 
species.
A(A) = e{X)Lc (14)
The proportionality constant e(/4) is called the absorptivity of the species at the 
wavelength, A. The way in which e(/l) depends on wavelength defines the spectrum of the 
substance in question. The wavelength at the maximum value is called the analytical 
wavelength of the substance. Figure 28 shows the absorbance spectrum of DNA with the 
wavelength at the absorbance maximum indicated as the analytical wavelength. Normally, 
the Beer’s law applies at the analytical wavelength. Hence, the sensitivity to concentration 
changes is the highest at that wavelength.
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Figure 28. UV-Vis spectrum o f DNA and protein 
To experimentally obtain the Beer’s Plot, the following steps can be followed:
• Prepare a series of samples of known concentration o f the substance, the analytical 
wavelength of which is known (danai).
• Measure the absorbance of each of the solutions of known concentration at the analytical
wavelength and plot the values of the absorbance as a function of the concentration (Figure 
29).
• Verify that, within experimental error, the absorbance is a linear function of the 
concentration. If linear, the slope of the best straight line through the experimental points in 
the absorbance vs. concentration plot gives the Beer's Law slope. The Beer's law slope has 
the value e(ylanai) 1, where 1 is the path length through the sample.
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Figure 29. Beer’s Law Plot 
(Source: http://icn2.umeche.maine.edu/genchemlabs/images/beerplot.gil)
The slope can be used to determine the concentration corresponding to an absorbance 
for samples of unknown concentration if the same experimental arrangement (same 
spectrometer, same cell) are used. If a different experimental arrangement will be used (e.g., 
a different cell), the Beer's Law slope will need to be adjusted by the path length through the 
cell used in the Beer's Law determination. This slope will provide the value of the 
absorptivity, e(danai), which should be characteristic only of the substance and the 
wavelength, and independent of the experimental arrangement used to determine it.
3.6 Glucose Sensor Components
An ideal glucose sensor needs to satisfy a number o f  criteria, such as selectivity, 
linear range and response time, biocompatibility, storage and operational stability at body 
temperature, reversibility o f signal, reproducibility o f sensor fabrication, which current 
endeavors have not been able to completely satisfy1. Moreover, the sensor components 
must be inexpensive and fabrication method must be simple.
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This section describes the components o f the glucose sensor designed in this 
research. The sensor is selective to glucose because of the use o f flavoenzyme GOx. The 
numerous advantages o f this enzyme have been enumerated in the following sections. 
The incorporation o f HPTS in the sensor makes it a ratiometric sensor o f glucose based 
on changes in pH. Being ratiometric, it is less affected by fluctuations in instrumental 
parameters. The sensor fabrication procedure, which will be described in the Chapter IV 
is simple and repeatable.
The following sections expound on the sensor components and their 
characteristics, which made them amenable to the constmction o f a glucose sensor.
3.6.1 Enzymes and Enzymatic Activity
Enzymes bind to one or more ligands (substrates) and convert them into one or 
more chemically modified products. This binding happens over and over with 
phenomenal speed. They speed up reactions by a factor o f a million or more, without 
themselves changing. They act as catalysts that permit cells to make or break covalent 
bonds in a controlled way. Catalysis is a vital function that creates and maintains the cell 
by aiding organizing sets o f chemical reactions, making life possible. Enzymes work in 
teams, with the product o f one enzyme becoming the substrate for the next. Thus an 
elaborate network o f metabolic pathways provides the cell with energy and produce 
molecules, both large and small that the cells need200.
The basic reaction path o f  an enzyme is as follows:
E + S “>EP">E-TP.
There is a limit to the amount o f substrate that a single enzyme molecule can 
process in a given time. Figure 30 shows the relationship between substrate concentration
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and enzyme activity. Enzyme activity (reaction rate) is defined as the number o f substrate 
molecules processed per second. With the increase in the concentration of substrate, the 
rate at which product is formed also increases, up to a maximum value (the enzyme is 
now saturated with substrate). The rate o f reaction Vmax at this point depends on how 
rapidly the enzyme can process the substrate molecule. The turnover number is defined as 
the enzyme rate divided by the enzyme concentration. It is typically 1000 substrate 
molecules processed per second per enzyme molecule, though, numbers between 1-1000 
are also known. Another important parameter in enzyme kinetics is Km , defined as the 
concentration o f the substrate that allows the reaction to proceed at one-half its maximum 
rate (0.5Vmax) . If  the Km is low, the enzyme generally binds tightly to the substrate and 
hence reaches its maximum catalytic rate at a low substrate concentration.
Vmax: uninhfcited
concentration of su b stra te  [S |
Figure 30. An illustration o f enzyme kinetics
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The enzyme increases the local concentration o f substrate molecules at the 
catalytic site, holds all the appropriate atoms in the correct orientation for the reaction 
that is to follow, and most importantly, the binding energy contributes directly to 
catalysis. Substrate molecules have to pass through a series o f  intermediate states (altered 
geometry and electron distribution) before they form the final products o f the reaction. 
Activation energy is the free energy required to attain the most unstable transition state 
(Figure 31); it is the major determinant o f the reaction rate. Enzymes have a much higher 
affinity for the transition state o f the substrate than they have for the stable form. The 
tight binding lowers the transition state energies tremendously, and hence accelerates a 
particular reaction by lowering the activation energy that is required.
By experimentally determining the rates o f enzyme reactions using standard 
assays, the effect o f various parameters (concentrations o f substrates, products, inhibitors, 
regulatory ligands, effect o f binding and entrapment o f enzymes in matrices) can be 
studied. This determination is particularly important in enzyme encapsulation studies 
because the effect o f encapsulation on enzyme conformation and hence activity, and the 
availability o f substrates to the enzyme after encapsulation, can be studied by measuring 
enzyme activity. By comparing activities o f the enzyme before and after encapsulation, 
the effect of encapsulation on the enzyme can be interpreted both for short and long 
periods o f time.
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Figure 31. Enzymatic acceleration of chemical reactions by decrease o f activation 
energy. (Source: http://w3.dwm.ks.edu.tw/bio/activeleamer/06/ch6c 1 .html)
3.6.2 Theory of Glucose Measurement 
Using GOx
Glucose oxidase is a slightly elongated globular protein with an axial ratio o f 
2.5:1, an average diameter o f 8nm201. The absorbance spectrum has maxima at 278, 382 
and 452nm. The enzyme is a dimer composed o f two identical subunits. The holoenzyme 
is made o f  two identical subunits, each with a M W  o f 80000. There is a long but narrow 
contact area connecting the monomers non-covalently with either salt linkages or 
hydrogen bonds. Each monomeric unit is a compact spheroid with dimensions 60A x 52 
A x 37 A202. It folds into two structural domains, one binding the FAD and the other 
involved with substrate binding. The carbohydrate content o f  the enzyme ranges from 8 
to 12, which accounts for variations in the isoelectric point between 3.9 and 4.3. It is 
anionic at physiological pH.
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Figure 32 illustrates the glucose oxidase reaction. Similar to other flavoenzymes, 
the enzymatic reaction can be divided in two steps203. The reductive half consists o f 
transfer o f  two protons and electrons from glucose to the enzyme yielding d- 
gluconolactone. The oxidative half reaction consists o f the oxidation o f the enzyme by 
molecular oxygen yielding hydrogen peroxide. Finally, d-gluconolactone can be 
hydrolyzed non-enzymatically to gluconic acid.
ClLjOU CTf,OfI
<;ox + H, 0
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Figure 32. The glucose oxidase reaction 
(Source: http://www.imb-jena.de/www_bioc/post/GOX/)
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GOx is easy and cheap to obtain; it is one of the most robust enzymes, which can 
withstand greater extremes of pH, ionic strength, and temperatures (these properties 
allow less stringent conditions during manufacturing and relatively carefree storage and 
use by home-users o f the biosensor incorporating it); the concentration range of glucose 
with which GOx reacts optimally coincidentally agrees with the range o f concentrations 
encountered in human blood.
3.6.3 HPTS as a pH Sensitive Dye
HPTS (Figure 33(a) and (b)) has many attractive features that make it an ideal 
fluorescent indicator, namely, large Stokes shifts, high quantum yield, high absorbance, 
excellent photostability, and non-toxicity204. It has a pKa o f 7.3, which is in the middle o f 
the physiological pH range. At near neutral pH, HPTS fluoresces green (conjugate base 
form exclusively) and independent o f  whether it was excited in its conjugate base or 
acidic form, or both205. The ratio o f fluorescence intensities resulting from excitation 
(Figure 33(b)) at 470nm and 405nm can be used to quantify pH values between 6 and 9. 
This ratio is not influenced by temperature and ionic strength206.
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Figure 33. (a) Structure ofHPTS, (b) Spectra o f HPTS 
(Source: http://www.probes.com/handbook/figures/0578.html)
In summary, this chapter described the techniques used to study the encapsulation 
efficiency, stability, and activity o f  encapsulated enzymes, comparison o f wall 
permeability o f capsules o f different architectures, and the study o f response o f glucose 
sensors. The next chapter describes the chemicals, materials and methods used to 
implement the goals o f this project using the techniques described in this chapter.
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CHAPTER IV
MATERIALS AND METHODS
This section describes the chemicals, instruments and methods used in 
experiments. Detailed information about the inventory o f these materials and instruments, 
can be found in Appendices A and B, respectively. Appendix A includes product name, 
number and vendor information for chemicals and other materials used. Appendix B 
contains vendor information about the instrumentation used.
The methods described here pertain to capsule preparation, visualization of 
capsules using CLSM, and characterization o f capsule topography before and after 
loading o f enzyme with the AFM. Procedures for testing glucose sensitivity o f HPTS- 
GOx sensors have also been described. Use o f specific equipment such as the UV-Vis 
spectrophotometer in studying the stability and activity o f  encapsulated enzyme has also 
been described. Chemical procedures involving labeling o f enzymes and polyions, as 
well as free radical polymerization o f acrylic acid monomers have been mentioned.
99
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4.1 Chemicals and Materials
4.1.1 Polvions
Poly (sodium 4-styrenesulfonate) (PSS, MW 70000), Poly (allylamine 
hydrochloride) (PAH, MW 15kDa), Poly (diallyldimethlyammoniumchloride) (PDDA, 
MW 100-200kDa) and Poly (vinyl sulfate, potassium salt) (PVS, MW 170,000) were 
purchased from Sigma. Chitosan (CHT, low molecular wt, 50,000 Da) was obtained from 
Aldrich.
4.1.2 Enzymes and Enzymatic Activity Assays
Glucose oxidase (GOx, 160K and 200000 units/g) was obtained from Sigma. 
Horseradish Peroxidase (HRP, 40K and 181 purpurogallin units/mg) was obtained from 
Sigma. Potassium Phosphate Buffer (lOOmM, pH 6.0 at 20°C), 0.5% (w/w) Hydrogen 
Peroxide, and 5% (w/v) Pyrogallol solution were used to prepare the enzymatic assay for 
HRP. 3,3’- Dimethoxybenzidine (O-dianisidine, FW 317.2, Sigma), /3-D (+) glucose 
(Sigma) and HRP were used to prepare the enzymatic assay for GOx. Sodium 
bicarbonate buffer was used for the labeling reaction and was obtained in powder form 
from Sigma.
4.1.3 Colloids (template)
Monodisperse melamine formaldehyde (MF) particles (5.25pm, 10% solids 
weight) with positive surface charges were purchased from Microparticles GMBH, 
Germany. Monodisperse manganese carbonate (MnCOs) microparticles (5.8pm) with 
positive surface charges were synthesized according to a previously established 
protocol207. Polymethacrylate (PMA) particles ( 6  pm, 10% solid content) were purchased 
from Fluka chemicals.
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4.1.4 Labeling Reactions
Tetramethylrhodamine-5 - (and-6 )-isothiocyanate (TRITC) was obtained from 
Molecular Probes and was used to label GOx to visualize loading o f the enzyme. Pyrene 
8 -hydroxy-1,4,6-trisulfonylchloride (HPTS, MW 513.78) was purchased from Marker 
Gene Technologies, Inc., and GOx was labeled with HPTS for sensor experiments. PD- 
10 desalting columns were obtained from Amersham Biosciences and were used for 
separation o f the labeled enzyme from the free dye. Tetramethylrhodamine-5- (and-6 )- 
isothiocyanate (TRITC) was obtained from Molecular Probes and was used to label HRP. 
All labeling reactions were performed using a standard amine labeling protocol208, which 
has been described in the methods section. Fluorescein isothiocyanate isomer I was 
obtained from Sigma and was used to label PAH.
4.1.5 Formation of Polv(Acrylic Acid)
Acrylic acid monomer (99%) and ammonium persulfate ((NFLO2S2O8) were 
purchased from Aldrich and Sigma, respectively.
4.1.6 Other Chemicals and Materials
Glacial acetic acid (99.7%) was purchased from J.T. Baker. L-Arginine was 
obtained from NOW Foods, Bloomingale, IL; N-(3 -DimethyaminopropyI)-N’ - 
ethylcarbodiimide hydrochloride (EDC, MW 191.7) and N-Hydroxysulfosuccimnimide 
Sodium salt (NHS, MW 217.13) were purchased from Fluka. Phosphate buffered saline 
(PBS) buffer was obtained from Fluka BioChemika. Coverslips and microscope slides 
were obtained from VWR Scientific and Cole Parmer Instruments respectively. 
Centrifuge tubes and cuvettes were purchased from Fisherbrand.
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All chemicals were reagent grade and used as received. Deionized water 
(18.75MO) was used for all solutions.
4.2 Methods
This section describes the procedure for preparation o f capsules for all 
experiments described in this dissertation. The first section describes the labeling 
procedures for labeling GOx, HRP and PAH with dyes (FITC, TRITC and HPTS) and the 
procedure for imaging o f capsules using the atomic force microscope. The second section 
describes the fabrication procedure for capsules with wall architectures {PVS- 
PAH}4(MF) {PSS-PAH}4(MF), {PSS-PDDA}4(MF), {PVS-PAH}2 + (PSS- 
PAH}2(MF),{PVS-CHT}2 + (PSS-PAH}2(MF) using MF template and (PSS- 
PAH}4(MC- internal arginine matrix) using the MC template. It also describes the 
procedure for loading GOx and evaluation o f encapsulation efficiency, long-term 
stability, and activity o f  encapsulated GOx. The third section describes the FRAP 
procedure for evaluation o f permeabilities o f various capsule architectures to FITC-GOx.
The fourth section describes the procedure for fabrication o f capsules and 
formation o f internal poly(acrylic acid) (PAA) matrix for encapsulation o f HRP, and 
evaluation o f  encapsulation efficiency, long-term stability, and activity o f the 
encapsulated HRP. It also explains the experimental procedure for studying the effect o f 
(acrylic acid:(NH4)2S208)) concentration on efficiency o f enzyme encapsulation and 
enzyme activity.
The fifth section explains the procedure for using PMMA as the template for 
fabrication o f microcapsules. Finally, the sixth section describes the experimental
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protocols for testing the glucose sensitivity o f HPTS-GOx both in solution and after 
encapsulation.
4.2.1 Labeling Reactions
The procedure was used for making FITC-PAH: 0.1 M sodium bicarbonate 
(NaHCOs) buffer was prepared and adjusted to pH 9 by HC1 and KOH. Next, 60 mg PAH 
was dissolved in 1 mL 0.1M NaHC03 buffer and 0.25mg FITC was dissolved in 100 pL 
N,N-Dimethylformamide (DMF). FITC solution was added into PAH solution and stirred at 
room temperature for one hour. Then, the FITC-PAH conjugate was precipitated in 30 mL 
acetone and centrifuged at 3000 rpm for five minutes. After removing the supernatant, the 
rem aining FITC-PAH conjugate solid was resuspended and dissolved in 30 mL pH 7 tris 
buffer. FITC-PLL was made in a similar way, but 5mg PLL was dissolved in 1 mL 0.1M 
NaHCCb buffer in place of the PAH.
A protein-labeling procedure for tagging GOx and HRP with FITC was developed 
from the guidelines provided by Molecular Probes and Sigma-Aldrich. For labeling GOx 
with FITC and TRITC, 0.1 M sodium bicarbonate buffer was prepared and adjusted to pH 9. 
Next, 20 mg of the enzyme was dissolved in 1 mL of 0.1 M NaHC03 buffer. Then, 2.5 mg 
FITC powder was dissolved in 5mL DMF. While stirring the enzyme solution slowly, the 
FITC solution was added. The reaction was incubated at room temperature with continuous 
stirring for one hour. Finally, the conjugate was separated from unreacted labeling reagent 
with an Amersham Pharmacia Biotech PD-10 desalting column. For labeling GOx with 
TRITC, lOmg/ml GOx and 0.5mg/ml TRITC were used. For labeling GOx with HPTS 
(lOmg/ml), 6 mg/ml of GOx and 70/iL of HPTS were used in the labeling reaction.
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4.2.2 Characterization of Capsule Surface 
Topology Using Atomic Force 
Microscopy CAFM)
A volume o f 10/d of the suspension to be imaged was dispensed onto a mica 
substrate and incubated at 60°C for five minutes, to remove water from the interior o f the 
capsules. Scanning probe microscopy (AFM Quesant, Model 250) was used to obtain 
morphological information o f the capsules before and after polymerization of acrylic 
acid, and after encapsulation of enzyme. The intermittent contact mode (Wave Mode) 
was used to scan the sample with a 40/im scanning head. The NSC16 cantilever used had 
the following tip specifications: -30° full tip cone angle, 15-20/rm tip height, tip 
curvature radius < 1 0 nm.
4.2.3 Capsule Fabrication
Among the architectures studied, {PSS-PAH}4(MF), |PSS-PDDA}4(MF), {PVS- 
PAH}2  + {PSS-PAH}2(MF) were hollow capsules and {PVS-CHT} 2 + {PSS- 
PAH}2(MF) , {PSS-PAH} 4(MC- internal arginine matrix) were believed to have internal 
matrices due to the capsule preparation procedures described in the next section. PAH, 
PDDA, PSS and PVS solutions were prepared using DI water, and 0.2M NaCl was added 
to each o f them. For the preparation o f CHT solution (1% wt), 0.5g o f chitosan was 
added to 49.5g water, 3ml o f 3% (3ml acetic acid and 97ml water) acetic acid was added 
to CHT solution, and this solution was sonicated at level 2-3 for 15-20 minutes.
The general procedure for coating particles is as follows: Depending on the type 
o f template used, the polyanion was added to 100/tL (10% solids) o f MF colloid 
suspension or 30mg of MC particles, and 15 minutes were allowed for complete 
adsorption saturation o f the polyanion. After rinsing with DI water, the sample was
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centrifuged at 5000rpm for 3 minutes. Three such rinse cycles followed every 
polyelectrolyte adsorption step. The particles were then immersed in polycation for 15 
minutes. This process o f adsorbing alternate layers of polycations and polyanions was 
continued until the desired numbers o f  bilayers were deposited on the template. Except 
for {PVS-CHT} 2 + {PSS-PAH}2 architecture with MF templates, the core material (MF 
or MC) was then dissolved by suspending the coated particles in 0.1M HC1 for five 
minutes and rinsed four to five times with DI water.
Capsules with {PVS-CHT} 2 + {PSS-PAH}2 architecture with MF templates were 
believed to have internal matrix formed during the process o f polyelectrolyte coating. MF 
begins to dissolve partially due to low pH (2-3) o f the CHT solution and hence a matrix 
was formed due to the interaction o f the template with the initial bilayer materials, 
consisting o f MF oligomers, CHT and PVS. No additional dissolution steps were required 
for these particles.
Capsules with {PSS-PAH}4  architecture with MC templates were used to test a 
novel method o f formation o f internal charged matrices using amino acid arginine using 
zero-length cross-linking reagent EDC with NHS. Briefly, 300/d o f 80mg/m! o f arginine 
monomer solution was added to 250/d o f freshly prepared capsules, followed by addition 
o f 300/d each (1:1 ratio) o f 15mg/ml EDC and NHS. All solutions were prepared with 
sodium bicarbonate buffer (pH 8.5). Though the crosslinking action o f  EDC/NHS is most 
effective between pH 4-5, the reaction was carried out at an alkaline pH because arginine 
is mildly protonated and more reactive. The mixture was incubated overnight to allow 
sufficient reaction time for the slower action o f EDC/NHS.
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4.2.4 Loading of Capsules
After fabrication of capsules, each capsule suspension was incubated with 
unlabeled GOx (2mg/ml, pH=5 in DI water) for six hours for long-term stability, and 
activity studies. At this pH, GOx (pl=4.2) is negatively charged. In the case o f {PVS- 
CHT} 2+ (PSS-PAH} 2(MF) capsules, the internal matrix inside the capsule was positively 
charged (likely due to chitosan and MF oligomers) at this pH, and GOx was 
electrostatically attracted into the capsule and entrapped in the matrix.
TRTTC-GOx was used for visualization o f {PSS-P AH}4 (MF), {PSS- 
PDDA}4(MF), {PVS-PAH}2+{PSS-PAH}2(MF), and {PVS-CHT}2+{PSS-P AH}2(MF) 
capsules. PAH}4(MC) capsules were visualized using FITC-GOx . A Leica TCS SP2 
system, Germany (HCXPL APO CS 63x1.4 oil immersion objective) was used to 
perform confocal imaging. After adding 3 ill o f capsule suspension to a coverslip, 3 /xl of 
labeled GOx (1 mg/ml, pH=5) was added to the drop o f capsules. Imaging was performed 
with the 488nm line o f the Ar : Kr laser set to 50% and the PMT voltage at 500V. The 
Leica Lite software was used to analyze data. For FRAP studies, 3 jul o f  capsules in 
loading solution was pipetted on a coverslip precoated with {PEI-PSS} 4 layers (to 
stabilize capsules on the surface o f the coverslip). The edges o f a coverslip were smeared 
with paraffin wax and was then placed on the sample and sealed by gently pressing 
against the surface o f the slide to prevent evaporation of the sample. Sealing was 
necessary to prevent evaporation during the experiment.
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4.2.5 UY-Vis Spectrophotometry for 
Stability and Activity Studies of 
Encapsulated GOx
A Perkin Elmer Lambda 45 UV/Vis spectrometer was used for estimation o f the 
quantity o f GOx encapsulated, stability o f the encapsulated GOx, and its activity. The 
percentage o f GOx encapsulated was estimated by measuring the absorbance at 280nm of 
the enzyme in the loading solution and the supemate after loading; the difference in the 
two absorbance values followed by conversion to mass using the Beer’s law (in mg) 
gives an estimate o f the mass o f enzyme encapsulated. For the activity study, the standard 
assay protocol from Sigma was used209. Upon addition o f 60/rl of capsules with 
encapsulated GOx, O-dianisidine, which is one o f the constituents of the assay, is 
oxidized by H2O2 (this reaction is catalyzed by peroxidase), which is a byproduct o f the 
reaction between glucose and GOx to a highly colored substance. The formation of this 
product can be measured at 500nm. The continuous spectrophotometric rate 
determination was used to record changes in absorbance at 500nm, at 30-second 
intervals, for a total o f 15 minutes. The initial linear increase in absorbance with time was 
taken as a quantitative measure o f the catalytic activity o f  glucose oxidase. The 
temperature was maintained at 25 °C for all activity tests using a Quantum Northwest 
temperature controller.
4.2.6 Long-term Stability and 
Activity Studies
Two samples per architecture were prepared for long-term stability and activity 
studies; one sample was used for activity study and the other for stability study. For long­
term leaching studies, GOx loaded capsules were stored in deionized water for a period
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of four weeks. Both stability and activity measurements were first made on the first week, 
on the day o f  loading. Subsequently, measurements were made one and three weeks after 
loading. For the stability measurements, each o f the samples was centrifuged to separate 
the loaded capsules from the supemate. The supemate was drawn off, and absorbance 
measurements were made to calculate the amount o f enzyme leached into the supemate 
during the storage period.
4.2.7 Protocol for FRAP Studies
A slide was coated with {PEI-PSS}4 layers (to stabilize capsules on the slide 
surface) and three /d o f capsules in loading solution was pipetted on the slide. The edges 
of a coverslip were smeared with paraffin wax, and it was placed on the sample. The 
edges o f the coverslip were sealed by gently pressing them against the surface of the slide 
to prevent evaporation o f the sample during the experiment.
The Marquardt procedure was used to fit the intensity of the FRAP signal with the 
theoretical curve given by equation (5). From the MATLAB code, it can be seen that 
three different models were used to perform curve fitting. Two parameters, k  -  bleaching 
constant and rD -  characteristic diffusion time characterize the theoretical curve. Ideal 
values o f k and Td (k_guess and Td respectively) were first obtained by random 
substitution o f values for these parameters in the theoretical curve to obtain an ideal 
representation for the diffusion recovery. To obtain the Least Squares Fit (LSQ) using 
modelO, the value o f k evaluated from equation x l (k_calc) was used in the theoretical 
curve equation and fitted for 7p. In model 1, td was fitted first, followed by k. In model2, 
both Tp and k were fitted simultaneously. For all architectures, model 1 and model2 
provided better fits for the data.
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4.2.8 Multilayer and Capsule Preparation 
And Polymerization of Acrylic Acid 
Matrix for Peroxidase 
Encapsulation
Manganese carbonate (MnCCb) particles were coated with four bilayers of 
PS S/PAH using the LbL nanoassembly approach37. Briefly, 0.5mL of PSS solution 
(2mg/ml, 0.2M NaCl) was added to 50/tL o f MnC0 3  particle suspension, and allowed to 
react for 15 minutes to achieve complete adsorption saturation. The sample was then 
rinsed with DI water and centrifuged at 5000rpm for 3 minutes. Three such rinse cycles 
followed every polyelectrolyte adsorption step. The particles were then dispersed in 0.5 
ml PAH (2mg/ml, 0.2M NaCl) for 15 minutes and then rinsed thrice with DI water. The 
consecutive adsorption o f alternating polyelectrolytes was continued to achieve 
deposition o f four bilayers o f PSS/PAH. After coating, the MnCCb core was dissolved by 
immersion in HC1 (0.1M) for 30 minutes,, followed by rinsing and immersion in EDTA 
for 15 minutes. The resulting suspension o f microcapsules was then rinsed four times 
with DI water. These capsules were used in the following process for free radical 
polymerization o f acrylic acid to form a poly (acrylic acid) matrix in the interior, 
followed by loading o f  HRP.
Figure 34 contains a schematic illustrating the process o f fabrication and 
spontaneous loading of microcapsules with HRP. An internal anionic poly (acrylic acid) 
matrix was formed by incubating capsules in a highly concentrated solution (99%) o f 
acrylic acid and 2mg/ml o f initiator in a microcentrifuge tube at 60°C.
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Figure 34. Schematic of acrylic acid matrix formation and loading and entrapment 
of peroxidase inside the capsule
In a pilot experiment, it was discovered that using lOOpl each of the monomer 
(99%) and snainitiator (2mg/ral) produced a highly viscous gel of polyacrylic acid and 
the capsules indicating a high degree of polymerization; progressively reducing the 
volumes of the reactants produced less viscous gels, indicating lower degrees of 
polymerization. Hence, acrylic acid and (NH4)2S20s were added in 1:1 ratio by volume to 
100j.il of freshly prepared microcapsules (three different volumes of reactants, lOpil, 50jil 
and lOOpl each of monomer and initiator; the corresponding concentrations of acrlylic
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were 0.23M, 1.18M and 2.36M, and o f the initiator were 0.13mM, 0.65mM, and 
1.3 ImM). The mixture was diluted with DI water to make up a total volume of 600/xl. 
This mixture was then incubated in an oven maintained at 60-70°C for 30-120 minutes. 
The sample with the highest volumes o f the reactants (monomer and initiator) was 
incubated only for 30 minutes, that with intermediate volumes for 45 minutes and the 
sample with the lowest volume o f reactants was incubated for 120 minutes. The change 
in viscosity o f the mixture, as assessed by visual observation was used as an indicator for 
polymerization o f acrylic acid monomers. After polymerization the capsules were rinsed 
with DI water and centrifuged (5000rpm for 10 minutes) twice, then dialyzed against DI 
water to remove unreacted monomers and the initiator from the capsule suspension. 
These capsules were then loaded with TRITC-HRPx as described in the next section.
4.2.9 Spontaneous Loading of Capsules with 
TRITC-HRP/HRP After Polymerization 
of Internal PAA Matrix
After polymerization and rinsing, the capsule suspension was incubated with 
1 mg/ml TRITC-HRP in DI water (pH 5) for 6  hours. At this pH, HRP is positively 
charged (pl=8 .8 ); since the acrylic acid matrix inside the capsule is negatively charged at 
this pH, TRITC-HRP was electrostatically attracted and spontaneously loaded into the 
capsules and entrapped in the matrix. The loaded capsules were then imaged to visualize 
loading and localization o f TRITC-HRP using a confocal microscope as described in the 
next section. For activity studies and estimation o f loading efficiency, unlabeled HRP 
(1 mg/ml) was used instead o f TRITC-HRP, and the same loading procedure described 
above was used.
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4.2.10 Assessment of Time-Dependent 
Loading Behavior of Capsules Using 
Confocal Laser Scanning 
Microscopy (CLSM)
A  Leica TCS SP2 system, Germany (63X, 1.4 oil immersion objective) was used 
to perform confocal imaging. After placing three microliters o f capsule suspension on a 
microcover glass (24x6Gmm, 0.16-0.19mm thickness), three microliters o f TRITC-HRP 
(1 mg/ml, pH -5) was added to the drop o f capsules. Imaging was performed with the 
intensity of with the 543nm line o f the Ar : Kr laser set to 50% and the PMT voltage at 
500V. A single capsule was located and multiple images o f the same x-y section of the 
capsule were collected over time (30second intervals) to record the spontaneous loading 
o f TRITC-HRP. The Leica Lite software was then used to analyze data; data analysis 
involved representation o f loading o f the capsule by considering a region of interest 
(ROI) in the capsule interior and plotting the average intensity in the ROI against time.
4.2.11 Assessment of Encapsulation 
Efficiency and Activity Using
UV-Vis Spectrophotometry
The procedure described previously in this chapter for estimation o f percentage 
encapsulation o f GOx in the capsules after loading was also used for HRP. The 
assessment o f activity o f  encapsulated HRP was done using the following procedure. 
60/d o f capsules with encapsulated peroxidase is added to the assay; pyrogallol, the dye 
constituent o f the assay, is oxidized by peroxidase to purpurogallin, which is a highly 
colored substance. The formation o f his product can be measured at 420nm. The 
continuous spectrophotometric rate determination was used to record changes in 
absorbance at 420nm, at 30-second intervals, for a total o f 60 minutes. The initial linear
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increase in absorbance with time was taken as a quantitative measure o f  the catalytic 
activity o f  peroxidase.
4.2.12 Effect of Acrylic AcidrfNHASqO*
Concentration on Efficiency of 
Enzyme Encapsulation 
and Enzyme Activity
Six batches o f {PSS/PAH} 4  capsules (three pairs, each with a different volume o f
reactants, acrylic acid and (NHU^SaOs in 1 :1  ratio) were prepared and the poly (acrylic
acid) matrix was formed as described previously. The capsules were split into three pairs,
each pair consisting o f one sample for stability tests and the other for activity tests. After
dialysis, loading, and rinsing, the capsules were used for activity studies and were
assessed for efficiency o f encapsulation as described in the previous section. The
encapsulation efficiencies and activities o f capsules were compared as a function o f the
volume o f reactants used in the preparation o f the internal poly (acrylic acid) matrix.
4.2.13 Capsule Preparation Using 
PMMA Template
The assembly o f oppositely charged polyelectrolytes was carried out on 
negatively charged PMMA. Three methods were attempted to improve the yield and 
quality o f microcapsules produced. In the first attempt, 50/d o f  6 /im PMMA template was 
coated with 6  bilayers o f PAH-FITC and PSS. The coated PMMA particles were then 
suspended in acetone overnight. This coating was followed by two more acetone rinses 
and finally with four rinses with deionized water. Since the first attempt produced a large 
number of broken capsules, the number o f bilayers in the subsequent attempts was 
increased. Also, since labeling o f PAH with FITC reduces the charge density o f PAH and 
hence weakens its electrostatic interaction with PSS, PAH-FITC was used in the
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fabrication o f only the three outermost bilayers, the other bilayers used unlabeled PAH. 
In the second attempt 50/xl o f 6 jtim PMMA template particles were coated with 
{PAH/PSS} 3  + {PAH-FITC/PSS}3 . This coating was followed by immersion in acetone 
for five hours. A small portion o f the sample was then observed with the confocal 
microscope, while the rest was left immersed in acetone. Another aliquot o f  the sample 
was observed after 17 hours, and yet another after 24 hours. In the third attempt, 6 jUm 
PMMA template particles were coated with eight bilayers o f PAH and PSS followed by 
three more bilayers o f FITC labeled PAH and PSS to help in visualization. They were 
immersed in acetone for 1.5 hours, followed by gradual titration o f DI water into the 
sample. The volume o f supernatant drawn off from the sample was gradually increased 
and replaced with an equal volume o f DI water. The capsules were visualized using 
confocal microscopy and AFM.
4.2.14 HPTS-GOx for Glucose Sensing
For studying glucose sensitivity o f  encapsulated GOx, capsules with architecture 
{PVS-CHT} 2  + {PSS-PAH}2(MF) were used. The procedure for fabrication o f these 
capsules has been described previously in this chapter. The loading o f the capsules has 
also been described previously. For visualization o f loading with confocal microscopy, 
TRITC-GOx was used to load capsules.
4.2.15 Study of Effect of Titration ofO.lM HC1 
on the Change in pH of PBS (pH-7.4) 
Buffered HPTS-GOx, PBS 
Buffer and HPTS
After mixing 40/d o f HPTS-GOx with 1.2ml o f PBS 7.4 buffer, the initial pH was 
recorded with a Thermo Orion pH meter. Aliquots o f 0.1M HC1 were added successively
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to the solution, and the pH was recorded after each increment. The solution was 
continuously stirred using a magnetic stir bar throughout the titration experiment. The 
variation o f pH o f HPTS in PBS was recorded similarly.
4.2.16 Fluorescence Spectroscopy to Record 
Change in Excitation Peak Ratio of HPTS
A scanning fluorescence spectrometer (QM1, Photon Technology International) was
used to record the change in peak ratio o f HPTS with the changes in pH. Fluorescence
excitation scans were obtained by using the “Excitation scan” mode o f the PTI. An
emission wavelength o f  520nm and an excitation range of 350nm-500nm were used. All
solutions and dispersions were continuously mixed (using magnetic stirring) during the
titration experiments. Measurements were made in triplicate.
4.2.17 Response of PBS Buffer (pH=7.4). 
PBS Buffered HPTS and HPTS-GOx 
to Titration of 0.1 M HC1
Initial excitation spectra o f HPTS-GOx in PBS buffer before addition o f acid were 
obtained. Measurements were made after each successive aliquot o f HC1 was added. The 
acid was added until changes were no longer observed in the acid to base peak ratio 
(405/454nm) after addition o f HC1. The experiment was carried out in a similar way for 
PBS buffered HPTS.
4.2.18 Glucose Sensitivity Study of HPTS-GOx 
Both in Solution and After Encapsulation
in Chitosan Capsules
Glucose sensitivity experiments were carried out using four different conditions, 
namely, (1) HPTS-GOx in DI water, (2) HPTS-GOx in PBS buffer, (3) HPTS-GOx
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encapsulated in chitosan capsules and suspended in DI water, and (4) HPTS-GOx 
encapsulated in chitosan capsules and suspended in PBS buffer.
In each case, initial excitation spectra o f the solution or dispersion were obtained 
before addition o f glucose. After each addition o f glucose measurements were made to 
observe the change in acid to base peak ratio. All spectra were normalized to 412nm, 
which is the isobestic point of the two emission peaks.
In summary, this chapter described the methods used to fabricate and visualize 
capsules and characterize capsule topography before and after loading o f enzyme, and 
procedures for testing glucose sensitivity o f HPTS-GOx sensors. Chemical procedures 
involving labeling o f enzymes and polyions, as well as free radical polymerization of 
acrylic acid monomers have also been described. The next chapter elucidates the results 
obtained using the aforementioned techniques.
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RESULTS AND DISCUSSION
Results o f the various stages o f the project are explained in detail in this chapter. 
A comparison of microcapsules with different wall architectures with respect to 
encapsulation, stability, and activity o f GOx is presented in the first section. As will 
become obvious, the type o f template material used, together with the wall architecture, 
determines the internal composition o f capsules (presence or absence o f an internal 
matrix). Melamine formaldehyde (MF) and manganese carbonate (MC) were used as 
templates for the fabrication o f microcapsules. Capsules with wall architectures 
(PSS/PAH}4, (PSS/PDDA}4, {PVS/PAH} 4 + {PSS/PAH} 4 , and {PVS/PAH}4 
+{PSS/CHT} 4 were fabricated using MF as template material. Internal matrices were 
formed in the case o f {P VS/P AH} 4 +{PSS/CHT} 4 capsules during the capsule fabrication 
process, due to the interaction o f CHT and PVS with the MF. In the case of {PSS/PAH} 4 
capsules fabricated using MC templates, internal matrices were fabricated by 
polymerizing amino acids using crosslinking agents EDC and NHS. The second section 
deals with the use o f fluorescence recovery after photobleaching (FRAP) to compare the 
effect o f capsule wall architecture on mobility o f labeled GOx. Finally, the third section 
describes the results for experiments demonstrating glucose sensitivity o f HPTS-GOx 
both in solution and after encapsulation in {P VS/P AH} 4 +{PSS/CHT}4 capsules. Also,
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while exploring various possibilities for encapsulation o f  GOx using capsules with 
charged internal matrices, a novel method o f encapsulation o f HRP using the “ship-in-a- 
bottle” concept was developed. The results o f this study have been described in 
APPENDIX A. Also, in APPENDIX B a short study to determine the possibility o f using 
PMMA as an alternative template has been described.
5.1 Effect of Polvelectrolvte Architectures on 
Microencapsulation- Encapsulation Efficiency,
Long-Term Stability and Activity 
of Glucose Oxidase
5.1.1 Evaluation of (PVS/PAHI^-fMF)
Microcapsules to Encapsulate GOx
It was previously reported that the formation of a charged matrix inside capsules 
fabricated by LbL assembly depends on the choice o f materials used to coat MF210"213. 
Different materials interact with the dissociating template in different ways; the 
innermost polyions that are in contact with the template can detach from the wall 
structure and participate in matrix formation by interacting with the MF oligomers. 
However, if  the innermost layers are strongly attached to the next layer, the likelihood o f 
dissociation during core dissolution is small and they will remain firmly in the wall 
structure. Initially, the effect o f capsule wall architecture on matrix formation was studied 
using PVS (Figure 35 [a]) instead o f PSS (Figure 35 [b]) as an alternative polyanion in 
multilayer assembly.
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Figure 35. Structures o f PSS and PVS
The procedures for fabrication o f capsules, loading, and imaging were described 
in Chapter IV. Figure 36 contains microscope images showing the spontaneous loading 
of the microcapsules with FITC-GOx. The concentration o f FITC-GOx used for the 
loading experiment was 2mg/ml. At t=0 seconds, prior to addition o f FITC-GOx, the 
fluorescence intensity o f the capsule interior was zero. The rapid increase in fluorescence 
intensity in the capsule interior for the first 20 seconds after addition o f the FITC-labeled 
enzyme can be characterized by the polynomial expression y = 2.6x2 - 53x + 270 (R2= l), 
where y is the intensity in the capsule interior which changes polynomially with time (x) . 
The intensity then plateaued due to saturation of the PMT.
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Figure 36. Loading o f {PVS/PAH}4 -(M F) microcapsules with FITC-GOx. Images:
Left to right: region o f interest (ROI) inside capsule (ROI Area=1.2/rm2) microcapsule 
imaged at 0s, 5s, 10s, 15s, 20s and so on after addition o f loading solution.
A typical linescan o f (PVS/PAH} 4 -(M F) capsule in a loading solution o f FITC- 
GOx is shown in Figure 37. It can be seen that the fluorescence intensity o f capsule 
interior is high enough to cause saturation o f the PMT o f the confocal instrument, while 
the intensity o f  the surrounding solution is zero. Though a quantitative estimate o f  the 
enzyme encapsulated was not made, the linescan data indicate that a large quantity of 
enzyme in the loading solution is drawn into the capsule interior and densely packed 
inside, indicating the presence o f an internal matrix.
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Figure 37. Linescan o f {PVS/PAH} 4  -(MF)microcapsule in a loading 
solution o f FITC-GOx.
The encapsulated enzyme was found to be active. The absolute activity o f the 
encapsulated enzyme was calculated as 2.0x1 O' 5 absorbance units/sec (not scaled to mass 
o f enzyme). Though the activity was not compared with that o f free GOx, it is important 
to state that the procedure for encapsulation did not inactivate the entire quantity of 
immobilized enzyme.
An examination o f the capsule using the transmission mode of the confocal 
microscope showed that the capsule interior was not hollow after core dissolution. 
Transmission images o f {PSS/PAH} 4 capsules (Figure 38[a]) show that hollow capsules 
after dissolution o f the core have the same contrast both inside and outside the capsule. 
The (PVS/PAH}4-(M F) capsules (Figures 38[b] and 38[c]), however, have a highly 
refractive interior indicating that the MF template did not dissolve completely. This 
observation is an example o f how the unpredictable quality o f  MF can lead to erratic 
results. The solubility o f MF varies inversely with its age. As the MF ages, it develops 
more stable crosslinks and does not dissolve completely into lower molecular weight
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oligomers214. Another influencing factor is the concentration o f the acid usedz14. The pH 
of the acid used determines the rates o f  two competing reactions— decomposition o f MF 
to form soluble oligomeric products and further polymerization which prevents 
degradation by acid. A pH lower than 1.1, decomposition surpasses polymerization 
reaction, and at higher pH values, polymerization surpasses decomposition leading to 
partial dissolution o f MF. Since the acid used had an appropriate pH (1.1), this factor was 
not responsible for the findings o f this experiment. Any of the other aforementioned 
reasons may have contributed to the behavior o f MF. Since a new batch o f MF was used 
for the experiments, age o f the capsule was not a factor contributing to the results. It is 
therefore presumed that the MF was defective, and that either manufacturing or handling 
conditions were responsible for its poor solubility.
Figure 38. Transmission mode images o f (a) & (b) {PVS/PAH} 4 -(M F) capsules,
(c) {PSS/PAH}4 capsules
An attempt to repeat the fabrication o f capsules o f the same architecture failed. The 
capsules collapsed and disintegrated after dissolution o f the core. The process o f 
dissolution o f these particles after LbL assembly o f (P VS/P AH} 4 was captured in the form 
of a time-lapse series o f confocal images (Figure 39). This experiment proved that it was 
difficult to fabricate capsules using only PVS as the polyanion. The reasoning behind this
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conclusion is that the bilayers are unstable because of interaction o f hydrophobic (PVS) 
and hydrophilic (PAH) polyions. As a result, the wall is not strong enough to withstand the 
osmotic pressures experienced during core dissolution. Since the fabrication o f stable 
microcapsules using {PSS/PAH} bilayers has been well documented in literature, hybrid 
capsules were prepared for further studies using two bilayers o f (P VS/P AH} followed by 
two bilayers o f {PSS/PAH}. These capsules did not disintegrate and collapse after core 
dissolution. With this hybrid architecture, stable capsules were fabricated, and the effect o f 
using PVS instead o f PSS on the formation o f internal MF matrices during the core 
dissolution process was studied.
wwm i stall
...
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Figure 39. Time-lapse images o f dissolution o f MF templates coated with 
(PVS/PAH}4 . Time based dissolution shown in succession in images(a)-(c), 
closeup o f clumps o f polyelectrolytes after dissolution o f  core shown in (d)
5.1.2 Long-term Studies Using Capsules with 
Different Wall Architectures; Comparison and 
Determination of Best Capsule Configuration 
for GOx Encapsulation
5.1.2.1 Zeta-Potential Measurements to Confirm Adsorption o f Polyion. Capsules 
with architectures {PVS-PAH}2 + {PSS-PAH}2(MF) and {PVS-CHT}2 + {PSS- 
PAH}2(MF) were fabricated as described in Chapter IV. The alternate assembly of
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oppositely charged polyions {PVS-PAH}2 + {PSS-PAH}2(MF) and {PVS-CHT}2 + 
{PSS-PAH}2(MF) was confirmed by zeta potential measurements, as shown in Figures 
40 and 41. The MF microparticles possessed strong positive surface charge (+69mV). 
The surface potential o f the coated microparticles changed regularly between positive for 
PAH and CHT to negative for PSS and PVS. Though surface potential values were not 
constant for each subsequent positive or negative layer deposited, they indicate that the 
polyelectrolytes were assembling.
68.44
41.6
32.02
MF PAH PVS PAH PSS PAH PSS PAHPVS-15 -
-35 -
-42 . 1,
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Figure 40. Zeta potential measurement o f {PVS-PAH}2 + {PSS-PAH}2(MF)
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Figure 41. Zeta potential measurement o f {PVS-CHT}2 + {PSS-PAH}2(MF)
5.1.2.2 Estimation of Percentage Encapsulation. The encapsulation or entrapment 
of GOx was different in terms o f both distribution and quantity for each architecture 
employed, depending upon the wall composition and the presence or absence o f an 
internal matrix. Figure 42 contains confocal images, corresponding line scans, and phase 
images of each o f the samples while still in a loading solution o f TRITC-GOx except for 
{PSS-PAH}4(MC- internal arginine matrix) capsules, which are in a loading solution o f 
FITC-GOx. It can be seen from Figures 42 (a), (b), (d), (e), (g) and (h) that in the case o f 
{PSS-PAH}4(MF), {PSS-PDDA}4(MF), {PVS-PAH}2 + {PSS-PA H )2(MF) capsules, 
GOx was entrapped mostly in the walls. The line scans show that the concentration o f the 
enzyme was the same inside the capsule as the loading solution, which suggests that 
loading in these three cases occurred by a process o f simple diffusion.
In contrast, for {PVS-CHT}2 + {PSS-PAH}2(MF) capsules, it can be seen from 
Figure 42 (j), (k) and (1) that the loading solution intensity was effectively zero while the
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intensity from the capsule interior shows that the concentration o f GOx was nearly 
uniform throughout the interior of the capsule. Also, it can be observed from the phase 
image o f  the capsule that, unlike the previous three architectures discussed, there is a 
refractive character to the interior, which is indicative o f the presence of a matrix. For 
{PSS-PAH}4  capsules with an internal matrix o f arginine (Figure 42 [m], [n], [o]) , the 
intensity o f  the capsule interior was approximately 12 times that in the loading solution, 
determined by taking the ratio o f the average intensities o f the linescan o f the interior to 
that of the loading solution. Thus, for capsules without internal matrices studied here, the 
enzyme was mainly entrapped in the walls due to electrostatic interaction o f the charged 
enzyme with the charges in the capsule walls. On the other hand, capsules with charged 
internal matrices attracted and encapsulated large quantities o f oppositely charged GOx 
in the capsule interior.
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Figure 42. Confocal images of {PSS-PAH}4(MF), {PSS-PDDA}4(MF), |PVS- 
PAH}2 + {PSS-PAH}2(MF),{PVS-CHT}2 + {PSS-PAH}2(MF) and {PSS- 
PAHJAMC- internal arginine matrix) capsules in loading solution. Figures 
1 .(a) through (1), in TRITC-GOx loading solution, Figure (m) through (o) in 
FITC-GOx loading solution
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Capsules o f different architectures were evaluated for the quantity o f enzyme 
encapsulated after loading with GOx and separation o f capsules from the remainder o f 
the enzyme by rinsing with DI water using the equation:
_  Enzymefn-E nzym e^
Enzymeper capsuie Number o f  capsules
Enzymein is the initial encapsulated enzyme mass and Enzymeo is the enzyme mass 
leached out at weekO immediately after loading and rinsing. Figure 43 contains a graph 
showing the comparison o f uptake efficiency o f the capsules. It can be seen that {PVS- 
CHT}2 + {PSS-PAH}2(MF) capsules, believed to have an internal matrix (comprising o f 
MF oligomers, CHT and PVS), had the maximum encapsulated GOx (37pg/capsule). 
Among the capsule architectures that did not have an internal matrix, {PSS- 
PDDA}4(MF) had a relatively high mass o f encapsulated GOx (31pg/capsule) entrapped, 
though this was primarily in the walls, as is evident from the confocal images o f Figure
42(a).
1-{PVS-CHT}i *  {PSS-PAH}2(MF)
2-{PSS-PDDA}4(MF)
3-{PSS-PAH}4(MC- internal arginine matrix)
4-{PVS-PAH}2 + {PSS-PAH^MF)
31 5-{PSS-PAH}4(MF)
3a
8 25 -
3  15
a
 -
11
g 10 -0)
m
0
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Figure 43. Mass o f  GOx encapsulated per capsule
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In the case o f {PSS-PAH}4 (MC) capsules it can be observed from the confocal 
line scans in Figure 42 (m) and (n) that the maximum entrapment o f enzyme occurs to a 
greater extent around the walls and progressively decreased towards the center o f the 
capsule. This indicates that the polymerization o f arginine is higher in the periphery o f 
the walls than the capsule interior. Hence, the mass o f GOx encapsulated enzyme is less 
compared with the {PVS-CHT}2 + {PSS-PAH}2(MF) capsules, which also have an 
internal matrix.
5.1.2.3 Leaching o f GOx from Microcapsules. Leaching o f encapsulated GOx was 
studied over a four-week period to evaluate the percentage o f the enzyme retained in the 
capsule for each of the different wall architectures. The percentage o f enzyme remaining 
in the capsules at the end o f the four-week study is graphically shown in Figure 44. These 
values were calculated by using the equation:
Enzyme jn —(Enzyme^+Enzyme\+Enzyme^)
Enzymerem = ----------------------- - ---------------------------------
Enzymejn
Enzymein is the initial encapsulated enzyme mass. Enzymeo is the enzyme mass 
leached out at weekO immediately after loading and rinsing. Enzymej and Enzymes are the 
enzyme masses leached out at weekl and weekS respectively
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Figure 44. Percentage o f GOx remaining in capsules with architectures (PSS- 
PAH}4(MF), (PSS-PDDA}4(MF), {PVS-PAH}2 + {PSS-PAH}2(MF),{PVS- 
CHT} 2 + {PSS-PAH}2(MF) and (PSS-PAH}4(MC- internal arginine matrix) at the 
end of the 4-week leaching study
It can be seen that {PSS-PAH}4  (MC) capsules with internal ariginine matrices 
had the least leaching o f GOx, with 97% of the enzyme remaining in the capsules. (PVS- 
CHT} 2 + (PSS-PAH}2(MF) capsules also retained a large quantity o f enzyme (79%). In 
contrast, (PSS-PAHMMF) capsules showed complete leaching o f GOx by the second 
week of study. From these results, it is apparent that capsules with internal matrices retain 
more encapsulated enzyme over a period o f time. Among the hollow capsules, (PSS- 
PDDA}4(MF) capsules retained the largest percentage o f encapsulated GOx (59%); 
(PSS-PAH}4(MF) capsules showed 100% leaching o f the enzyme and (PVS-PAH}2 + 
(PSS-PAH)2(MF) could retain only 14% o f the initial encapsulated GOx. Different 
materials interact with GOx in different ways; some can entrap enzymes more efficiently
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than others. These interactions may be electrostatic, hydrophobic and hydrophilic 
interactions, hydrogen bonding and coordination bonding or a combination o f many or all 
o f these interactions. Also, depending on the elasticity o f the materials used, the walls 
react differently to the osmotic pressures generated during core dissolution, as a result o f 
which wall structures are also different; some capsules may have larger pores than others. 
The wall structure also determines the quantity o f enzyme entrapped.
5.1.2.4 Estimation of Number o f  Capsules in Each o f the Samples. The Coulter 
counter was used to obtain sizes and concentrations o f the capsule samples. The results 
obtained are shown in Figure 45. Though a distribution of values for size and 
concentration are indicated in the figures, the mean values o f size and concentration have 
been considered for calculations.
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Figure 45. Results o f sizing and concentration o f capsules
5.1.2.5 Activity o f Entrapped/Encapsulated GOx Over a Four-Week Period. The 
activity/unit mass is a measure o f  the percentage of active entrapped enzyme; i.e., the 
fraction of encapsulated enzyme that is active. Higher encapsulation efficiency does not 
necessarily mean that the entire percentage o f encapsulated enzyme is efficiently 
available for reaction. There are a number o f reasons for this. Tight packing o f enzymes 
in the capsule and interaction o f enzymes with the matrix in the capsule interior may 
cause the enzyme to conform unfavorably, which may lead to concealment o f its active 
site. Also, constraints placed on diffusion o f the analyte and components o f the activity
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assay may lead to difficulty in accessibility of the enzyme. Hence, the net activity
or assay, or the activity of the fraction of the encapsulated enzyme that has been able to 
retain its most stable conformation, or a combination of both factors. A possible reason 
for variability in results is that the concentration of capsules/active enzyme is not 
sufficient because of which the signal to noise (SNR) ratio is small. Among the 
significant contributors to noise are the continuous stirring of the assay using a magnetic 
stir bar and scattering of light by the capsules themselves. In order to compare activities 
of each of the capsule architectures over the four-week period (Figure 46), student t-tests 
were used to determine if the activity/unit mass values differed significantly over the 
weeks ( a  value of 0.05).
obtained is either that of a fraction of the active enzyme that is accessible to the analyte
0.0012 D {PSS-PAH }4
□  {PSS-PDDAJ4
0.001 □ {PVS-PAH}2 + {PSS-PAHJ2
□  {PVS-CHT}2 + (PSS-PAHJ2 +
'Em 0 .0008  
E ■  {PSS-PA H }4 (M C) with arginine matrix
3
<
0.0006
’> *  T
<  0 .0004
J
0.0002
0
wO w  1 w 3
Figure 46. Activity of effective active encapsulated GOx in capsules over a 
four-week period. Calculated activity is per unit mass. Symbols indicate 
significant difference in activity over time, determined using student t-tests 
using a  = 0.5
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According to the tests, capsules with architectures {PSS-PDD A} 4 (MF) and {PVS- 
CHT} 2  + (PSS-PAH}2 (MF) did not show a significant change in activity over the four- 
week period. Except for {PSS-PAH}4 (MF) capsules, which completely lose activity by 
the second week, a distinct trend in change in activity was not identifiable in the case o f 
the other architectures. Since the activities were normalized to enzyme mass the 
activity/unit mass is indicative o f the effects o f materials comprising the capsule wall and 
capsule interior on the encapsulated enzyme. From Figure 46, it is can be concluded that 
since there were no significant differences in activity/unit mass over the four-week study 
in the case o f both {PSS-PDDA}4(MF) and {PVS-CHT}2 + {PSS-PAH}2(MF) capsules, 
the capsule materials did not have an adverse effect on enzyme conformation.
Summarizing the above results, {PSS-PDD A) 4(MF) and {PVS-CHT}2 + {PSS- 
PAH}2(MF) capsules retained a significant portion o f encapsulated enzyme at the end of 
the four-week study (59% and 79%, respectively). However, it has to be underscored that 
the enzyme was entrapped in the walls and there was no internal matrix in the case of 
{PSS-PDDA}4(MF) capsules, whereas in the case o f {PVS-CHT}2 + {PSS-PAH}2(MF) 
capsules it was encapsulated in the internal charged matrix. This may be the reason why a 
higher percentage o f GOx leached out in the former case.
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5.2 Comparison of Diffusion Properties of 
Different Wall Architectures by 
Fluorescent Recovery After 
Photobleaching (FRAP)
5.2.1 FRAP Experiments to Study the Effect 
of Capsule Wall Architecture on 
Diffusion of FITC-GOx.
Diffusion coefficients for GOx were obtained in the case o f  each of the four
architectures by performing FRAP experiments and using mathematical models for
calculation o f diffusion coefficients o f GOx as described in Chapter IV. Figure 47
contains a graph showing the comparison o f diffusion coefficients for various wall
architectures.
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Figure 47. Comparison o f  average GOx diffusion coefficients o f the 4 capsule 
types. Models, M l and M2 were used to estimate diffusion coefficients from raw 
data o f fluorescence recovery obtained after photobleaching o f capsules.n= 8  for 
{PSS-PAH}4(MF) and {PSS-PDDA}4(MF) , n= 6  for (PVS-PAH} 2 + {PSS- 
PAH}2(MF) and {PVS-CHT} 2 + {PSS-PAH}2(MF)
Student t-tests were performed to statistically verify i f  the diffusion coefficients 
were significantly different from each other. Average diffusion coefficients for GOx were 
three times higher for {PSS-PDDA}4(MF) capsules than for {PSS-PAH}4(MF) capsules 
indicating that {PSS-PDDA}4(MF) capsule walls are more permeable than {PSS- 
PAH}4(MF) capsule walls. However, referring back to the leaching results, larger 
quantities o f GOx leached out (PSS-PAH}4(MF) capsules than {PSS-PDDA}4(MF) 
capsules. The two results cannot be corroborated because the entrapment o f GOx in the
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two cases occurs in the capsule walls; though the diffusion coefficients are indicative o f 
the permeability o f  the walls, they cannot be used to describe the capacity o f capsules to 
retain the enzyme entrapped in the walls. Hence, though {PSS-PDDA}4(MF) are highly 
permeable to GOx by simple diffusion, they entrap and retain GOx more efficiently in the 
walls than (PSS-PAH}4(MF) capsules.
Diffusion coefficients o f GOx for {PSS-PDDA}4(MF) and {PVS-PAH} 2 + {PSS- 
PAH} 2(MF) capsules were comparable. This result was expected, because {PVS-PAH} 2 
+ {PSS-PAH}2(MF) capsules had only two bilayers o f PSS-PAH, and it has already been 
mentioned that the inner PVS-PAH layers are weak. Hence, the inner PVS-PAH bilayers 
may have partially disintegrated during the core dissolution process or may be 
discontinuous and for this reason, more permeable than {PSS-PAH}4(MF) capsules.
GOx had higher diffusion coefficients in the case o f {PVS-CHT} 2 + {PSS- 
PAH} 2(MF) capsules compared with the other three types o f capsules. A possible reason 
for this result is that the internal charged matrix o f the capsules played an important role 
in attracting and hence rapidly drawing the enzyme into the capsule interior, whereas in 
the other three cases, the enzyme entered the capsules by simple diffusion.
The mobile fraction (R) was calculated in each o f  the four cases (Figure 48). 
The mobile fraction can change due to. different circumstances: interaction o f the 
fluorescent labeled molecules with other molecules or materials (capsule wall, internal 
matrix etc), which could prevent or restrict the free diffusion o f molecules. Capsules with 
architectures {PSS-PDD A} 4(MF) and {PVS-PAH} 2 + {PSS-PAH} 2(MF) had 
comparable mobile fractions that were approximately twice that o f {PVS-CHT}2 + 
(PSS-PAH}2(MF) and {PSS-PAH}4(MF) capsules. For capsules with higher mobile
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fractions, diffusion coefficients for GOx were higher, except for {PVS-CHT}2 + {PSS- 
PAH} 2(MF) capsules. A possible reason is that while the presence o f a matrix reduces 
the mobile fraction, the inward movement o f  the labeled enzyme is faster because of 
electrochemical attraction by the charged matrix.
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Figure 48. Comparison of average mobile fractions o f the 4 capsule types.n= 8  
for {PSS-PAH}4(MF) and (PSS-PDDA}4(MF) , n= 6  for{PVS-PAH} 2 + {PSS- 
PAH}2(MF) and {PVS-CHT} 2 + (PSS-PAH}2(MF)
Recently, a novel LbL assembly o f photosensitive diazoresin was 
demonstrated215. This technique is advantageous in that it can be used to improve stability 
o f multilayer films by converting weak interactions between adjacent layers into strong 
covalent bonds, and can be applied to a variety o f materials containing sulfonate groups, 
carboxylic acid groups, or phenol groups216. Further, the procedure is uncomplicated and 
comprises o f two steps: first, self-assembly involving ionic (for sulfonate groups) or 
hydrogen-bonding (for carboxylic acid or phenol groups) forms the initial multilayer;
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second, the weak interaction between the neighboring layers is converted to a covalent 
one by UV irradiation. A previous report described how the stability o f hollow capsules 
based on DAR was improved by this procedure. A useful conclusion drawn from this 
work was that DAR-based systems can be prospective candidates for permanent
217encapsulation o f materials . Another recent publication reported the stable 
encapsulation o f GOx using DAR-based microcapsules184. Confocal microscopy and 
atomic force microscopy confirmed stable encapsulation o f enzyme after UV irradiation, 
and activity assays revealed that encapsulated enzyme possessed 52.8% of the catalytic
1 84.activity exhibited by the same amount o f free enzyme . The following section describes 
the application of the FRAP procedure to study the effect o f number o f  DAR bilayers on 
diffusion o f labeled GOx.
5.2.2 FRAP Experiments for Study of Effect 
of Number of DAR Bilayers in Capsule Wall 
on Diffusion of FITC-GOx.
Figure 49 shows that alternation o f zeta-potential with coating of each charged
layer confirms the successful deposition o f five bilayers o f DAR/PSS.
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Figure 49. Zeta-potential measurements o f {DAR/PSS}s
FRAP experiments performed to obtain diffusion coefficients for MC- 
{DAR/PSS}5  and MC- {DAR/PSS}8 showed no significant differences between the 
values o f diffusion coefficients obtained for capsules with five bilayers and eight bilayers 
(Figure 50).
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Figure 50. Diffusion coefficients o f MC-{DAR/PSS}5 and MC-
{DAR/PSS}g
Figure 51 contains a graph comparing the mobile fractions for MC- {DAR/PSS} 5 
and MC-{DAR/PSS}8 capsules. Though the diffusion coefficients o f the labeled enzyme 
are comparable in both cases, the mobile fraction reduces by a factor o f  5 after addition 
o f three bilayers o f DAR/PSS. The reduction o f the mobile fraction indicates that the 
addition of layers does obstruct the diffusion o f GOx, which reduces enzyme recovery in 
the capsule interior.
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Figure 51. Comparison o f average mobile fractions for MC-{DAR/PSS} 5 and 
MC-{DAR/PSS}g.n= 6  for MC-{DAR/PSS} 5 and MC-{DAR/PSS} 8
From the results o f the procedures described in this section to compare 
microcapsules with different architectures, it was concluded that {PVS/CHT}2- 
{PSS/PAH}2 capsules were the most stable and showed minimal leaching (79% of 
enzyme retained) and the activity o f the encapsulated enzyme did not change 
significantly over four weeks.
Capsules with wall architecture {PVS/CHT} 2- {PSS/PAH} 2 were selected for 
demonstration o f glucose sensing. The experiments performed to characterize these 
sensors and the corresponding results and discussion are described in the next section.
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5,3 Fluorescence Sensors for Glucose Using
pH-Sensitive Fvrene 8-Hvdroxv-l ,4,6- 
Trisulfonvlchloride (HPTS)
Capsules with an internal charged matrix o f chitosan, PVS, and melamine 
formaldehyde oligomers were fabricated by LbL assembly o f {PVS-CHT}2 + {PSS- 
PAH} 2 on MF templates. They were loaded with TRITC-GOx for visualization with 
confocal microscopy. Morphology of unloaded capsules was studied using AFM. The 
capsules were loaded with unlabeled GOx to study the stability o f enzyme-loaded 
capsules and activity o f the encapsulated enzyme over a period o f four weeks, using 
techniques described in Chapter IV. The results o f stability and activity studies were 
described in section 5.1. A pH-sensitive dye (HPTS), was used to label GOx, and HPTS- 
GOx was loaded into the capsules. Since HPTS has dual excitation peaks and shows 
ratiometric variation in response to changes in pH, no reference dye was required to 
account for variation o f sensor response from fluctuations in instrument parameters or 
environmental changes. In order to study the effect o f labeling on the pH response o f 
HPTS, pH sensitivities o f both conjugated and free HPTS were studied. The sensors were 
evaluated for glucose sensitivity and response.
5.3.1 Visualization of Loaded Capsules 
Using CLSM and AFM
Confocal fluorescence and transmission images o f capsules in loading solution of 
TRITC-GOx and a typical line scan of loaded capsules are shown in Figures 52(a) 
through (d). The transmission image o f a capsule shows that it has an opaque interior, 
which indicates that it is not hollow and empty. The linescan (Figure 52 [d]) proves that 
the intensity in the interior o f the capsules and the walls is 1 0 0  times the intensity o f the
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loading solution, indicating that the quantity of GOx inside the capsules is far more than 
that in the loading solution. From AFM images of “empty” capsules, (Figure 52 [e] 
through [g]) it is clear that the capsule is not flat. An estimate of the average height of 
capsules was calculated by averaging the heights at 40 random points on the imaged 
capsule. The average height was calculated to be 1.3pm. Assuming the average thickness 
of the wall to be (4x4nm=;16nm), the height should not exceed (2xl6nm=32nm) when the 
capsules collapse after drying if the capsules did not have a matrix,. Thus, the height of 
the capsule with an internal matrix is 41 times the height of a collapsed capsule without 
an internal matrix, clearly indicating the presence of a matrix.
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Figure 52. (a),(b) Confocal fluorescence and (c) transmission mode images, and (d) line 
scan of chitosan capsule loaded with TRITC-GOx, (e)AFM 3-D and (f),(g) 2-D images of 
unloaded Chitosan capsule
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
145
5.3.2 Working of HPTS Dye
The pH-sensitive dye HPTS consists o f a conjugate acid and conjugate base pair. The 
excitation spectra o f HPTS (Figure x) indicate the presence o f two excitation maxima, 
namely, 405nm (excites the conjugate acid part) and 454nm (excites the conjugate base 
part). The pH o f the solution decides the relative concentrations of the acid and base 
components, and consequently also decides the intensities o f the two peaks. Hence, the 
peak ratio (405/454nm) varies with the pH.
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Figure 53. Spectra o f HPTS 
(Source: http ://www.probes.com/handbook/figures/0578.html)
5.3.3 Buffer Solution Equilibrium: Effect of 
Addition of Acid on pH of Buffer, HPTS and 
HPTS-GOx (Both in Buffer) Solutions
The standard equilibrium equation for a phosphate buffer system is
H2PO4' + H20 < ->  H30 + + HPO42' (14)
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The equilibrium constant Ka= 6.3xl0"8 is calculated using:
Ka -  [H30 +] [HPO42-]
------------------------  (15)
[H2PCV]
Addition o f 0.1M HC1 causes the equilibrium to shift to lower pH values due to 
the reaction ofHCl with the conjugate base. This corresponding reaction is:
HC1 + HPO42' -> H2P (V  + C f (16)
After estimation o f the change in number o f moles o f the conjugate acid and base 
from equation (16), the final value o f the number o f moles o f H30 + is calculated 
using equations (14) and (15). The pH of the buffer after addition of the acid is 
given by:
pH = -log[H30 +] (17)
In this way, values for pH o f the buffer following each successive addition of HC1 
were calculated. These values were also experimentally determined by measuring the pH 
of solutions o f PBS 7.4 buffer, HPTS in PBS 7.4 buffer and HPTS-GOx in PBS 7.4 
buffer while titrating 0.1M HC1. Figure 54 contains a comparison o f the experimental and 
predicted values o f changes in pH o f PBS buffer, and the experimental values o f HPTS 
and HPTS-GOx in PBS buffer during acid titration. The experimental values in all three 
cases, PBS, HPTS in PBS and HPTS-GOx in PBS indicate that pH changes follow the 
same trend, irrespective o f the presence or absence o f  the dye or the enzyme. The 
predicted values agreed with the experimental values with a maximum variation o f 18% 
for the last two datapoints. It was experimentally determined that the pH electrode 
absorbed 12-15/il o f buffer solution after every measurement. However, the variation
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between the predicted and experimental values for the last two datapoints was observed 
even after accounting for the volume changes of the buffer associated with the 
measurement process.
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Figure 54. Change in pH with titration of 0.1M HCI solution: comparison of 
calculated results with experimental result in the case of PBS 7.4 buffer, HPTS in PBS 
buffer and HPTS-GOx in PBS buffer.
5.3.4 Comparison of Response of HPTS 
Solution and HPTS-GOx in PBS Buffer 
to Titration of 0.1M HCI
The response of the conjugated dye in solution to changes in pH was studied by
recording the fluorescence spectra of HPTS-GOx after subsequent additions of 0.1M
HCI. As mentioned in the previous section, the pH of the solution changed significantly
with the addition of aliquots of acid. It is also apparent that in both cases pH changes
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approximately matched up with each other at every point o f titration. The decrease in pH 
caused a corresponding increase in the excitation peak ratio (405/454nm), as shown in 
Figures 55(b) and 55(d). The pH changed from 7.4 to 4.4 at the end o f the titration 
experiment. The peak intensity ratio also changes comparably in both cases. The shapes 
and consequently the ratios obtained in the two cases are different because the number o f 
HPTS molecules in a solution o f HPTS is far more than those in the same volume o f 
HPTS-GOx due to which a stronger fluorescence signal is obtained from the former. 
Also, the process o f conjugation o f HPTS with GOx can alter the spectra o f HPTS 
because o f the change in the local environment o f the ligand and its structure after 
conjugation218.
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Figure 55 Changes in fluorescence intensities of the acid (405nm) and base (454nm) 
peaks of (a) HPTS and (c) HPTS-GOx with addition of aliquots of 0.1M HCI. Peak 
intensity ratios of (b) HPTS and (d) HPTS-GOx vs. addition of 0.1M HCI.
The experiments performed in 5.5.3 and 5.5.4 verified that the pH of the buffer 
changed in a predictable manner with the addition of HCI, both in the presence and the 
absence of the labeled enzyme. Also, though the shape of the curve and the peak ratios 
were altered due to labeling, there was an increase in peak ratio with the addition of acid 
in both cases. According to the glucose oxidation reaction, for every molecule of glucose 
oxidized, a corresponding hydrogen ion is generated, and so the pH changes due to the
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addition o f  glucose can be correlated with those due to addition o f HCI. Hence, the 
equilibrium equations for the PBS buffer system can be used to estimate pH changes due 
to addition o f glucose.
5.3.5 Glucose Titration Test for 
HPTS-GOx in PI Water
Initial spectra o f HPTS-GOx in DI water (measured pH of DI water =5) showed a 
prominent acid peak (405nm), and the absence o f a basic peak (454nm). Addition o f 2/d 
o f 0.2M KOH to the solution sufficiently raised the pH (7.8-8) to produce a strong basic 
peak. Subsequent addition of small volumes o f glucose( 1 OOmg/ml) rapidly reduced the 
pH of the solution. It can be seen from Figure 56 that addition o f only 9/imoles of glucose 
reduced the pH from 8 to 5 and completely suppressed the basic peak.
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Figure 56. Spectra o f HPTS-GOx solution (in DI water) during glucose titration
experiment
The final pH o f the solution was found to be approximately 5. Hence, HPTS-GOx 
solution in DI water is not a good medium for testing the glucose sensitivity o f the 
protein-dye conjugate because the protons generated by the catalytic action o f GOx on 
glucose rapidly lower the pH of the entire volume o f the solution. Moreover, since the 
primary application o f the sensor is intended to be in vivo, and most regions o f the body 
are buffered to a pH o f 7.4, a physiological buffer PBS 7.4 was used to study the 
sensitivity of HPTS-GOx to glucose.
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5.3.6 Glucose Titration Tests for HPTS-GOx 
in PBS 7.4 Buffer
At the pH of the PBS buffer used (7.4), both the conjugate acid and base forms o f 
HPTS exist. Therefore, both acid and base peaks at 405nm and 454nm, respectively, are 
prominent in the initial spectra before addition o f glucose. Figure 57 shows the effect o f 
serial addition of known aliquots o f glucose (lOOmg/ml), which increased the glucose 
concentration o f the solution from GmM to 266mM at the end o f the titration experiment.
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Figure 57. Response o f HPTS-GOx in PBS 7.4 buffer to glucose titration.
Since three consecutive measurements were made after addition o f glucose, and 
the error in measurements was within 2% o f the average value, it can be assumed that the 
added glucose reacted completely before each measurement was made. Each addition o f 
glucose reduces the pH o f the solution in a controlled manner due to the buffering action
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of PBS, resulting in a finite reduction o f the acid-to-base peak ratio. The buffer 
neutralizes a portion o f the protons generated by the enzymatic reaction between the 
conjugated GOx and glucose. However, addition of large quantities o f glucose surpasses 
the buffering action o f PBS, and the overall pH o f the solution at the end o f the glucose 
titration experiment was found to be between three and four.
Figure 58(a) shows the sensitivity curve, i.e. the curve showing the change in 
peak ratio(405/454nm) o f HPTS-GOx with titration o f known aliquots o f glucose. With 
each addition o f glucose to the solution, the cumulative concentration o f acid generated 
due to oxidation o f glucose increased. The peak ratio increased approximately linearly 
between OmM to 112mM, due to a steady increase in acidity o f the solution with each 
successive aliquot o f glucose, caused by the enzymatic catalysis o f glucose by GOx with 
acidic byproducts (gluconic acid). The slope of the sensitivity curve in the linear region
•5
was calculated as 3.3x10" ratio/mM. The pH of the solution changes significantly (pH 3- 
4) at the end o f the titration experiment due to addition o f a large quantity o f glucose and 
generation o f acidic products, which cannot be compensated by the buffering action of 
PBS. The measured value o f the final pH agrees with the predicted value (3.6), which 
was calculated using the Le Chatelier’s principle and the equilibrium equations for PBS 
buffer. Above the linear range, the signal appears to plateau, since HPTS becomes 
insensitive to pH changes at very low pH values (pH values around three). The linear 
region of the sensitivity curve, which was obtained by titrating known aliquots of 
glucose, can be used as a calibration curve to measure unknown glucose concentrations. 
To measure unknown glucose concentrations, the measured intensity ratio after adding an
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aliquot o f  glucose is corroborated with the x-axis values (intensity ratios) o f the 
sensitivity curve, and the corresponding y-axis value indicates the glucose concentration.
The estimated error in predicted glucose concentration was calculated as follows 
for all glucose sensitivity experiments:
The measured glucose (G) is given by
G = (18)
A  is the actual glucose concentration and ^  is the standard deviation in peak
O  ratio
intensity ratio. S is the sensitivity o f measurement given by , The value of
AmM s
is a measure o f the error in glucose concentration. This value indicates the level o f noise 
in the system and hence the error in the values o f predicted glucose concentrations.
Figure 58(b) shows the inverse relation between glucose added and the measured 
intensity ratio, with glucose values on plotted on the ordinate and the corresponding 
intensity ratios on the abscissa. This curve indicates the contribution o f instrumental 
noise to glucose measurement. It is apparent from Figure 58(b), that the noise level 
(standard deviation in the concentration o f glucose sensed) is not consistent across all 
data points. When smaller quantities o f glucose are added, the acid generated is 
correspondingly low. Hence, the change in intensity ratio is small and the measurements 
are easily affected by noise. The sources o f noise can be due to continuous stirring o f the 
sample, the inherent noise contributed by the electronics (PMT), and the measurement 
process- the two excitation peaks (400nm and 454nm) are not measured at the same time 
and hence the contribution o f instrumental noise at each peak may vary. The normal 
physiological glucose range is 3.8-6.6mM (70-120mg/dl). It can be observed from
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Figure 58 (b), that there is significant contribution from instrumental noise in this range. 
Hence, the predicted value o f glucose will not be accurate because a single standard 
deviation in the sensitivity curve can indicate a false-positive for hypo- or hyperglycemic 
condition. This system is inappropriate for glucose sensing in the physiological range o f
interest.
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Figure 58. (a) Change in peak ratio (405/454nm) o f HPTS-GOx with titration 
o f known aliquots of glucose (b) Inverse graph of (a) indicating standard error 
o f calibration due to instrumental noise
5.3.7 Glucose Titration Tests for Encapsulated 
HPTS-GOx in DI Water
Initial spectra o f HPTS-GOx encapsulated in {PVS-CHTH + {PSS-PAHH
capsules in DI water (pH=5) showed a prominent acid peak (405nm) and the absence of
a basic peak (454nm). Approximately 2/xl o f  KOH was added to raise the pH o f the
solution (pH=7.8-8) to produce the basic peak. Subsequently, small aliquots of glucose
(lOOmg/ml) were titrated to the suspension. From Figure 59 it can be seen that there is a
progressive decrease in 454nm peak with the increase in the 402nm peak with titration o f
glucose.
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Figure 59. Response o f HPTS-GOx encapsulated in {PVS-CHT}2 + 
{PSS-PAH}2  capsules suspended in DI water to glucose titration.
Just like the glucose titration test with HPTS-GOx solution in DI water, local changes 
in peak intensities also lead to global changes in the overall pH o f the dispersion. This 
was verified by measuring the pH of the dispersion after the titration experiment was 
conducted. The final pH was between 2 and 3.
The variation in peak intensity with consecutive addition o f glucose aliquots (the 
sensitivity curve) is shown in Figure 60(a). The peak ratio increased approximately 
linearly (R2-96% ) between OmM and 35mM o f glucose addition. The slope o f the 
sensitivity curve in the linear region was 21xl0‘3 ratio/mM. The excitation ratio remains 
approximately steady beyond the linear region, since HPTS is insensitive to pH changes 
below pH 3. Figure 60(b) shows the inverse relation between glucose added and the 
measured intensity ratio, indicating the contribution o f instrumental noise to glucose
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measurement, with glucose values plotted on the ordinate and the corresponding intensity 
ratios on the abscissa. The contribution of instrumental noise to glucose measurement is 
low' in the physiological range of interest (3.8-6.6mM). Unknown glucose concentrations 
in the physiological range can be determined by using the sensitivity curve as a 
calibration curve and corroborating the changes in intensity ratio with the x-vaiues and 
determining the corresponding y-values.
According to confocal images (also indicated at the respective time of acquisition in 
Figure 60[a]) of the capsules before and after the glucose sensitivity test, the fluorescence 
intensity from the capsule interior indicate that HPTS-GOx did not leach out of the 
capsules after the glucose test and that the capsules were intact after the test. Hence, the 
response to glucose additions was from the capsule interior.
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Figure 60.(a) Change in peak ratio (405/454nm) of HPTS-GOx encapsulated in 
{PVS-CHT} 2  + {PSS-PAH} 2 capsules in DI water with titration of known aliquots 
of glucose (b) Inverse graph of (a) indicating standard error of calibration due to 
instrumental noise
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Figure 61 is an illustration o f the reaction involving oxidation o f glucose by HPTS 
labeled GOx encapsulated in a microcapsule and suspended in DI water. Changes in local 
pH (inside the capsule) were responsible for a corresponding change in peak intensity 
ratio o f HPTS. In spite o f the possible buffering action o f the indicator (HPTS) in the 
capsule interior during the sensing process, some protons diffuse to the solution 
surrounding the capsule, and the absence o f any kind of buffering action by the DI water 
raised the pH globally as well as local to the sensor.
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Figure 61. Illustration o f the working of HPTS-GOx sensors during glucose 
titration test in DI water.
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5,3.8 Glucose Titration Test for HPTS-GOx 
Encapsulated in Chitosan Capsules (Capsules 
Suspended in PBS 7.4 Buffer)
Both acid and base peaks at 405nm, and 454nm, respectively, were prominent in 
the initial spectra before addition o f glucose. Figure 62 contains spectra showing the 
effect o f serial addition o f aliquots of glucose.
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Figure 62. Response o f HPTS-GOx encapsulated in {PVS-CHT}2 + (PSS- 
PAH}2 capsules suspended in PBS 7.4 buffer to glucose titration. The peak 
ratio increases steadily with each successive addition o f glucose.
The variation in peak intensity with consecutive addition o f glucose aliquots (the 
sensitivity curve) is shown in Figure 63(a) with the inverse graph in Figure 63(b). There 
is a linear increase in peak ratio between OmM and 32mM (R2=93%) of glucose, which 
covers the physiological range o f interest. The slope o f the sensitivity curve in the linear
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region was calculated to be 3.7xl(F3 ratio/mM. The contribution from instrumental noise 
to glucose measurement as indicated in Figure 63(b); given a real value of 
glucose=5.5mM, the indicated value due to instrumental noise can be anywhere between
4.6 and 6.4mM. Similarly, at the lower end of the physiological range of interest, for 
actual glucose value=3.3mM, the indicated value can vary anywhere between 2.5 and 
4.1mM. For smaller quantities of glucose added, the acid generated is correspondingly 
low; this factor combined with the low sensitivity of the sensors leads to smaller changes 
in intensity ratio, and the measurements are more easily affected by noise.
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Figure 63. .(a) Change in peak ratio (405/454nm) of HPTS-GOx encapsulated in 
{PVS-CHT}2 + {PSS-PAH}2 capsules in PBS 7.4 with titration of known aliquots of 
glucose (b) Inverse graph of (a) indicating standard error of calibration due to 
instrumental noise
Confocal images also indicated at the respective time of acquisition in Figure 
63(a) of the capsules before and after the glucose sensitivity test prove that just like the 
previous case, the capsules were intact and HPTS-GOx did not leach out of the capsules 
after the test. The pH of the entire suspension was measured with a pH strip both before 
and after glucose titration test and was found to remain approximately constant. Hence, it 
is apparent that local pH changes (inside the capsule) were responsible for change in peak
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intensity ratio o f HPTS-GOx. Protons that diffuse rapidly into the solution around the 
sensors are compensated by the buffering action o f PBS. Each addition o f glucose causes 
the pH o f the encapsulated HPTS-GOx to reduce in a controlled manner due to the 
buffering action o f PBS, resulting in a steady reduction o f the acid-to-base peak ratio. In 
this case, global changes in the overall pH o f the suspension were not observed; the pH 
did not vary significantly when measured before and after the glucose test.
Figure 64 illustrates a possible mechanism by which there are pH induced 
changes in the response of HPTS inside the capsule, while the pH of the suspension 
remains approximately constant during the glucose titration experiment. HPTS consists 
of a conjugate acid- conjugate base pair, and essentially acts as a buffer for protons. The 
conjugate base reacts with protons thus altering the fluorescent properties o f the dye 
depending on the equilibrium between the conjugate acid-conjugate base pair. Protons 
generated inside the capsule interact with HPTS before they interact with phosphate 
buffer due to proximity o f the pH-sensitive dye to the reaction products o f HPTS-GOx 
catalyzed oxidation o f glucose. Since these protons are bound to the dye producing a 
change in its response, they can no longer change the pH o f the suspension. In this way, 
HPTS buffers the internal environment o f the capsule, and predominates over the effect 
o f PBS buffer. The protons that do not interact with HPTS are buffered by PBS. There 
are references describing this effect when analyte specific dyes are introduced in 
cells219’220. Dyes that are pH-sensitive have been shown to buffer the internal cell 
environment221.
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The reactions representing a system involving glucose oxidase are:
A + E <------> Xi  > F  + gluconate
kj,k-j h
X2 > F  + H20 2
h,k-3
where ki, k2 , k3, k4 and k-i, k .3 are the forward and reverse reaction rate constants, 
respectively, A and C are the primary and co-substrates (glucose and oxygen), F and E 
are the reduced and oxidized form o f the enzyme. X] and X2 are the complexes formed 
due to binding o f enzyme with glucose and oxygen, respectively. Since the total enzyme 
concentration in the system is constant, and according to the pseudo-steady-state 
assumption the formation and dissociation o f intermediate complexes (Xi and X2) occur 
very rapidly, and the two coupled differential equations representing the system are:
where Dg and D0 are the diffusion coefficients for glucose and oxygen
^  = DgFX-k,AE + k.,X,
d t  S  r ) v 2
(19)
(20)
respectively. Furthermore, (19) can be related to proton (H4)  production and diffusion by
8 H +
d t
=  k (21)
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where Du is the proton diffusivity. The protons produced during the oxidation of 
glucose are available for reaction with HPTS. The base form o f HPTS reacts with H+ 
producing the acid form of HPTS.
H+ + HPTS <—► HPTS (H^)
(base) (acid)
Since the acid and base forms o f HPTS are excited at different peaks (405nm and 
454nm respectively), the peak ratio changes with the change in pH.
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Figure 64. Illustration o f the working o f HPTS-GOx sensors during glucose 
titration test in PBS buffer.
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Le Chatelier’s principle and using equilibrium equations for PBS described in 
section 5.5.3 were applied for prediction o f change in pH of PBS buffer with addition of 
aliquots o f 0.1M HC1 to determine the final internal pH o f the sensors suspended in PBS 
after performing the glucose titration experiment (Figure 65). For every mole o f glucose 
added, correspondingly a mole o f H+ is generated, with the assumption that all the 
glucose has reacted. The assumption is valid because after addition of an aliquot o f 
glucose, three consecutive measurements were made and the maximum error in 
measurements was within 2% o f the measured ratio, which indicates that for every 
measurement all o f the added glucose was oxidized. Another assumption was that the 
concentration o f PBS molecules is the same inside the capsule as the surrounding 
solution. The reason for this assumption is that the sensitivities o f free and encapsulated 
HPTS-GOx in PBS solution are comparable (3.3x1 O'3 and 3.7x1 O'3 respectively) 
indicating that the availability o f PBS to the labeled enzyme is the same in capsules as in 
solution. The value o f pH was calculated to be 3.2 at the end o f the glucose titration 
experiment. Since HPTS is insensitive to pH changes below pH 3, the peak ratio remains 
steady with the decrease in pH.
A comparison o f the properties o f the HPTS-GOx sensing system both in 
solution and after encapsulation is presented in Table 1. It can be seen that encapsulated 
HPTS-GOx tested in DI water has higher sensitivity than that tested in PBS because in 
the latter case, protons generated during oxidation o f glucose are compensated by PBS. 
From the experiments performed above, it is apparent that the response o f sensors 
fabricated by encapsulating HPTS-GOx in {PVS-CHT}2  + {PSS-PAH}2 was linear in 
the physiological range o f interest, both when the sensitivity experiments were
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performed in DI water and in buffer. Since most regions o f the human body are 
buffered at approximately pH 7.34, the results o f the glucose sensitivity experiment in 
PBS buffer are more appropriate for in vivo applications.
In order to alleviate the effects of instrumental noise in order to improve the 
response o f the sensors in the physiological region o f interest, especially for experiments 
performed in PBS, a number o f  steps can be taken: optimization o f stirring speed o f 
sample during measurement, using higher concentrations o f sample to minimize the 
effects o f the inherent noise contributed by the electronics (PMT), and using a dual 
emission channel fluorometer (the two excitation peaks are not measured at the same 
time and hence the contribution o f instrumental noise at each peak may vary). The 
sensitivity o f HPTS-GOx is 10 times less in PBS than in DI water because o f which the 
effects o f  noise are more pronounced when experiments are peformed in buffer. In order 
to improve the sensitivity o f HPTS-GOx in buffer, the labeling ratio and the strength of 
the buffer can be optimized. Also, by controlling the surface charge of the outermost 
layer o f the wall, diffusion o f PBS buffer molecules into the capsule interior can be 
prevented by Donnan exclusion222,223.
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Table 1. Range and sensitivity o f (a) HPTS-GOx solution in PBS buffer, (b) 
Encapsulated HPTS-GOx in DI water, and (c) Encapsulated HPTS-GOx in PBS 
buffer
HPTS-GOx 
solution in 
PBS buffer
HPTS-GOx 
encapsulated in 
{PVS-CHT}2 + 
{PSS-PAH}2 tested 
in DI water
HPTS-GOx
encapsulated in {PVS-
CHT}2 + |PSS-PAH}2
tested in PBS buffer
Linear Range (m i) 0-112 0-35 0-32
Sensitivity (ratio/mM) 3.3x1 O'3 21x1 O'3 3.7x1 O'3
A study o f  microcapsules with different wall architectures and the effect o f 
capsule wall components on the encapsulation o f GOx has been described. Though the 
HPTS-GOx based sensors described in this dissertation have not actually been used to 
measure glucose, a novel method o f measuring glucose using pH-sensitive dyes 
immobilized in microcapsules has been demonstrated. The sensors exhibit a linear 
response in the physiological range o f interest. Future work involves conducting 
experiments to demonstrate measurement o f unknown glucose values by using the 
sensitivity curves obtained in the experiments as calibration curves. Further, the 
aforementioned measures need to be implemented in order to decrease the effects of 
instrumental noise on measurements, especially in PBS buffer.
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CHAPTER VI
CONCLUSIONS
This dissertation is a useful contribution to the science o f enzyme encapsulation 
and glucose sensing. The methods described, particularly the application o f LbL 
assembly to develop microdevices for biomedical applications, and experimental 
techniques to study, compare, and characterize micro-containers serve as a useful guide 
to students involved in similar research. Capsules with architectures {PSS/PAH}4, 
{PSS/PDDA}4, {PVS/PAH}4 + {PSS/PAH}4 , and {PVS/PAH}4 +{PSS/CHT}4 were 
fabricated using MF template. Among these, internal matrices were formed in the case o f 
{PVS/PAH}4 +{PSS/CHT}4 capsules during the capsule fabrication process, due to the 
interaction o f CHT and PVS with the MF. In the case o f {PSS/PAH}4 capsules fabricated 
using MC templates, internal matrices were fabricated by polymerizing amino acids using 
zero-length crosslinkers EDC and NHS. {PSS-PDDA}4(MF) and {PVS-CHTU + {PSS- 
PAH}2(MF) capsules retained a significant portion o f encapsulated enzyme at the end of 
the four-week study (59% and 79%, respectively). While the enzyme was entrapped in 
the walls and there was no internal matrix in the case o f (PSS-PDDA) 4(MF) capsules, in 
the case o f {PVS-CHTU + (PSS-PAHUCMF) capsules it was encapsulated in the 
internal charged matrix. This may be the reason why a higher percentage o f GOx leached 
out in the former case.
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FRAP was used to compare the effect o f capsule wall architecture on mobility of 
labeled GOx. Average diffusion coefficients for GOx were three times higher for {P8S- 
PDDA}4(MF) capsules than for (PSS-PAH}4(MF) capsules indicating that {PSS- 
PDDA}4(MF) capsule walls are more permeable than (PSS-PAH}4(MF) capsule walls. 
Though {PSS-PDDA}4(MF) are highly permeable to GOx by simple diffusion, they 
entrap and retain GOx more efficiently in the walls than (PSS-PAH}4(MF) capsules. 
Diffusion coefficients o f GOx for (PSS-PDDA}4(MF) and {PVS-PAH}2 + {P8S- 
PAH}2 (MF) capsules were comparable. Diffusion coefficients o f GOx were higher in the 
case of {PVS-CHT} 2  + {PSS-PAH}2(MF) capsules compared with the other three types 
of capsules. A possible reason for this result is that the internal charged matrix o f the 
capsules played an important role in attracting and hence rapidly drawing the enzyme 
into the capsule interior, whereas in the other three cases, the enzyme entered the 
capsules by simple diffusion. For capsules with higher mobile fractions, diffusion 
coefficients for GOx were higher, except for {PVS-CHT}2 + {PSS-PAH}2(MF) capsules. 
A possible reason is that while the presence o f a matrix reduces the mobile fraction, the 
inward movement o f the labeled enzyme is faster because o f electrochemical attraction 
by the charged matrix.
Finally, experiments were performed to demonstrate glucose sensitivity o f 
HPTS-GOx both in solution and after encapsulation. Capsules with an internal charged 
matrix o f chitosan, PVS, and melamine formaldehyde oligomers were fabricated by 
LbL assembly o f {PVS-CHT}2 + {PSS-PAH}2 on MF templates. They were loaded 
with TRITC-GOx for visualization with confocal microscopy. Morphology o f unloaded 
capsules was studied using AFM. A pH-sensitive dye (HPTS), was used to label GOx,
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and HPTS-GOx was loaded into the capsules. Since HPTS has dual excitation peaks 
and shows ratiometric variation in response to changes in pH, no reference dye was 
required to account for variation o f sensor response from fluctuations in instrument 
parameters or environmental changes. In order to study the effect o f labeling on the pH 
response o f HPTS, pH sensitivities o f both conjugated and free HPTS were studied. 
The sensors were evaluated for glucose sensitivity. The response o f sensors was linear 
in the physiological range o f interest, both when the sensitivity experiments were 
performed in DI water and in buffer. Since most regions o f the human body are 
buffered at approximately pH 7.34, the results o f the glucose sensitivity experiment in 
PBS buffer are more appropriate for in vivo applications.
For future work, a number o f steps need to be taken in order to alleviate the 
effects o f instrumental noise in order to improve the response o f the sensors in the 
physiological region of interest, especially for experiments performed in PBS. These 
include optimization o f stirring speed o f sample during measurement, using higher 
concentrations o f sample to minimize the effects o f the inherent noise contributed by the 
electronics (PMT), and using a dual emission channel fluorometer (the two excitation 
peaks (400nm and 454nm) are not measured at the same time and hence the contribution 
o f instrumental noise at each peak may vary). The sensitivity o f HPTS-GOx is 10 times 
less in PBS than in DI water because o f which the effects o f noise are more pronounced 
when experiments are peformed in buffer. In order to improve the sensitivity of HPTS- 
GOx in buffer, the labeling ratio can be optimized. Also, experiments need to be 
performed to demonstrate measurement o f unknown glucose values by using the 
sensitivity curves obtained in the experiments as calibration curves.
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APPENDIX A
ATTRACTION AND ENCAPSULATION OF H E P  BY
POLYMERIZING ACRYLIC ACID MONOMERS 
BY POLYELECTROLYTE 
MICROCAPSULES
In the process o f exploring various possibilities for encapsulation of GOx, a novel 
method o f encapsulation o f HRP was developed. This method is unsuitable for 
encapsulation o f GOx for reasons explained later in the chapter. The procedure was 
developed and studied to demonstrate new and uncomplicated methods to encapsulate 
macromolecules. The following section describes the results o f this short study.
Polyelectrolyte microcapsules with shell architecture {PAH/PSS} 4  were 
fabricated by LbL assembly o f polyelectrolytes on MnCOs, followed by dissolution of 
the core. After free-radical polymerization o f acrylic acid inside the capsules using 
initiator (NTL^SaOg, which created a negatively charged matrix inside the capsule, the 
spontaneous loading o f cationic HRP into the capsules was visualized with CLSM, and 
the effect o f using increasing quantities o f monomer and initiator on percentage 
encapsulation o f HRP and activity was evaluated.
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A l.l Visualization of Spontaneous Loading 
of HRP Inside Capsules Using CLSM
The spontaneous loading o f TRITC-HRP (1 mg/ml) was followed by 
CLSM as shown in Figure 2. The terra “spontaneous” has been used to emphasize the 
fact that the internal charge of the capsule matrix is responsible for loading of enzyme; 
the properties o f the wall are not altered in any way (by changing pH, salt composition o f 
loading solution etc) to facilitate loading. It can be observed from the first confocal image 
at t=0 seconds that the capsule interior had zero intensity prior to addition o f cationic 
TRITC-HRP (pl=8). After addition o f the labeled enzyme, the intensity in the capsule 
interior increased increased rapidly and reached a high intensity within 90 seconds as the 
TRITC-HRP diffused inside the capsule. Thus, the process o f  loading was simple and the 
capsules were loaded quickly, and with high efficiency. It can be observed from Figure 
65 that the fluorescence intensity inside the capsule reached steady state within 120 
seconds. The charge o f the capsule matrix is responsible for loading of enzyme; the 
properties o f the wall are not altered in any way (by changing pH, salt composition of 
loading solution etc) to facilitate loading.
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Figure 65. Loading o f microcapsules with TRITC-POx. Images: Left to right: 
microcapsule imaged at 0s, 30s , 60s, 90s, 120s and 150s after addition of 
loading solution. Data points on the graph represent change in the averaged 
intensity in a fixed region o f interest (ROI, Area=1.2/nn2) inside in the imaged 
capsule.
A1.2 Microcapsules at Various Stages Studied 
Using Confocal Imaging and AFM
The process o f polymerization was not precisely controlled and limited to the 
capsule interior only. Hence, the monomers polymerized even on the surface o f the 
capsules. However, the fact that there is sufficient polymerization occurring in the 
capsule interior can be indirectly verified by confocal microscopy imaging o f the 
capsules. Figure 66 contains a capsule with an internal PAA matrix, which was loaded 
with HRP and rinsed with DI water after loading.
t=150s
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Figure 66. Confocal image and corresponding line scan o f capsule with 
polymerized acrylic acid matrix in loading solution o f HRP
From the image, it is apparent that the capsule interior is filled with the labeled 
enzyme. The acrylic acid polymerized in the surrounding solution was previously 
removed by rinsing and dialyzing against DI water. For comparison, capsule without the 
internal matrix is shown in Figure 68. A linescan of the capsule in a loading solution o f 
TRITC-GOx indicates equilibrium loading, with the intensity being approximately the 
same inside the capsule as in the loading solution. Further, when these capsules were 
rinsed, only TRITC-GOx entrapped in the walls was retained and the enzyme in the 
capsule interior was removed during the rinsing process, indicating that the presence o f a 
charged internal matrix helps encapsulate and retain a larger quantity o f enzyme.
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Figure 67. Confocal image and corresponding line scan o f capsule without 
polymerized acrylic acid matrix in loading solution o f HRP
AFM imaging was used in order to compare the topographic features o f capsules 
before and after formation o f the acrylic acid matrix, and after encapsulation o f HRP. 
Figure 69(a) contains an image o f a dried capsule prior to polymerization o f PAA internal 
matrix.
wrnrnmmmIIP
(a)
Figure 68. AFM images o f microcapsules. Left to right (a) capsules after dissolution o f 
core and before polymerization o f PAA matrix ;(B) after polymerization (c) after loading 
with HRP
The capsule is flat with folds and invaginations. After polymerization o f acrylic
acid and loading with enzyme, it can be seen from Figures 69(b) and 69(c) that the
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capsule is no longer flat and has a “bean bag” structure. An estimate o f the average height 
o f capsules in each o f the three cases was calculated by averaging the heights at 20 
random points on the imaged capsules. The average heights o f the capsules (N -3) before 
and after formation o f the PAA matrix and after loading were calculated to be 163±2.4, 
292±0.98 and 757±4.34nm, respectively. Thus, polymerization o f acrylic acid inside the 
capsule interior caused an increase in the average height to approximately twice that o f an 
empty dried capsule. Loading the capsules with HRP increased the average height to five 
times its original height. The additional increase in the average height after incubation in 
loading solution and rinsing, as compared to capsules after polymerization but before 
loading o f HRP can thus be attributed to loading o f  HRP inside the capsules.
A.I.3 Effect of (Acrylic Acid 
Volumes on Efficiency of Enzyme 
Encapsulation and 
Enzyme Activity
Several groups have reported detrimental effects o f free radicals (peroxides, 
reactive oxides, free radical sulfates, etc.) on enzyme activity224. Most free radicals are 
known to inactivate enzymes by oxidizing the enzymes, whereas some act as both 
oxidizing and reducing substrates, e.g. H2O2 225 Based on this consideration, it was 
hypothesized that use o f higher quantities o f initiator may be detrimental to enzyme 
activity due to higher quantities o f  residual initiator, post termination o f the 
polymerization reaction, despite careful rinsing o f the capsules and dialysis. It has also 
been shown that larger quantities o f monomers produce higher quantities o f the 
polymerized end product and thus, higher internal ionic strength o f the capsules226. 
Therefore, it was also hypothesized that a stronger internal charge will attract and retain
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more enzyme into the capsule matrix. Hence, though higher monomer volumes are 
necessary to encapsulate more enzyme, if  the initiator is not efficiently removed from the 
capsule suspension after the reaction, it is detrimental to enzyme activity. To test these 
hypotheses, the effect o f using three different volumes o f monomers and initiators (1:1 by 
volume) on the enzyme encapsulation efficiency and activity was studied.
Table 2 contains a comparison o f mass encapsulated per capsule and the 
activity/unit mass in the three cases. From Table 2, it can be seen that there was a 
correlation between the quantities of the monomer and initiator used and the percentage 
o f HRP in the loading solution encapsulated in the polymerized capsules.
Table 2. Enzyme encapsulation efficiency and activity for loaded capsules with three 
different volumes (10/d, 50/d and 100/d each) o f initiator: monomer (1:1 ratio by 
volume) used in the polymerization o f acrlylic acid to form the internal matrix. Number 
o f capsules=2050000, estimated by Coulter counter
Characteristic 10fjL(1:1) 50fjL(1:1) 1Q0/jL(1:1)
% Encapsulated 45% 49% 59%
Mass/capsule (ng) 0.18 0.2 0.24
Activity/unit mass 
(au/mg.s)
0.007 0.025 0.51
The capsules with 100/d o f monomer and initiator encapsulated 59% of the total 
mass o f enzyme in the loading solution, whereas the others encapsulated 45% and 49% of 
HRP. The estimated mass o f HRP encapsulated per capsule was 0.18, 0.2, and 0.24ng, 
respectively, for capsules with increasing reactant volumes. These data support the 
hypothesis that higher volumes o f reactants attract and entrap higher quantities of 
oppositely-charged enzyme. There is an approximately linear relationship (R2=97%)
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between the increase in the volumes o f the reactants and the mass of enzyme 
encapsulated.
The activity o f the encapsulated enzyme increased exponentially with the increase 
in volumes o f reactants. The sample having capsules with the highest volumes o f 
monomers and initiator and correspondingly the highest percentage o f encapsulated 
enzyme was nearly 70 times as active as one with the lowest volumes o f the reactants and 
a lower percentage o f encapsulation o f enzyme. Since the activity is normalized to mass, 
it is independent o f the mass o f encapsulated jenzyme and indicates the effect o f other 
factors, such as effect of material used to create the internal matrix as well as favorability 
o f the internal matrix structure to enzyme conformation, availability o f  enzyme to 
substrate and assay. Since the materials used for fabrication o f the matrix are the same in 
all the three cases, the effect o f this factor on activity can be ruled out. According to the 
kinetics o f free-radical polymerization, increasing the monomer or initiator concentration 
increases the rate o f polymerization; higher initiator concentrations however produce 
numerous lower molecular weight polymeric units. Hence, it is possible that some of 
these may diffuse out over time because o f which the internal matrix is not very stable 
causing the encapsulated enzyme to also leach out. Hence, the effective activity is the 
activity o f two populations o f enzymes- free enzyme in the solution and encapsulated 
enzyme.
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Figure 69. Activity/unit mass/unit capsule o f encapsulated POx for for capsules 
with three different volumes (10/d, 50/d and 100/d each) o f  initiator and monomer.
Presence o f residual initiator due to inefficient separation o f  capsules from the 
initiator after the polymerization reaction can also inactivate the enzyme. However, in 
this case, apparently, the quantity o f the free radical initiator used for the polymerization 
reaction did not affect the activity, as is evident from the high activity o f the sample using 
the highest volume o f initiator. This is because all samples were dialyzed overnight, 
which removed the unreacted initiator from the capsule solution. Hence, an important 
consideration for the maintenance o f activity o f the encapsulated enzyme is an efficient 
separation of the initiator from the capsules prior to loading o f the enzyme.
In this study, a monomer: initiator volume ratio (and hence concentration ratio) 
has been maintained constant, though the volumes have been changed to study the effect 
o f increasing quantities o f the reactants on the encapsulated enzyme. Hence, future work
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will involve studying the effect o f factors such as initiator to monomer ratio, and the 
reaction incubation time on the formation o f PAA and activity o f  the encapsulated 
enzyme. Also, long-term effects o f encapsulation on the enzyme stability and activity 
(activity/unit mass) will have to be studied. Such a study is important to understand if  the 
entire encapsulated enzyme is equally active or if  there are different populations o f 
enzymes with different conformations depending on their position in the matrix. If  the 
enzyme is bound too tightly in the matrix, it may not be able to move or change its 
conformation during catalysis, and is hence inefficient.
A1.4 Attempt to Load GOx Into Capsules 
With Polvacrvlic Acid Matrix in 
the Capsule Interior
With the successful encapsulation o f HRP, the method was tested for the 
encapsulation o f GOx. Various methods, such as varying the pH o f the loading solution 
o f FITC-GOx (pH 5 and pH 9), were attempted in order to study the effect o f varying the 
charge o f FITC-GOx and the PAA matrix on loading. Figure 71 shows the typical results 
in each case. The attempts to load FITC-GOx using this method were unsuccessful. The 
successful loading o f HRP and the failure to load GOx can be explained by the fact that 
GOx(pI=4.2) has an acidic isoelectric point whereas that o f HRP is basic (pl=8.1). Also, 
the isoelectric point o f PAA is at a low acidic pH.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
182
Figure 70. {PSS/PAH} capsules with poly(acrylic acid) matrices in the core in (a) 
acidic (pH 5) loading solution, and (b) basic (pH 9) loading solution
So, at basic pHs o f loading solution, TRITC-GOx is negative and PAA matrix is 
also strongly negative. Therefore, the internal matrix electrostatically repels the like- 
charged enzyme molecules. At acidic pHs, TRITC-GOx is positively charged, and the 
PAA matrix is close to its p i and hence weakly negatively charged. The results concluded 
that in both cases GOx is repelled by the capsule interior and cannot be encapsulated by 
this method.
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APPENDIX B
STUDY OF PMMA AS AN ALTERNATIVE 
TEM PLATE TO M.F
This work was aimed at developing a novel and repeatable method for fabrication 
o f  microcapsules using LbL assembly o f polyions on PMMA templates, followed by 
dissolution o f the PMMA core using acetone. The main challenge was to have the 
appropriate number and types o f polyions (wall composition and thickness) and most 
appropriate procedure for titrating water into the suspension of capsules (after dissolution 
with acetone) in order to counter the tremendous osmotic pressure that resulted during 
dissolution o f the core. As described in the chapter IV, three different methods were used 
to fabricate the capsules, which were then qualitatively assessed using the confocal 
microscope to assess the quality o f the yield.
The zeta-potential measurements o f  the assembly o f PAH and PSS are shown in 
Figure 71. The assembly o f polyions was confirmed by the alternation o f zeta-potential 
values with the assembly o f each consecutive layer.
183
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Figure 71. Zeta-potential measurement o f coating o f {PAH/PSSjs + {PAH- 
FITC/PSS}3
It was observed from confocal images, that approximately 40-50% of capsules 
produced by the first method (involving overnight immersion in acetone followed by 
rinses with acetone and DI water) described in chapter IV were ruptured. It was 
speculated that the overnight immersion in acetone might have damaged the capsules 
because the acetone may have a detrimental effect on capsule wall materials. Figure 72 
contains images o f various stages o f  this method.
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Figure 72. Confocal images o f  capsules with architecture {PAH /PSS}3 + {PAH- 
FITC /PSS}3 ,(a) acetone overnight, (b) acetone rinse 1, (c) acetone rinse2, (d) DI 
water rinse 1, (e) DI water rinse2, (f) DI water rinseS, (g) DI water rinse4
Since the first method involving immersion of coated particles in acetone for a 
prolonged period o f time, in second method the capsules were imaged after varying the 
acetone immersion time. This method did not improve the yield o f capsules for all times 
of immersion (Figure 73).
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Figure 73. Confocal images o f capsules with architecture {PAH /PSS } 3  + {PAH-FITC 
/PSS}3 ,(a) undissolved coated PMMA particles, (b)after five-hour immersion in 
acetone, (c) afterl 7-hour immersion in acetone, (d) after 24-hour immersion in acetone.
Increasing the wall thickness and titrating DI water into the sample after acetone 
Immersion for an hour resulted in damage to approximately 30-40% o f the capsules 
(Figure 74). Hence, the yields were comparable in all three cases.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
187
d e
Figure 74. Confocal images o f  capsules with architecture {PAH /PSS}s + {PAH-FITC
f P S S h
In the case o f MF template, it was previously cited that during the core dissolution 
process, there is a possibility o f the rupture o f the walls o f capsules, i f  the MF oligomers 
do not diffuse out o f the interior sufficiently fast227. From Figure 75, it can be seen from 
the indicated areas in the capsule walls that PMMA dissociated into chunks that were too 
big to diffuse out o f the capsule wall. This effect has two main consequences: first, it 
increases the osmotic pressure so much so that it causes the capsules to burst; second, 
large pieces o f PMMA are always present in the capsules or capsule walls.
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Figure 75. Confocal and transmission images o f capsules with architecture {PAH 
/PSS}8 + {PAH-FITC /PSS}3 in loading solution o f GOx-TRITC. The dark regions in 
(a) and the indicated regions in (b) are undissolved pieces o f  PMMA
The integrity o f the capsules with architecture {PAH /PSS}s + {PAH-FITC 
/PSS}3 was evaluated by a “salt test.” Three pL of a capsule sample was applied to the 
surface o f a bare slide after which five juL o f 1M NaCl salt solution were added to the 
capsule sample. Figure 76(a) contains the initial images o f the capsules before the 
addition o f salt. It can be seen that the capsules are spherical and show no signs o f 
collapsing. Figures 76(b) and 76(c) contain images o f capsules after addition o f salt 
solution. It can clearly be seen that the capsules collapsed after salt addition. This 
collapse confirms the integrity o f  capsules; that is, if  the capsules were ruptured, they 
would be unaffected by the large osmotic forces exerted by the salt solution. 
Approximately 70% o f the capsules collapsed, while the rest remained intact, suggesting 
that the latter were ruptured.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 8 9
a. b. c.
Figure 76. “Salt test” for confirmation o f integrity o f {PAH /PSSjs + {PAH-FITC 
/PSS}3 capsules
This study demonstrated that though PMMA proves to be an alternative to MF, 
much work still needs to be done in order to improve the overall yield o f capsules. Other 
organic solvents such as toluene can also dissolve PMMA, however, they are difficult to 
handle when compared with acetone. For future work, choices o f alternative solvents for 
PMMA may be considered. Recently, the use o f alternative templates that can be simply 
and inexpensively mass—produced in the lab, and which can be dissolved using acid or 
non-acid solvents producing a high yield o f microcapsules, has been demonstrated44,176.
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APPENDIX C
CHEMICALS
Polyelectrolvtes. buffers and microspheres
• FDD A (Cat number: 40,903-0, Sigma)
• PSS (Cat number: 43,457-4, Sigma)
• PVS (Cat number: 27,196-9, Sigma)
• PAH (Cat number: 283215, Sigma)
• Chitosan (448869, Sigma)
• PEI (P-3143, Sigma)
Enzymes /amino acids
• Glucose Oxidase (G-2133, Sigma)
• Peroxidase (P-8250, Sigma)
Dyes
• FITC (F7250, Sigma)
• TRITC (T-490, Molecular Probes)
• HPTS (M0535, Marker Gene Technologies) 
Other chemicals
• O-dianisidine (D-3252, Sigma)
• Glucose (G5250, Sigma)
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• PBS buffer (Cat number: 79382, Fluka)
• Sodium bicarbonate bu£fer(S-8875, Sigma)
• Acrylic acid (Cat number: 147230)
• Ammonium Persulfate (A9164, Sigma)
• Pyrogallol (P0381, Sigma)
• EDC (03450, Fluka)
• NHS (56485, Fluka)
• DMF - N,N-Dimethylformamide (DMF) (D4551, Sigma)
• Hydrogen Peroxide (349887, Sigma)
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APPENDIX D
EQUIPMENT/MATERIALS
1. Scanning fluorescence spectrometer (QMI, Photon Technology International)
2. UV-Vis spectrophotometer (Perkin Elmer, Lambda 45)
3. Scanning Probe Microscope (Atomic Force Microscope Quesant, Model 250)
4. Zeta potential- Zeta Potential Analyzer (Zeta Plus, Brookhaven Instruments 
Corp.)
5. Gel-filtration columns (Amersham Pharmacia Biotech PD-10 desalting column)
6. pH-meter (Thermo Orion, Model A -210)
7. Sonicator (Branson, 1510)
8. Micro cover glass for imaging with confocal and FRAP experiments (VWR 
Scientific, Cat number: 48395 252
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APPENDIX E
MATLAB PROGRAM FOR DETERMINATION OF 
DIFFUSION COEFFICIENTS USING
FRAP PROCEDURE
%removes stored information about variables 
clear all 
close all
%These parameters must be properly identified for file to function 
%properly. Make sure the current directory contains the files to be 
%imported
%Make sure that the first 2 time/fluorescence data points reflect 
%the pre-bleach lapse
%These are the ONLY parameters that need to be adjusted
m olecularjw eight-160kDa';
%file_name:=(['matlab input for pss pah 70 diffusion studies 3 19 04']);
file_name=(['mcdar81ine3']);
sheet_name=([’mcdar81ine3']);
capsule_structure-MF-(PSS/PVS)_2+(PSS/PAH)_2!;
% Data importing commands 
a=xlsread(file_name,sheet_name);
%defines the intensity values before and after
%bleaching
Iprebleach=a(2,2);
Ipostbleach=a(3,2);
%Put fluorescence recovery data in fractional form 
f_fractionai_form=(a( 1: end,2)-a(3,2))/(a(end,2)-a(3,2));
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%Since data contains info about prebleach,
%that data is ignored, by defining time t=0
%as the first recovery point with the corresponding%intensity value. 
trecovery=a(3 :end, 1 )-a(3,1); 
ffecovery=f_fractional_form(3: end, 1); 
processed_time_and_recov_data=[trecovery,frecovery];
%Calculation of k 
syms ratio;
Ipre=num2str(Iprebleach);
Ipost=num2str(Ipostbleach); 
ratio=[Ipost'/' Ipre -exp(-k)']; 
x=solve(ratio,'k'); 
k_calc-eval(x( 1));
%FRAP model from Blonk et. a ll
%Note: model_parm(l)=k 
% model_parm(2)=tau
k_guess=5;
tau_guess=50;
modelparmO=[k_guess,tau_guess];
t=trecovery';
N=50;
n=[0:N];
%LSQ curve fitting using a calsulated k value, then fitting tau
f_string=['sum( ( ( ( - '  num2str(k_calc) ').A (transpose^' num2str(n) '])*ones(l,' 
num2str(length(frecovery)) ')) )./ (transpose(factorialarray([' num2str(n) ']))*ones(l,'
num2str(length(frecovery))')) * l./(l+(transpose([' num2str(n) '])*one$(l,' 
num2str(length(frecovery)) ')).*(l+2*(ones((' num2str(N) '+1), 1 )*t)/tau_k_calc) ) ) ) '] ;  
f=inline(f_string,'tau_k_calcVt');
[tau_k_calc,resid] = lsqcurvefit(f,tau_guess,trecovery’,frecovery'); 
model_k_calc=eval(f_string);
%LSQ curve fitting tau first, then fitting for k
f_string-['sum( ( ( (-' num2str(k_guess) ').A (transpose([' num2str(n) ’])*ones(l,' 
num2str(length(frecovery)) ’))) ./ (transpose(factorialarray([’ num2str(n) ']))*ones(l,' 
num2str(length(frecovery)) ')) * l./(l+(transpose([' num2str(n) '])*ones(l,' 
num2str(length(frecovery)) ')).*(l+2*(ones((' num2str(N) '+ l),l)* t)/tau )) )) ']; 
f=inline(f_string,'tauVt');
[tau,resid] = lsqcurvefit(f,tau_guess,trecovery',frecovery');
f_string=['sum( ( ( (-k).A (transpose([' num2str(n) '])*ones(l,' 
num2str(length(frecovery)) ')) )./ (transpose(factorialarray(['num2str(n) ']))*ones(l,’
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 9 5
num2str(length(frecovery))')) * 1 „/(l+(transpose([' num2str(n) '])*ones(l,' 
num2str(length(frecovery)) ')).*(l+2*(ones((' num2str(N) '+ l),l)* t)/ ’ num2str(tau)' ) ) )
)’];
f=inline(f_string,'kVt');
[k,resid] = lsqcurvefit(f,k_guess,trecovery',frecovery'); 
model 1 =e val(f_string);
%LSQ curve fitting using for k anf tau simultaneously
f_string=['sum( ( ( (-model_parm( 1)).A (transpose([' num2str(n) '])*ones(l,' 
num2str(length(frecovery))')))./ (transpose(factorialarray([! num2str(n) ']))*ones(l,' 
num2str(length(frecovery)) ')) * l./(l+(transpose([’num2str(n) '])*ones(l,' 
num2str(length(frecovery)) ')).*(l+2*(ones((' num2str(N) '+1), 1 )*t)/model_parm(2)) ) ) 
)’];
f=inline(f_string,'model_parmVt’);
[model_parm,resid] = lsqcurvefit(f,modelparmO,trecovery',frecovery'); 
model2=eval(f_string);
%delete first recovery point, since it is 0
mpe_model0=mean(abs(ffecovery(2: end)-model_k_calc(2: end)')./fr eco very(2: end))* 100; 
m pem odel 1 =mean(abs(ffecovery(2: end)-model 1 (2: end)')./frecovery(2: end))* 100; 
mpe_model2=mean(abs(ffecovery(2:end)-model2(2:end)')./frecovery(2:end))*100;
%solving for diffusion coefficient 
%w_squared was wxperimentally determined 
w_squared=!(.0000557)A2;
D0==w_squared/(4*tau_k_calc);
D 1 =w_squared/ (4*tau);
D2=w_squared/(4*model_parm(2));
%spreadsheet information
[file_type, sheet_names]=xlsfinfo(file_name);
%plotting analysis 
textplace_x=. 1 *max(trecovery); 
textplace_ymain=. 6*max(model 1); 
textplace_ysub=.45 *max(model 1); 
textplace_ysub2=. 3 *max(model 1); 
textplace_ysub3=. 15*max(model 1);
figure(l)
subplot(2,l,l)
plotO jm odelJ^calc/rg’jtjmodelljTj'jtjmodelS,'--r',trecovery,frecovery, !k’s'LineWidth',2) 
title([capsule_structure,', FITC-GOx Mw=', molecular w eight,' (', sheet_name,')' ])
xlabel(Time (sec)')
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ylabel(Tluorescence Intensity (A.U.)')
legend((['ModelO Output (tau)']),(['Modell Output (tau then k)']),([’Mode!2 Output 
(simul)’]) , 'Exp. Data’,4)
legend('boxoff)
text(textplace_x,textplace_ymain,['M_0: {\tau}JD-,num2str(tau_k_calc),'s; 
D=',num2str(DQ),'cmA2/s ',K -,num 2str(k_calc )]) 
text(textplace_x,textplace_ysub,['M__l: {\tau}_D=',num2str(tau),'s;
D=',num2str(D 1 ),'cmA2/s ',K -',num 2str(k )])
text(textplace_x,textplace_ysub2,['M_2: {\tau}_D-,num2str(model_parm(2)),'s; 
D=',num2str(D2),'cmA2/s’,K=',num 2str(m odel_parm (2))]) 
text(textplace_x,textplace_ysub3,['MPE_0-,num2str(mpe_model0),';
MPE l =',num2str(mpe_model 1 ) , MPE_2-',num2str(mpe_model2)])
subplot(2,l,2)
p!ot(a(l :end,l),a(l:end,2), ’kVLinewidth',2) 
title([TJnprocessed FRAP Data']) 
xlabel('Time (sec)') 
ylabel('Fluorescence Intensity (A.U.)')
legend('Unprocessed Data',0) 
legend('boxoff)
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